HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 07DEC21:22:31:4507DEC21:22:31:45 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS IS SASDATA 9.4 Linux 07DEC21:22:31:4507DEC21:22:31:45 Immunogenicity Specimen Assessment HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002200000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier ISSEQ Sequence Number ISGRPID Group ID ( ISREFID Reference ID 6ISTESTCDImmunogenicity Test/Exam Short Name BISTEST Immunogenicity Test or Examination Name H ISTSTDTLMeasurement, Test or Examination Detail Z ISCAT Category for Immunogenicity Test [ ISORRES Results or Findings in Original Units c ISORRESUOriginal Units f ISSTRESCResult or Finding in Standard Format hISSPEC Specimen Type kISMETHODMethod of Test or Examination pISBLFL Baseline Flag ISLLOQ Lower Limit of Quantitation VISITNUMVisit Number VISIT Visit Name EPOCH Epoch  ISDTC Date/Time of Collection ISDY Study Day of Visit/Collection/Exam HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001ISC4591001 1005 10051317J,IMMUNOGENICITYNA0039413979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1005 10051317J,IMMUNOGENICITYNA0042416953C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-15B9C4591001ISC4591001 1005 10051317J,IMMUNOGENICITYNA0044562554C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-06BC4591001ISC4591001 1005 10051317J,IMMUNOGENICITYNA0042424190C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-17ByC4591001ISC4591001 1005 10051328J,IMMUNOGENICITYNA0039409568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1005 10051328J,IMMUNOGENICITYNA0042416832C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-11B5C4591001ISC4591001 1005 10051328J,IMMUNOGENICITYNA0043383965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-10BC4591001ISC4591001 1005 10051328J,IMMUNOGENICITYNA0042357780C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-15BwC4591001ISC4591001 1005 10051339J,IMMUNOGENICITYNA0039414014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1005 10051339J,IMMUNOGENICITYNA0042416962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B2C4591001ISC4591001 1005 10051339J,IMMUNOGENICITYNA0041774059C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-10BC4591001ISC4591001 1005 10051410J,IMMUNOGENICITYNA0042358176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1005 10051410J,IMMUNOGENICITYNA0041758458C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1005 10051410J,IMMUNOGENICITYNA0043382830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1005 10051412J,IMMUNOGENICITYNA0042416738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1005 10051412J,IMMUNOGENICITYNA0041758345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B:C4591001ISC4591001 1005 10051412J,IMMUNOGENICITYNA0044722141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1005 10051413J,IMMUNOGENICITYNA0042416715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1005 10051413J,IMMUNOGENICITYNA0041758578C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1005 10051413J,IMMUNOGENICITYNA0043360733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1005 10051414J,IMMUNOGENICITYNA0041579201C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1005 10051414J,IMMUNOGENICITYNA0041758590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1005 10051414J,IMMUNOGENICITYNA0041772896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1005 10051415J,IMMUNOGENICITYNA0041579380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1005 10051415J,IMMUNOGENICITYNA0041758588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1005 10051415J,IMMUNOGENICITYNA0043340187C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1005 10051417J,IMMUNOGENICITYNA0042416743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1005 10051417J,IMMUNOGENICITYNA0043257978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1005 10051417J,IMMUNOGENICITYNA0044646443C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1005 10051418J,IMMUNOGENICITYNA0042416744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1005 10051418J,IMMUNOGENICITYNA0043257980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1005 10051418J,IMMUNOGENICITYNA0044722156C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1005 10051419J,IMMUNOGENICITYNA0042416729C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1005 10051419J,IMMUNOGENICITYNA0041758602C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1005 10051419J,IMMUNOGENICITYNA0041758318C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-24BGC4591001ISC4591001 1005 10051420J,IMMUNOGENICITYNA0042416707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1005 10051420J,IMMUNOGENICITYNA0041758591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1005 10051420J,IMMUNOGENICITYNA0043340167C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1005 10051421J,IMMUNOGENICITYNA0042417062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1005 10051421J,IMMUNOGENICITYNA0042424151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1005 10051421J,IMMUNOGENICITYNA0043383953C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1005 10051422J,IMMUNOGENICITYNA0042417057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1005 10051422J,IMMUNOGENICITYNA0042424155C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1005 10051422J,IMMUNOGENICITYNA0043384180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1005 10051424J,IMMUNOGENICITYNA0042417059C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1005 10051424J,IMMUNOGENICITYNA0042424164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1005 10051424J,IMMUNOGENICITYNA0044723938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1005 10051425J,IMMUNOGENICITYNA0042416730C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1005 10051425J,IMMUNOGENICITYNA0041758362C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B6C4591001ISC4591001 1005 10051425J,IMMUNOGENICITYNA0044646451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1005 10051427J,IMMUNOGENICITYNA0042417076C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1005 10051427J,IMMUNOGENICITYNA0041758346C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1005 10051427J,IMMUNOGENICITYNA0043384186C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1005 10051428J,IMMUNOGENICITYNA0042417049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1005 10051428J,IMMUNOGENICITYNA0043257984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1005 10051428J,IMMUNOGENICITYNA0044723921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1005 10051429J,IMMUNOGENICITYNA0042417052C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1005 10051429J,IMMUNOGENICITYNA0042357777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1005 10051429J,IMMUNOGENICITYNA0044722158C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1005 10051430J,IMMUNOGENICITYNA0043238928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051430J,IMMUNOGENICITYNA0041758364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051430J,IMMUNOGENICITYNA0041773725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-22BzC4591001ISC4591001 1005 10051431J,IMMUNOGENICITYNA0043238923C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051431J,IMMUNOGENICITYNA0041758354C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051431J,IMMUNOGENICITYNA0049355558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1005 10051436J,IMMUNOGENICITYNA0043238945C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051436J,IMMUNOGENICITYNA0042424159C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1005 10051436J,IMMUNOGENICITYNA0044646436C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1005 10051437J,IMMUNOGENICITYNA0042416727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051437J,IMMUNOGENICITYNA0042424145C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1005 10051437J,IMMUNOGENICITYNA0043343872C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1005 10051438J,IMMUNOGENICITYNA0042416742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051438J,IMMUNOGENICITYNA0042424152C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1005 10051438J,IMMUNOGENICITYNA0043343851C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1005 10051439J,IMMUNOGENICITYNA0043238936C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051439J,IMMUNOGENICITYNA0041758339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051439J,IMMUNOGENICITYNA0044646425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1005 10051440J,IMMUNOGENICITYNA0043238959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051440J,IMMUNOGENICITYNA0041758348C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051440J,IMMUNOGENICITYNA0043383970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1005 10051441J,IMMUNOGENICITYNA0043238389C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051441J,IMMUNOGENICITYNA0043257982C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1005 10051441J,IMMUNOGENICITYNA0044646279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1005 10051444J,IMMUNOGENICITYNA0043238364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051444J,IMMUNOGENICITYNA0041758352C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051444J,IMMUNOGENICITYNA0043340163C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1005 10051445J,IMMUNOGENICITYNA0043238343C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1005 10051445J,IMMUNOGENICITYNA0041758361C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1005 10051445J,IMMUNOGENICITYNA0043340186C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1005 10051447J,IMMUNOGENICITYNA0043238733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1005 10051447J,IMMUNOGENICITYNA0042358300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1005 10051447J,IMMUNOGENICITYNA0049355550C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1005 10051448J,IMMUNOGENICITYNA0043238349C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1005 10051448J,IMMUNOGENICITYNA0041757899C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1005 10051448J,IMMUNOGENICITYNA0043340146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1005 10051449J,IMMUNOGENICITYNA0043238745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1005 10051449J,IMMUNOGENICITYNA0041757905C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1005 10051449J,IMMUNOGENICITYNA0043344179C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1005 10051450J,IMMUNOGENICITYNA0043238735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1005 10051450J,IMMUNOGENICITYNA0041757918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1005 10051450J,IMMUNOGENICITYNA0043340185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1005 10051451J,IMMUNOGENICITYNA0043238737C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1005 10051451J,IMMUNOGENICITYNA0041773866C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B3C4591001ISC4591001 1005 10051451J,IMMUNOGENICITYNA0043339978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-09BC4591001ISC4591001 1006 10061183J,IMMUNOGENICITYNA0038257630C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1006 10061183J,IMMUNOGENICITYNA0042372209C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09BHC4591001ISC4591001 1006 10061183J,IMMUNOGENICITYNA0044646129C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1006 10061183J,IMMUNOGENICITYNA0043398203C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BmC4591001ISC4591001 1006 10061184J,IMMUNOGENICITYNA0042440999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1006 10061184J,IMMUNOGENICITYNA0042436504C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B6C4591001ISC4591001 1006 10061184J,IMMUNOGENICITYNA0042509024C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1006 10061184J,IMMUNOGENICITYNA0034746140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BC4591001ISC4591001 1006 10061188J,IMMUNOGENICITYNA0042441025C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1006 10061188J,IMMUNOGENICITYNA0042371930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1006 10061188J,IMMUNOGENICITYNA0044645958C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061188J,IMMUNOGENICITYNA0043286908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BlC4591001ISC4591001 1006 10061189J,IMMUNOGENICITYNA0038257965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1006 10061189J,IMMUNOGENICITYNA0042436493C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1006 10061189J,IMMUNOGENICITYNA0042508673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1006 10061189J,IMMUNOGENICITYNA0042443307C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BlC4591001ISC4591001 1006 10061190J,IMMUNOGENICITYNA0038257876C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1006 10061190J,IMMUNOGENICITYNA0042371905C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1006 10061190J,IMMUNOGENICITYNA0042509010C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1006 10061190J,IMMUNOGENICITYNA0043300446C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BkC4591001ISC4591001 1006 10061191J,IMMUNOGENICITYNA0038257919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1006 10061191J,IMMUNOGENICITYNA0042371902C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1006 10061191J,IMMUNOGENICITYNA0041602624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1006 10061191J,IMMUNOGENICITYNA0042366544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BbC4591001ISC4591001 1006 10061196J,IMMUNOGENICITYNA0044646135C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .BCOVID_A1 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1006 10061196J,IMMUNOGENICITYNA0038257935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1006 10061196J,IMMUNOGENICITYNA0042436516C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1006 10061196J,IMMUNOGENICITYNA0043289017C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BlC4591001ISC4591001 1006 10061200J,IMMUNOGENICITYNA0038257644C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1006 10061200J,IMMUNOGENICITYNA0042371891C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B9C4591001ISC4591001 1006 10061200J,IMMUNOGENICITYNA0043397721C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-16BhC4591001ISC4591001 1006 10061201J,IMMUNOGENICITYNA0038257880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1006 10061201J,IMMUNOGENICITYNA0042442133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B9C4591001ISC4591001 1006 10061201J,IMMUNOGENICITYNA0044640211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1006 10061203J,IMMUNOGENICITYNA0034736269C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1006 10061203J,IMMUNOGENICITYNA0042371914C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B0C4591001ISC4591001 1006 10061203J,IMMUNOGENICITYNA0041602614C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1006 10061203J,IMMUNOGENICITYNA0043288987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BhC4591001ISC4591001 1006 10061206J,IMMUNOGENICITYNA0038257987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061206J,IMMUNOGENICITYNA0042436492C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1006 10061207J,IMMUNOGENICITYNA0038257679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061207J,IMMUNOGENICITYNA0042436497C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1006 10061209J,IMMUNOGENICITYNA0038257730C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061209J,IMMUNOGENICITYNA0043289008C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B6C4591001ISC4591001 1006 10061209J,IMMUNOGENICITYNA0042508672C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1006 10061209J,IMMUNOGENICITYNA0042371889C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BcC4591001ISC4591001 1006 10061212J,IMMUNOGENICITYNA0038257658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061212J,IMMUNOGENICITYNA0042436501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1006 10061212J,IMMUNOGENICITYNA0043287458C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061212J,IMMUNOGENICITYNA0038257706C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BcC4591001ISC4591001 1006 10061213J,IMMUNOGENICITYNA0038257687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061213J,IMMUNOGENICITYNA0043282672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1006 10061213J,IMMUNOGENICITYNA0042508819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1006 10061213J,IMMUNOGENICITYNA0042443302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BcC4591001ISC4591001 1006 10061214J,IMMUNOGENICITYNA0038257992C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1006 10061214J,IMMUNOGENICITYNA0042436523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1006 10061214J,IMMUNOGENICITYNA0044646134C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061214J,IMMUNOGENICITYNA0043397684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BbC4591001ISC4591001 1006 10061219J,IMMUNOGENICITYNA0038257577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061219J,IMMUNOGENICITYNA0043283007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1006 10061219J,IMMUNOGENICITYNA0034746139C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BsC4591001ISC4591001 1006 10061220J,IMMUNOGENICITYNA0034736396C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061220J,IMMUNOGENICITYNA0042443329C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B6C4591001ISC4591001 1006 10061220J,IMMUNOGENICITYNA0042508809C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1006 10061221J,IMMUNOGENICITYNA0040704993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061221J,IMMUNOGENICITYNA0043289019C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B6C4591001ISC4591001 1006 10061221J,IMMUNOGENICITYNA0040705017C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1006 10061221J,IMMUNOGENICITYNA0038258005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BgC4591001ISC4591001 1006 10061223J,IMMUNOGENICITYNA0040704989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061223J,IMMUNOGENICITYNA0043308458C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B:C4591001ISC4591001 1006 10061223J,IMMUNOGENICITYNA0044646068C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1006 10061223J,IMMUNOGENICITYNA0034745505C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BkC4591001ISC4591001 1006 10061224J,IMMUNOGENICITYNA0040705028C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061224J,IMMUNOGENICITYNA0042371951C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B6C4591001ISC4591001 1006 10061224J,IMMUNOGENICITYNA0041628213C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1006 10061224J,IMMUNOGENICITYNA0034746121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BsC4591001ISC4591001 1006 10061226J,IMMUNOGENICITYNA0040702854C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061226J,IMMUNOGENICITYNA0043282741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1006 10061226J,IMMUNOGENICITYNA0044645999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061226J,IMMUNOGENICITYNA0042366800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BeC4591001ISC4591001 1006 10061227J,IMMUNOGENICITYNA0040704998C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1006 10061227J,IMMUNOGENICITYNA0043289021C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1006 10061227J,IMMUNOGENICITYNA0042508828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1006 10061227J,IMMUNOGENICITYNA0043398192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BeC4591001ISC4591001 1006 10061228J,IMMUNOGENICITYNA0040705014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061228J,IMMUNOGENICITYNA0042443316C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1006 10061228J,IMMUNOGENICITYNA0044645976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061228J,IMMUNOGENICITYNA0042442134C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BdC4591001ISC4591001 1006 10061229J,IMMUNOGENICITYNA0040702863C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061229J,IMMUNOGENICITYNA0042372214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B8C4591001ISC4591001 1006 10061229J,IMMUNOGENICITYNA0043300433C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-18BIC4591001ISC4591001 1006 10061230J,IMMUNOGENICITYNA0040702853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061230J,IMMUNOGENICITYNA0043308434C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B9C4591001ISC4591001 1006 10061230J,IMMUNOGENICITYNA0049613044C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1006 10061231J,IMMUNOGENICITYNA0038257707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061231J,IMMUNOGENICITYNA0043288985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1006 10061231J,IMMUNOGENICITYNA0042508829C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1006 10061231J,IMMUNOGENICITYNA0042372201C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BdC4591001ISC4591001 1006 10061232J,IMMUNOGENICITYNA0040702840C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061232J,IMMUNOGENICITYNA0043282644C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1006 10061232J,IMMUNOGENICITYNA0044646016C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061232J,IMMUNOGENICITYNA0042366823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BbC4591001ISC4591001 1006 10061233J,IMMUNOGENICITYNA0040704984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1006 10061233J,IMMUNOGENICITYNA0042443131C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1006 10061233J,IMMUNOGENICITYNA0044646009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061233J,IMMUNOGENICITYNA0042366824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BbC4591001ISC4591001 1006 10061234J,IMMUNOGENICITYNA0040702866C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061234J,IMMUNOGENICITYNA0043282740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1006 10061234J,IMMUNOGENICITYNA0038257722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1006 10061234J,IMMUNOGENICITYNA0042443306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BdC4591001ISC4591001 1006 10061235J,IMMUNOGENICITYNA0038257678C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061235J,IMMUNOGENICITYNA0043288979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1006 10061235J,IMMUNOGENICITYNA0044646010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1006 10061235J,IMMUNOGENICITYNA0042365189C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BdC4591001ISC4591001 1006 10061236J,IMMUNOGENICITYNA0040702864C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061236J,IMMUNOGENICITYNA0043288257C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1006 10061236J,IMMUNOGENICITYNA0042508703C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1006 10061236J,IMMUNOGENICITYNA0042366561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BcC4591001ISC4591001 1006 10061237J,IMMUNOGENICITYNA0038257584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061237J,IMMUNOGENICITYNA0043288254C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1006 10061237J,IMMUNOGENICITYNA0044645967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061237J,IMMUNOGENICITYNA0042365217C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BaC4591001ISC4591001 1006 10061239J,IMMUNOGENICITYNA0038257626C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061239J,IMMUNOGENICITYNA0043282781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1006 10061239J,IMMUNOGENICITYNA0044645939C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1006 10061239J,IMMUNOGENICITYNA0043398182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BcC4591001ISC4591001 1006 10061241J,IMMUNOGENICITYNA0038257690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061241J,IMMUNOGENICITYNA0043283020C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1006 10061241J,IMMUNOGENICITYNA0042509002C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1006 10061241J,IMMUNOGENICITYNA0034745462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BlC4591001ISC4591001 1006 10061242J,IMMUNOGENICITYNA0038257688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1006 10061242J,IMMUNOGENICITYNA0043282742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B4C4591001ISC4591001 1006 10061242J,IMMUNOGENICITYNA0044640168C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1006 10061242J,IMMUNOGENICITYNA0034746128C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1006 10061243J,IMMUNOGENICITYNA0038257995C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1006 10061243J,IMMUNOGENICITYNA0043288990C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B0C4591001ISC4591001 1006 10061243J,IMMUNOGENICITYNA0049613064C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1006 10061243J,IMMUNOGENICITYNA0043300408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BdC4591001ISC4591001 1006 10061244J,IMMUNOGENICITYNA0038257708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1006 10061244J,IMMUNOGENICITYNA0043263108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B0C4591001ISC4591001 1006 10061244J,IMMUNOGENICITYNA0043307083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1006 10061244J,IMMUNOGENICITYNA0038257986C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BgC4591001ISC4591001 1006 10061245J,IMMUNOGENICITYNA0038257598C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1006 10061245J,IMMUNOGENICITYNA0043288993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B0C4591001ISC4591001 1006 10061245J,IMMUNOGENICITYNA0044645955C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061245J,IMMUNOGENICITYNA0042443135C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BgC4591001ISC4591001 1006 10061247J,IMMUNOGENICITYNA0038257613C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1006 10061247J,IMMUNOGENICITYNA0044646202C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061247J,IMMUNOGENICITYNA0042443137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BcC4591001ISC4591001 1006 10061248J,IMMUNOGENICITYNA0038257909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061248J,IMMUNOGENICITYNA0042371974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1006 10061248J,IMMUNOGENICITYNA0044645959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1006 10061249J,IMMUNOGENICITYNA0042442117C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061249J,IMMUNOGENICITYNA0043308428C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B8C4591001ISC4591001 1006 10061249J,IMMUNOGENICITYNA0049613077C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1006 10061249J,IMMUNOGENICITYNA0043287303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1006 10061250J,IMMUNOGENICITYNA0042443129C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061250J,IMMUNOGENICITYNA0043308462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B8C4591001ISC4591001 1006 10061250J,IMMUNOGENICITYNA0044646014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1006 10061250J,IMMUNOGENICITYNA0038257736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1006 10061252J,IMMUNOGENICITYNA0042442809C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061252J,IMMUNOGENICITYNA0043288982C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B1C4591001ISC4591001 1006 10061252J,IMMUNOGENICITYNA0049613051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1006 10061252J,IMMUNOGENICITYNA0034745494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BjC4591001ISC4591001 1006 10061253J,IMMUNOGENICITYNA0042442099C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061253J,IMMUNOGENICITYNA0042371942C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B5C4591001ISC4591001 1006 10061253J,IMMUNOGENICITYNA0044646175C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1006 10061253J,IMMUNOGENICITYNA0042443265C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1006 10061254J,IMMUNOGENICITYNA0042442771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061254J,IMMUNOGENICITYNA0044640186C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1006 10061254J,IMMUNOGENICITYNA0042443132C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1006 10061256J,IMMUNOGENICITYNA0042442094C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061256J,IMMUNOGENICITYNA0042372218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B5C4591001ISC4591001 1006 10061256J,IMMUNOGENICITYNA0042452369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1006 10061256J,IMMUNOGENICITYNA0043288227C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BgC4591001ISC4591001 1006 10061257J,IMMUNOGENICITYNA0042443289C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1006 10061257J,IMMUNOGENICITYNA0042442091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B1C4591001ISC4591001 1006 10061257J,IMMUNOGENICITYNA0043398208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-19BGC4591001ISC4591001 1006 10061258J,IMMUNOGENICITYNA0042443337C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061258J,IMMUNOGENICITYNA0043308801C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B9C4591001ISC4591001 1006 10061258J,IMMUNOGENICITYNA0041628219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1006 10061258J,IMMUNOGENICITYNA0042365199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BYC4591001ISC4591001 1006 10061259J,IMMUNOGENICITYNA0043288214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061259J,IMMUNOGENICITYNA0042371969C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1006 10061259J,IMMUNOGENICITYNA0043397690C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-19B`C4591001ISC4591001 1006 10061260J,IMMUNOGENICITYNA0043288765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061260J,IMMUNOGENICITYNA0042371972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1006 10061260J,IMMUNOGENICITYNA0044646213C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1006 10061260J,IMMUNOGENICITYNA0042443335C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B`C4591001ISC4591001 1006 10061261J,IMMUNOGENICITYNA0043288243C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061261J,IMMUNOGENICITYNA0042372192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1006 10061261J,IMMUNOGENICITYNA0041628250C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1006 10061261J,IMMUNOGENICITYNA0042443324C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B`C4591001ISC4591001 1006 10061262J,IMMUNOGENICITYNA0043288752C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061262J,IMMUNOGENICITYNA0043308444C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B:C4591001ISC4591001 1006 10061262J,IMMUNOGENICITYNA0043308741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1006 10061263J,IMMUNOGENICITYNA0043288738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061263J,IMMUNOGENICITYNA0043308456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B6C4591001ISC4591001 1006 10061263J,IMMUNOGENICITYNA0044640184C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1006 10061263J,IMMUNOGENICITYNA0042443332C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B^C4591001ISC4591001 1006 10061264J,IMMUNOGENICITYNA0043288225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1006 10061264J,IMMUNOGENICITYNA0043308457C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1006 10061264J,IMMUNOGENICITYNA0044640174C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1006 10061264J,IMMUNOGENICITYNA0043397682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B_C4591001ISC4591001 1006 10061265J,IMMUNOGENICITYNA0043288776C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1006 10061265J,IMMUNOGENICITYNA0043308809C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B1C4591001ISC4591001 1006 10061265J,IMMUNOGENICITYNA0034746117C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BcC4591001ISC4591001 1006 10061266J,IMMUNOGENICITYNA0043288739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1006 10061266J,IMMUNOGENICITYNA0042442783C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B:C4591001ISC4591001 1006 10061267J,IMMUNOGENICITYNA0043288222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1006 10061267J,IMMUNOGENICITYNA0043286910C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19BCC4591001ISC4591001 1006 10061267J,IMMUNOGENICITYNA0043307081C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-21BC4591001ISC4591001 1006 10061267J,IMMUNOGENICITYNA0042442132C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BXC4591001ISC4591001 1006 10061269J,IMMUNOGENICITYNA0043288211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1006 10061269J,IMMUNOGENICITYNA0049613050C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1006 10061269J,IMMUNOGENICITYNA0034745490C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BdC4591001ISC4591001 1006 10061270J,IMMUNOGENICITYNA0043288743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1006 10061270J,IMMUNOGENICITYNA0043308461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1006 10061270J,IMMUNOGENICITYNA0043287330C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-18BAC4591001ISC4591001 1006 10061271J,IMMUNOGENICITYNA0043288577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1006 10061271J,IMMUNOGENICITYNA0043308449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1006 10061271J,IMMUNOGENICITYNA0044640199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1006 10061271J,IMMUNOGENICITYNA0034745479C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BcC4591001ISC4591001 1006 10061272J,IMMUNOGENICITYNA0043288245C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1006 10061272J,IMMUNOGENICITYNA0043287007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1006 10061272J,IMMUNOGENICITYNA0044640171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1006 10061273J,IMMUNOGENICITYNA0043288919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1006 10061273J,IMMUNOGENICITYNA0043287009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B4C4591001ISC4591001 1006 10061273J,IMMUNOGENICITYNA0044646027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061273J,IMMUNOGENICITYNA0034745521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BbC4591001ISC4591001 1006 10061274J,IMMUNOGENICITYNA0043288552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1006 10061274J,IMMUNOGENICITYNA0043286995C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B4C4591001ISC4591001 1006 10061274J,IMMUNOGENICITYNA0042508640C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1006 10061274J,IMMUNOGENICITYNA0042443338C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BZC4591001ISC4591001 1006 10061276J,IMMUNOGENICITYNA0043288926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1006 10061276J,IMMUNOGENICITYNA0042372176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1006 10061276J,IMMUNOGENICITYNA0044645934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1006 10061276J,IMMUNOGENICITYNA0042443297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B[C4591001ISC4591001 1006 10061277J,IMMUNOGENICITYNA0043288927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1006 10061277J,IMMUNOGENICITYNA0042372210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1006 10061277J,IMMUNOGENICITYNA0043308733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1006 10061278J,IMMUNOGENICITYNA0043263101C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1006 10061278J,IMMUNOGENICITYNA0042508648C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1006 10061278J,IMMUNOGENICITYNA0043263097C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BYC4591001ISC4591001 1006 10061279J,IMMUNOGENICITYNA0043261455C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1006 10061279J,IMMUNOGENICITYNA0043308827C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1006 10061279J,IMMUNOGENICITYNA0044646165C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1006 10061279J,IMMUNOGENICITYNA0043397683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B]C4591001ISC4591001 1006 10061280J,IMMUNOGENICITYNA0043288904C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1006 10061280J,IMMUNOGENICITYNA0038257981C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B8C4591001ISC4591001 1006 10061280J,IMMUNOGENICITYNA0049613122C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1006 10061280J,IMMUNOGENICITYNA0042371935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BYC4591001ISC4591001 1006 10061282J,IMMUNOGENICITYNA0043288551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1006 10061282J,IMMUNOGENICITYNA0042442108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1006 10061282J,IMMUNOGENICITYNA0041628207C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1006 10061282J,IMMUNOGENICITYNA0043397728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BUC4591001ISC4591001 1006 10061283J,IMMUNOGENICITYNA0043283001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1006 10061283J,IMMUNOGENICITYNA0043308440C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1006 10061283J,IMMUNOGENICITYNA0034746249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1006 10061283J,IMMUNOGENICITYNA0042365197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BSC4591001ISC4591001 1006 10061284J,IMMUNOGENICITYNA0043282991C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1006 10061284J,IMMUNOGENICITYNA0043282656C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1006 10061284J,IMMUNOGENICITYNA0044645952C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1006 10061284J,IMMUNOGENICITYNA0034746235C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BcC4591001ISC4591001 1006 10061285J,IMMUNOGENICITYNA0040781065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1006 10061285J,IMMUNOGENICITYNA0043286888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B:C4591001ISC4591001 1006 10061285J,IMMUNOGENICITYNA0034746122C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26B`C4591001ISC4591001 1006 10061286J,IMMUNOGENICITYNA0040781088C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1006 10061286J,IMMUNOGENICITYNA0042372195C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B3C4591001ISC4591001 1006 10061286J,IMMUNOGENICITYNA0042508612C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1006 10061286J,IMMUNOGENICITYNA0043398198C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BYC4591001ISC4591001 1006 10061287J,IMMUNOGENICITYNA0040781095C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1006 10061287J,IMMUNOGENICITYNA0043286984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1006 10061287J,IMMUNOGENICITYNA0034746224C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BcC4591001ISC4591001 1006 10061288J,IMMUNOGENICITYNA0043288558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1006 10061288J,IMMUNOGENICITYNA0043308421C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1006 10061288J,IMMUNOGENICITYNA0043308747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1006 10061289J,IMMUNOGENICITYNA0040781090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061289J,IMMUNOGENICITYNA0043287300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1006 10061289J,IMMUNOGENICITYNA0044645993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1006 10061289J,IMMUNOGENICITYNA0034745444C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BbC4591001ISC4591001 1006 10061290J,IMMUNOGENICITYNA0040781079C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061290J,IMMUNOGENICITYNA0043287345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1006 10061290J,IMMUNOGENICITYNA0041628220C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1006 10061290J,IMMUNOGENICITYNA0034746211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BbC4591001ISC4591001 1006 10061291J,IMMUNOGENICITYNA0040781091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061291J,IMMUNOGENICITYNA0043300420C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1006 10061291J,IMMUNOGENICITYNA0034745488C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1006 10061291J,IMMUNOGENICITYNA0034746568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BbC4591001ISC4591001 1006 10061292J,IMMUNOGENICITYNA0043282999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061292J,IMMUNOGENICITYNA0043308811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1006 10061292J,IMMUNOGENICITYNA0044645944C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061292J,IMMUNOGENICITYNA0034745461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24B]C4591001ISC4591001 1006 10061293J,IMMUNOGENICITYNA0043288580C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061293J,IMMUNOGENICITYNA0043286980C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1006 10061293J,IMMUNOGENICITYNA0042452399C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1006 10061293J,IMMUNOGENICITYNA0034745481C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24B]C4591001ISC4591001 1006 10061294J,IMMUNOGENICITYNA0040781075C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1006 10061294J,IMMUNOGENICITYNA0042372203C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1006 10061294J,IMMUNOGENICITYNA0044646178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1006 10061294J,IMMUNOGENICITYNA0034745509C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23B\C4591001ISC4591001 1006 10061295J,IMMUNOGENICITYNA0043462677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1006 10061295J,IMMUNOGENICITYNA0043286978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B1C4591001ISC4591001 1006 10061295J,IMMUNOGENICITYNA0044646062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1006 10061295J,IMMUNOGENICITYNA0034745464C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24B[C4591001ISC4591001 1006 10061296J,IMMUNOGENICITYNA0043462672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1006 10061296J,IMMUNOGENICITYNA0043286878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1006 10061296J,IMMUNOGENICITYNA0034746679C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BWC4591001ISC4591001 1006 10061297J,IMMUNOGENICITYNA0043462658C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1006 10061297J,IMMUNOGENICITYNA0043300411C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1006 10061297J,IMMUNOGENICITYNA0034745485C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BWC4591001ISC4591001 1006 10061298J,IMMUNOGENICITYNA0040781078C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1006 10061298J,IMMUNOGENICITYNA0043287339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1006 10061298J,IMMUNOGENICITYNA0044646065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1006 10061298J,IMMUNOGENICITYNA0034746155C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BVC4591001ISC4591001 1006 10061299J,IMMUNOGENICITYNA0043467132C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1006 10061299J,IMMUNOGENICITYNA0043397712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B8C4591001ISC4591001 1006 10061299J,IMMUNOGENICITYNA0042508643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1006 10061299J,IMMUNOGENICITYNA0034745513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BSC4591001ISC4591001 1006 10061300J,IMMUNOGENICITYNA0043263065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1006 10061300J,IMMUNOGENICITYNA0042366552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1006 10061300J,IMMUNOGENICITYNA0051271492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1006 10061300J,IMMUNOGENICITYNA0043263066C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BAC4591001ISC4591001 1007 10071409J,IMMUNOGENICITYNA0033068092C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071409J,IMMUNOGENICITYNA0034753943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-15B7C4591001ISC4591001 1007 10071409J,IMMUNOGENICITYNA0044620080C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-10BC4591001ISC4591001 1007 10071414J,IMMUNOGENICITYNA0033070060C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071414J,IMMUNOGENICITYNA0034754288C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B2C4591001ISC4591001 1007 10071414J,IMMUNOGENICITYNA0045191161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-06BC4591001ISC4591001 1007 10071414J,IMMUNOGENICITYNA0045190904C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1007 10071414J,IMMUNOGENICITYNA0043505196C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BC4591001ISC4591001 1007 10071415J,IMMUNOGENICITYNA0033068063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071415J,IMMUNOGENICITYNA0043293035C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-07BNC4591001ISC4591001 1007 10071415J,IMMUNOGENICITYNA0045225803C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-07BC4591001ISC4591001 1007 10071415J,IMMUNOGENICITYNA0044558689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BC4591001ISC4591001 1007 10071417J,IMMUNOGENICITYNA0033096870C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071417J,IMMUNOGENICITYNA0034754217C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B2C4591001ISC4591001 1007 10071417J,IMMUNOGENICITYNA0045190983C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-06BC4591001ISC4591001 1007 10071428J,IMMUNOGENICITYNA0040707232C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071428J,IMMUNOGENICITYNA0034754177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B6C4591001ISC4591001 1007 10071428J,IMMUNOGENICITYNA0045190962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-10BC4591001ISC4591001 1007 10071429J,IMMUNOGENICITYNA0038320398C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1007 10071429J,IMMUNOGENICITYNA0034753951C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B2C4591001ISC4591001 1007 10071429J,IMMUNOGENICITYNA0042381800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-10BC4591001ISC4591001 1007 10071467J,IMMUNOGENICITYNA0033097009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071467J,IMMUNOGENICITYNA0043504622C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071467J,IMMUNOGENICITYNA0045225828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1007 10071469J,IMMUNOGENICITYNA0033097059C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071469J,IMMUNOGENICITYNA0043505252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B4C4591001ISC4591001 1007 10071469J,IMMUNOGENICITYNA0045225892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071471J,IMMUNOGENICITYNA0038320295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071471J,IMMUNOGENICITYNA0043505164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071471J,IMMUNOGENICITYNA0041739027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1007 10071472J,IMMUNOGENICITYNA0038320046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071472J,IMMUNOGENICITYNA0043505235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071472J,IMMUNOGENICITYNA0045190946C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071472J,IMMUNOGENICITYNA0044559358C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BmC4591001ISC4591001 1007 10071475J,IMMUNOGENICITYNA0033097082C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071475J,IMMUNOGENICITYNA0043505174C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071475J,IMMUNOGENICITYNA0045225886C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1007 10071476J,IMMUNOGENICITYNA0040683298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071476J,IMMUNOGENICITYNA0041758660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B4C4591001ISC4591001 1007 10071476J,IMMUNOGENICITYNA0041739913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1007 10071478J,IMMUNOGENICITYNA0040707348C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071478J,IMMUNOGENICITYNA0043505169C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071478J,IMMUNOGENICITYNA0042385003C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1007 10071480J,IMMUNOGENICITYNA0033076964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1007 10071480J,IMMUNOGENICITYNA0041758639C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1007 10071480J,IMMUNOGENICITYNA0045191176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071481J,IMMUNOGENICITYNA0034754475C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071481J,IMMUNOGENICITYNA0041758648C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1007 10071481J,IMMUNOGENICITYNA0041738998C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-07BC4591001ISC4591001 1007 10071482J,IMMUNOGENICITYNA0034754477C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071482J,IMMUNOGENICITYNA0043505197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1007 10071482J,IMMUNOGENICITYNA0041707012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1007 10071483J,IMMUNOGENICITYNA0034771314C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071483J,IMMUNOGENICITYNA0041765753C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B9C4591001ISC4591001 1007 10071483J,IMMUNOGENICITYNA0041766666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-30BxC4591001ISC4591001 1007 10071484J,IMMUNOGENICITYNA0034754470C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071484J,IMMUNOGENICITYNA0041768359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B9C4591001ISC4591001 1007 10071484J,IMMUNOGENICITYNA0045190910C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1007 10071484J,IMMUNOGENICITYNA0041766665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BkC4591001ISC4591001 1007 10071485J,IMMUNOGENICITYNA0034754585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071485J,IMMUNOGENICITYNA0043505192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1007 10071485J,IMMUNOGENICITYNA0045225152C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1007 10071488J,IMMUNOGENICITYNA0034771353C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071488J,IMMUNOGENICITYNA0043399451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1007 10071488J,IMMUNOGENICITYNA0045225820C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1007 10071490J,IMMUNOGENICITYNA0034754476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071490J,IMMUNOGENICITYNA0043505167C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1007 10071490J,IMMUNOGENICITYNA0045225830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1007 10071492J,IMMUNOGENICITYNA0034754503C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1007 10071492J,IMMUNOGENICITYNA0041758647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1007 10071492J,IMMUNOGENICITYNA0045226031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1007 10071492J,IMMUNOGENICITYNA0044558669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BcC4591001ISC4591001 1007 10071494J,IMMUNOGENICITYNA0034771317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1007 10071494J,IMMUNOGENICITYNA0043505242C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1007 10071494J,IMMUNOGENICITYNA0045225786C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071494J,IMMUNOGENICITYNA0041766651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BjC4591001ISC4591001 1007 10071495J,IMMUNOGENICITYNA0034771312C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1007 10071495J,IMMUNOGENICITYNA0043399436C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1007 10071495J,IMMUNOGENICITYNA0041739921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1007 10071495J,IMMUNOGENICITYNA0041766039C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BaC4591001ISC4591001 1007 10071496J,IMMUNOGENICITYNA0034754484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1007 10071496J,IMMUNOGENICITYNA0043399416C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1007 10071496J,IMMUNOGENICITYNA0041739906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1007 10071496J,IMMUNOGENICITYNA0042381730C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BjC4591001ISC4591001 1007 10071497J,IMMUNOGENICITYNA0034771342C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1007 10071497J,IMMUNOGENICITYNA0043399412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1007 10071497J,IMMUNOGENICITYNA0049582395C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1007 10071497J,IMMUNOGENICITYNA0041768291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BjC4591001ISC4591001 1007 10071499J,IMMUNOGENICITYNA0034754405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1007 10071499J,IMMUNOGENICITYNA0043399414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B1C4591001ISC4591001 1007 10071499J,IMMUNOGENICITYNA0045225491C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1007 10071499J,IMMUNOGENICITYNA0042381959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BjC4591001ISC4591001 1007 10071500J,IMMUNOGENICITYNA0034754247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1007 10071500J,IMMUNOGENICITYNA0043505286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B2C4591001ISC4591001 1007 10071500J,IMMUNOGENICITYNA0045225122C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071504J,IMMUNOGENICITYNA0034754469C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071504J,IMMUNOGENICITYNA0041765385C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1007 10071504J,IMMUNOGENICITYNA0045225141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1007 10071505J,IMMUNOGENICITYNA0034754480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071505J,IMMUNOGENICITYNA0041739930C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1007 10071506J,IMMUNOGENICITYNA0034754294C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071506J,IMMUNOGENICITYNA0041765721C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1007 10071506J,IMMUNOGENICITYNA0045225827C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071507J,IMMUNOGENICITYNA0034754577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071507J,IMMUNOGENICITYNA0041768318C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1007 10071507J,IMMUNOGENICITYNA0042381412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1007 10071507J,IMMUNOGENICITYNA0044559482C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BcC4591001ISC4591001 1007 10071508J,IMMUNOGENICITYNA0034754370C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071508J,IMMUNOGENICITYNA0041765740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1007 10071508J,IMMUNOGENICITYNA0045225143C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071509J,IMMUNOGENICITYNA0034754473C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071509J,IMMUNOGENICITYNA0041768315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1007 10071509J,IMMUNOGENICITYNA0045191030C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1007 10071511J,IMMUNOGENICITYNA0034754570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071511J,IMMUNOGENICITYNA0041768350C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1007 10071511J,IMMUNOGENICITYNA0042381769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071511J,IMMUNOGENICITYNA0041765842C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B^C4591001ISC4591001 1007 10071512J,IMMUNOGENICITYNA0034754603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071512J,IMMUNOGENICITYNA0041768354C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1007 10071512J,IMMUNOGENICITYNA0045225702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071514J,IMMUNOGENICITYNA0034754222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1007 10071514J,IMMUNOGENICITYNA0041768427C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1007 10071514J,IMMUNOGENICITYNA0045225124C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1007 10071515J,IMMUNOGENICITYNA0034754197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071515J,IMMUNOGENICITYNA0041765395C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071515J,IMMUNOGENICITYNA0045225464C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1007 10071516J,IMMUNOGENICITYNA0034754308C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071516J,IMMUNOGENICITYNA0041765766C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071516J,IMMUNOGENICITYNA0042381847C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071517J,IMMUNOGENICITYNA0034753952C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071517J,IMMUNOGENICITYNA0041765654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071517J,IMMUNOGENICITYNA0045225696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071518J,IMMUNOGENICITYNA0034754274C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071518J,IMMUNOGENICITYNA0041768351C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071518J,IMMUNOGENICITYNA0041706973C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1007 10071519J,IMMUNOGENICITYNA0034754134C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071519J,IMMUNOGENICITYNA0041768445C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1007 10071519J,IMMUNOGENICITYNA0044613975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-31BrC4591001ISC4591001 1007 10071519J,IMMUNOGENICITYNA0044559498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B]C4591001ISC4591001 1007 10071520J,IMMUNOGENICITYNA0034754212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071520J,IMMUNOGENICITYNA0041768454C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1007 10071520J,IMMUNOGENICITYNA0045225910C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-09BC4591001ISC4591001 1007 10071520J,IMMUNOGENICITYNA0041766016C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B]C4591001ISC4591001 1007 10071521J,IMMUNOGENICITYNA0034754562C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071521J,IMMUNOGENICITYNA0041768435C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1007 10071521J,IMMUNOGENICITYNA0045225909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071522J,IMMUNOGENICITYNA0034754364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071522J,IMMUNOGENICITYNA0041765343C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1007 10071522J,IMMUNOGENICITYNA0041739909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1007 10071523J,IMMUNOGENICITYNA0034754153C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071523J,IMMUNOGENICITYNA0041765223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071523J,IMMUNOGENICITYNA0045225131C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071524J,IMMUNOGENICITYNA0034754594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071524J,IMMUNOGENICITYNA0041765381C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B:C4591001ISC4591001 1007 10071524J,IMMUNOGENICITYNA0042381740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-25BPC4591001ISC4591001 1007 10071525J,IMMUNOGENICITYNA0034754187C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071525J,IMMUNOGENICITYNA0041765214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B:C4591001ISC4591001 1007 10071525J,IMMUNOGENICITYNA0045225709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1007 10071526J,IMMUNOGENICITYNA0034754165C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071526J,IMMUNOGENICITYNA0041765410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071526J,IMMUNOGENICITYNA0045225127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071527J,IMMUNOGENICITYNA0034754252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1007 10071527J,IMMUNOGENICITYNA0041765402C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1007 10071527J,IMMUNOGENICITYNA0041739914C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1007 10071528J,IMMUNOGENICITYNA0034754193C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071528J,IMMUNOGENICITYNA0041765378C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071528J,IMMUNOGENICITYNA0045225486C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1007 10071529J,IMMUNOGENICITYNA0034754300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071529J,IMMUNOGENICITYNA0041768343C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071529J,IMMUNOGENICITYNA0041708369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1007 10071529J,IMMUNOGENICITYNA0041766652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BcC4591001ISC4591001 1007 10071530J,IMMUNOGENICITYNA0034754067C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071530J,IMMUNOGENICITYNA0041765403C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071530J,IMMUNOGENICITYNA0045225149C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071531J,IMMUNOGENICITYNA0034754070C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071531J,IMMUNOGENICITYNA0041765426C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071531J,IMMUNOGENICITYNA0041739645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1007 10071533J,IMMUNOGENICITYNA0034754315C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071533J,IMMUNOGENICITYNA0041768424C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071533J,IMMUNOGENICITYNA0041739935C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1007 10071535J,IMMUNOGENICITYNA0034754075C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071535J,IMMUNOGENICITYNA0041768322C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071535J,IMMUNOGENICITYNA0042381416C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1007 10071536J,IMMUNOGENICITYNA0034754225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071536J,IMMUNOGENICITYNA0041768431C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B1C4591001ISC4591001 1007 10071536J,IMMUNOGENICITYNA0041739186C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1007 10071536J,IMMUNOGENICITYNA0041765040C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B[C4591001ISC4591001 1007 10071537J,IMMUNOGENICITYNA0034754275C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071537J,IMMUNOGENICITYNA0041768453C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071537J,IMMUNOGENICITYNA0045225806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1007 10071539J,IMMUNOGENICITYNA0034754031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071539J,IMMUNOGENICITYNA0041765733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071539J,IMMUNOGENICITYNA0041739612C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1007 10071540J,IMMUNOGENICITYNA0034754037C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071540J,IMMUNOGENICITYNA0041768423C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071540J,IMMUNOGENICITYNA0041739012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1007 10071541J,IMMUNOGENICITYNA0034754593C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071541J,IMMUNOGENICITYNA0041765755C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1007 10071541J,IMMUNOGENICITYNA0043371837C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-09B?C4591001ISC4591001 1007 10071542J,IMMUNOGENICITYNA0034754556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071542J,IMMUNOGENICITYNA0041765384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1007 10071542J,IMMUNOGENICITYNA0045225140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1007 10071542J,IMMUNOGENICITYNA0044613888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BdC4591001ISC4591001 1007 10071543J,IMMUNOGENICITYNA0034754208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071543J,IMMUNOGENICITYNA0041768312C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071544J,IMMUNOGENICITYNA0034754486C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1007 10071544J,IMMUNOGENICITYNA0041765745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1007 10071544J,IMMUNOGENICITYNA0041656507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1007 10071546J,IMMUNOGENICITYNA0034754147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071546J,IMMUNOGENICITYNA0041768328C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1007 10071546J,IMMUNOGENICITYNA0045225129C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1007 10071547J,IMMUNOGENICITYNA0034754579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071547J,IMMUNOGENICITYNA0041765735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1007 10071547J,IMMUNOGENICITYNA0042379900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1007 10071550J,IMMUNOGENICITYNA0033070268C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071550J,IMMUNOGENICITYNA0041768425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1007 10071550J,IMMUNOGENICITYNA0045226064C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1007 10071551J,IMMUNOGENICITYNA0034754073C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071551J,IMMUNOGENICITYNA0041765390C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1007 10071551J,IMMUNOGENICITYNA0041739912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1007 10071552J,IMMUNOGENICITYNA0034754127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071552J,IMMUNOGENICITYNA0041768316C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1007 10071552J,IMMUNOGENICITYNA0041739919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1007 10071554J,IMMUNOGENICITYNA0033096780C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071554J,IMMUNOGENICITYNA0041765396C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1007 10071554J,IMMUNOGENICITYNA0045226045C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1007 10071555J,IMMUNOGENICITYNA0034753971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1007 10071555J,IMMUNOGENICITYNA0041768452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B0C4591001ISC4591001 1007 10071555J,IMMUNOGENICITYNA0045225121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1007 10071555J,IMMUNOGENICITYNA0044558715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BYC4591001ISC4591001 1007 10071557J,IMMUNOGENICITYNA0034754072C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071557J,IMMUNOGENICITYNA0041768362C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B5C4591001ISC4591001 1007 10071557J,IMMUNOGENICITYNA0044613970C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B_C4591001ISC4591001 1007 10071558J,IMMUNOGENICITYNA0034754557C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071558J,IMMUNOGENICITYNA0041765635C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1007 10071558J,IMMUNOGENICITYNA0045226054C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1007 10071559J,IMMUNOGENICITYNA0034754057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071559J,IMMUNOGENICITYNA0043371841C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B9C4591001ISC4591001 1007 10071559J,IMMUNOGENICITYNA0041739017C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1007 10071560J,IMMUNOGENICITYNA0034754154C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071560J,IMMUNOGENICITYNA0041765659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1007 10071560J,IMMUNOGENICITYNA0044614007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071560J,IMMUNOGENICITYNA0042381817C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B]C4591001ISC4591001 1007 10071561J,IMMUNOGENICITYNA0034754257C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071561J,IMMUNOGENICITYNA0041765399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1007 10071561J,IMMUNOGENICITYNA0045225451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1007 10071562J,IMMUNOGENICITYNA0034754069C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071562J,IMMUNOGENICITYNA0041768324C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1007 10071562J,IMMUNOGENICITYNA0045191154C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071562J,IMMUNOGENICITYNA0041766667C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BUC4591001ISC4591001 1007 10071563J,IMMUNOGENICITYNA0034753979C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071563J,IMMUNOGENICITYNA0041768438C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1007 10071563J,IMMUNOGENICITYNA0041768294C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071563J,IMMUNOGENICITYNA0041765831C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BUC4591001ISC4591001 1007 10071564J,IMMUNOGENICITYNA0034754290C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071564J,IMMUNOGENICITYNA0043371802C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B9C4591001ISC4591001 1007 10071564J,IMMUNOGENICITYNA0041656515C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071565J,IMMUNOGENICITYNA0040683280C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071565J,IMMUNOGENICITYNA0043371793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B9C4591001ISC4591001 1007 10071565J,IMMUNOGENICITYNA0041656521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071566J,IMMUNOGENICITYNA0034754063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1007 10071566J,IMMUNOGENICITYNA0041765863C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BVC4591001ISC4591001 1007 10071567J,IMMUNOGENICITYNA0034754042C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071567J,IMMUNOGENICITYNA0041765347C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1007 10071567J,IMMUNOGENICITYNA0041708383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1007 10071568J,IMMUNOGENICITYBP90WX C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071568J,IMMUNOGENICITYNA0041765359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1007 10071568J,IMMUNOGENICITYNA0041739021C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1007 10071569J,IMMUNOGENICITYBP90X1 C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071569J,IMMUNOGENICITYNA0041765360C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1007 10071569J,IMMUNOGENICITYNA0041739633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1007 10071569J,IMMUNOGENICITYNA0044558676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B]C4591001ISC4591001 1007 10071570J,IMMUNOGENICITYBP90X3 C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071570J,IMMUNOGENICITYNA0041768369C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1007 10071570J,IMMUNOGENICITYNA0041739201C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1007 10071570J,IMMUNOGENICITYNA0042381723C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B]C4591001ISC4591001 1007 10071571J,IMMUNOGENICITYBP90X7 C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071571J,IMMUNOGENICITYNA0041765218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1007 10071571J,IMMUNOGENICITYNA0041706994C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071571J,IMMUNOGENICITYNA0041766645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B]C4591001ISC4591001 1007 10071572J,IMMUNOGENICITYBP90XB C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071572J,IMMUNOGENICITYNA0041765338C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1007 10071572J,IMMUNOGENICITYNA0041707004C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1007 10071573J,IMMUNOGENICITYBP90XF C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1007 10071573J,IMMUNOGENICITYNA0041765628C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1007 10071573J,IMMUNOGENICITYNA0041708386C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071574J,IMMUNOGENICITYBP90XK C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071574J,IMMUNOGENICITYNA0041765367C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1007 10071574J,IMMUNOGENICITYNA0041708378C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1007 10071574J,IMMUNOGENICITYNA0042381734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT REPEAT SCREENING 1 2021-03-17B\C4591001ISC4591001 1007 10071575J,IMMUNOGENICITYNA0043271991C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071575J,IMMUNOGENICITYNA0041765351C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1007 10071575J,IMMUNOGENICITYNA0041656508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071576J,IMMUNOGENICITYNA0043305745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071576J,IMMUNOGENICITYNA0041765210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1007 10071576J,IMMUNOGENICITYNA0045191235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-12BC4591001ISC4591001 1007 10071577J,IMMUNOGENICITYNA0043305127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071577J,IMMUNOGENICITYNA0041765400C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1007 10071577J,IMMUNOGENICITYNA0044620063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-19B}C4591001ISC4591001 1007 10071578J,IMMUNOGENICITYNA0043305137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071578J,IMMUNOGENICITYNA0041765625C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1007 10071578J,IMMUNOGENICITYNA0041739656C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1007 10071579J,IMMUNOGENICITYNA0043305771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071579J,IMMUNOGENICITYNA0043371842C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1007 10071579J,IMMUNOGENICITYNA0041656500C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1007 10071579J,IMMUNOGENICITYNA0041764836C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B[C4591001ISC4591001 1007 10071580J,IMMUNOGENICITYNA0043305115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1007 10071580J,IMMUNOGENICITYNA0041765207C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1007 10071580J,IMMUNOGENICITYNA0041656482C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1007 10071581J,IMMUNOGENICITYNA0043271997C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071581J,IMMUNOGENICITYNA0041765666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071581J,IMMUNOGENICITYNA0041739620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1007 10071581J,IMMUNOGENICITYNA0042381788C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B\C4591001ISC4591001 1007 10071582J,IMMUNOGENICITYNA0043305769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071582J,IMMUNOGENICITYNA0041768404C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071582J,IMMUNOGENICITYNA0043505291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B\C4591001ISC4591001 1007 10071583J,IMMUNOGENICITYNA0043305151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071583J,IMMUNOGENICITYNA0041765671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071583J,IMMUNOGENICITYNA0042377940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071584J,IMMUNOGENICITYNA0043305130C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071584J,IMMUNOGENICITYNA0041765424C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071584J,IMMUNOGENICITYNA0041707002C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1007 10071585J,IMMUNOGENICITYNA0043271989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071585J,IMMUNOGENICITYNA0041768384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071585J,IMMUNOGENICITYNA0045190982C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071585J,IMMUNOGENICITYNA0042381814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B\C4591001ISC4591001 1007 10071586J,IMMUNOGENICITYNA0043272016C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071586J,IMMUNOGENICITYNA0041765337C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071586J,IMMUNOGENICITYNA0041739941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1007 10071587J,IMMUNOGENICITYNA0043305121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1007 10071587J,IMMUNOGENICITYNA0041768370C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1007 10071587J,IMMUNOGENICITYNA0041656513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1007 10071588J,IMMUNOGENICITYNA0043293031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071588J,IMMUNOGENICITYNA0043371805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071588J,IMMUNOGENICITYNA0041708381C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071589J,IMMUNOGENICITYNA0043318583C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071589J,IMMUNOGENICITYNA0041765238C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071589J,IMMUNOGENICITYNA0042381854C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071590J,IMMUNOGENICITYNA0043293046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071590J,IMMUNOGENICITYNA0043371881C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071590J,IMMUNOGENICITYNA0041708215C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071591J,IMMUNOGENICITYNA0043318528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071591J,IMMUNOGENICITYNA0043305618C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B:C4591001ISC4591001 1007 10071591J,IMMUNOGENICITYNA0041739204C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1007 10071592J,IMMUNOGENICITYNA0043317668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071592J,IMMUNOGENICITYNA0043399422C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B;C4591001ISC4591001 1007 10071592J,IMMUNOGENICITYNA0041708196C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1007 10071593J,IMMUNOGENICITYNA0043318570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071594J,IMMUNOGENICITYNA0043318579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071594J,IMMUNOGENICITYNA0043305632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1007 10071594J,IMMUNOGENICITYNA0041706828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071595J,IMMUNOGENICITYNA0043279170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071595J,IMMUNOGENICITYNA0041765631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071595J,IMMUNOGENICITYNA0045190987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071596J,IMMUNOGENICITYNA0043318564C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071596J,IMMUNOGENICITYNA0043371795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071596J,IMMUNOGENICITYNA0041739923C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1007 10071597J,IMMUNOGENICITYNA0043317637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071597J,IMMUNOGENICITYNA0042381774C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B:C4591001ISC4591001 1007 10071597J,IMMUNOGENICITYNA0041708457C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1007 10071599J,IMMUNOGENICITYNA0043318523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071599J,IMMUNOGENICITYNA0043371884C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071599J,IMMUNOGENICITYNA0041708387C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1007 10071600J,IMMUNOGENICITYNA0043317632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071600J,IMMUNOGENICITYNA0041765520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071601J,IMMUNOGENICITYNA0043279165C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071601J,IMMUNOGENICITYNA0041765176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-16BOC4591001ISC4591001 1007 10071601J,IMMUNOGENICITYNA0041707147C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1007 10071602J,IMMUNOGENICITYNA0043279164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1007 10071602J,IMMUNOGENICITYNA0043371853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1007 10071602J,IMMUNOGENICITYNA0041707155C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1007 10071603J,IMMUNOGENICITYNA0043318510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071603J,IMMUNOGENICITYNA0043399430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1007 10071603J,IMMUNOGENICITYNA0041708371C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1007 10071604J,IMMUNOGENICITYNA0043317456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071604J,IMMUNOGENICITYNA0041768382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1007 10071604J,IMMUNOGENICITYNA0041708180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071605J,IMMUNOGENICITYNA0043293024C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071605J,IMMUNOGENICITYNA0043371797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1007 10071605J,IMMUNOGENICITYNA0041706999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1007 10071606J,IMMUNOGENICITYNA0043279146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071606J,IMMUNOGENICITYNA0041765848C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04BBC4591001ISC4591001 1007 10071606J,IMMUNOGENICITYNA0041708412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071607J,IMMUNOGENICITYNA0043317673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071607J,IMMUNOGENICITYNA0042381765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B:C4591001ISC4591001 1007 10071607J,IMMUNOGENICITYNA0042380089C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071608J,IMMUNOGENICITYNA0043318574C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071608J,IMMUNOGENICITYNA0042381772C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B:C4591001ISC4591001 1007 10071608J,IMMUNOGENICITYNA0045191005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071609J,IMMUNOGENICITYNA0043318561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071609J,IMMUNOGENICITYNA0043317461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1007 10071609J,IMMUNOGENICITYNA0041708176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071610J,IMMUNOGENICITYNA0043293019C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071610J,IMMUNOGENICITYNA0041768373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1007 10071610J,IMMUNOGENICITYNA0041707141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1007 10071612J,IMMUNOGENICITYNA0043318535C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071612J,IMMUNOGENICITYNA0042381736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B;C4591001ISC4591001 1007 10071612J,IMMUNOGENICITYNA0041708174C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1007 10071613J,IMMUNOGENICITYNA0043317666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071613J,IMMUNOGENICITYNA0041765208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1007 10071613J,IMMUNOGENICITYNA0041739657C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1007 10071614J,IMMUNOGENICITYNA0043318553C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071614J,IMMUNOGENICITYNA0041768395C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1007 10071614J,IMMUNOGENICITYNA0042384996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1007 10071615J,IMMUNOGENICITYNA0043318581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071615J,IMMUNOGENICITYNA0043305646C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1007 10071615J,IMMUNOGENICITYNA0041708418C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1007 10071616J,IMMUNOGENICITYNA0043279178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071616J,IMMUNOGENICITYNA0043505210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1007 10071616J,IMMUNOGENICITYNA0041708442C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1007 10071617J,IMMUNOGENICITYNA0043317467C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071617J,IMMUNOGENICITYNA0043371827C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1007 10071617J,IMMUNOGENICITYNA0044620062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-19BpC4591001ISC4591001 1007 10071618J,IMMUNOGENICITYNA0043293012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1007 10071618J,IMMUNOGENICITYNA0042381709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B:C4591001ISC4591001 1007 10071618J,IMMUNOGENICITYNA0041708392C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1007 10071619J,IMMUNOGENICITYNA0043317659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071619J,IMMUNOGENICITYNA0042381779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1007 10071619J,IMMUNOGENICITYNA0041706986C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071620J,IMMUNOGENICITYNA0043279172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071620J,IMMUNOGENICITYNA0043505212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1007 10071620J,IMMUNOGENICITYNA0041708411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071621J,IMMUNOGENICITYNA0043293038C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071621J,IMMUNOGENICITYNA0043305759C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1007 10071621J,IMMUNOGENICITYNA0041708216C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071622J,IMMUNOGENICITYNA0043317462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071622J,IMMUNOGENICITYNA0041708388C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-14BC4591001ISC4591001 1007 10071623J,IMMUNOGENICITYNA0043317465C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071623J,IMMUNOGENICITYNA0042381944C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1007 10071624J,IMMUNOGENICITYNA0043279140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071624J,IMMUNOGENICITYNA0042381786C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B8C4591001ISC4591001 1007 10071624J,IMMUNOGENICITYNA0045191074C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1007 10071625J,IMMUNOGENICITYNA0043279173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071625J,IMMUNOGENICITYNA0042381793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B8C4591001ISC4591001 1007 10071625J,IMMUNOGENICITYNA0045191214C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1007 10071626J,IMMUNOGENICITYNA0043317676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071626J,IMMUNOGENICITYNA0041765526C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1007 10071626J,IMMUNOGENICITYNA0041707019C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1007 10071627J,IMMUNOGENICITYNA0043318536C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071627J,IMMUNOGENICITYNA0043371806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1007 10071627J,IMMUNOGENICITYNA0041708421C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1007 10071628J,IMMUNOGENICITYNA0043279185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071628J,IMMUNOGENICITYNA0042381707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1007 10071628J,IMMUNOGENICITYNA0041708294C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1007 10071629J,IMMUNOGENICITYNA0043318518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071629J,IMMUNOGENICITYNA0043371810C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1007 10071629J,IMMUNOGENICITYNA0041739009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1007 10071630J,IMMUNOGENICITYNA0043318287C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071630J,IMMUNOGENICITYNA0041765707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1007 10071630J,IMMUNOGENICITYNA0041739219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1007 10071631J,IMMUNOGENICITYNA0043293045C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071631J,IMMUNOGENICITYNA0042381738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B:C4591001ISC4591001 1007 10071631J,IMMUNOGENICITYNA0041706993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1007 10071632J,IMMUNOGENICITYNA0043293014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071632J,IMMUNOGENICITYNA0042381752C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1007 10071632J,IMMUNOGENICITYNA0045191143C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1007 10071633J,IMMUNOGENICITYNA0043317458C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1007 10071633J,IMMUNOGENICITYNA0042381790C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B8C4591001ISC4591001 1007 10071633J,IMMUNOGENICITYNA0041708193C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1007 10071634J,IMMUNOGENICITYNA0043318558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071634J,IMMUNOGENICITYNA0043305793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071634J,IMMUNOGENICITYNA0041708219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071635J,IMMUNOGENICITYNA0043305669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071635J,IMMUNOGENICITYNA0042381782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071636J,IMMUNOGENICITYNA0043317643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071636J,IMMUNOGENICITYNA0043305782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071636J,IMMUNOGENICITYNA0041708436C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071638J,IMMUNOGENICITYNA0043305784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071638J,IMMUNOGENICITYNA0041758665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1007 10071638J,IMMUNOGENICITYNA0041708177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1007 10071639J,IMMUNOGENICITYNA0043318559C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071639J,IMMUNOGENICITYNA0041766033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B9C4591001ISC4591001 1007 10071640J,IMMUNOGENICITYNA0043305654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071640J,IMMUNOGENICITYNA0044559374C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B:C4591001ISC4591001 1007 10071640J,IMMUNOGENICITYNA0041739915C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1007 10071641J,IMMUNOGENICITYNA0043317463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071641J,IMMUNOGENICITYNA0042381942C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1007 10071641J,IMMUNOGENICITYNA0041706829C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1007 10071642J,IMMUNOGENICITYNA0043305731C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071642J,IMMUNOGENICITYNA0041707001C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1007 10071643J,IMMUNOGENICITYNA0043305742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071643J,IMMUNOGENICITYNA0041739032C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1007 10071643J,IMMUNOGENICITYNA0041766043C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BCC4591001ISC4591001 1007 10071644J,IMMUNOGENICITYNA0043317633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071644J,IMMUNOGENICITYNA0041758630C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071644J,IMMUNOGENICITYNA0041708195C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071645J,IMMUNOGENICITYNA0043318522C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071645J,IMMUNOGENICITYNA0042381714C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071645J,IMMUNOGENICITYNA0041739619C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1007 10071646J,IMMUNOGENICITYNA0043305756C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071646J,IMMUNOGENICITYNA0042381683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1007 10071646J,IMMUNOGENICITYNA0041739191C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1007 10071647J,IMMUNOGENICITYNA0043317665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1007 10071647J,IMMUNOGENICITYNA0042381941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1007 10071647J,IMMUNOGENICITYNA0041708449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1007 10071648J,IMMUNOGENICITYNA0043305777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071648J,IMMUNOGENICITYNA0043305113C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1007 10071648J,IMMUNOGENICITYNA0044620096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-20BjC4591001ISC4591001 1007 10071649J,IMMUNOGENICITYNA0043318507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071649J,IMMUNOGENICITYNA0041765518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1007 10071649J,IMMUNOGENICITYNA0041706831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1007 10071650J,IMMUNOGENICITYNA0043305798C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071650J,IMMUNOGENICITYNA0042381704C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1007 10071650J,IMMUNOGENICITYNA0041739640C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1007 10071651J,IMMUNOGENICITYNA0043279161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071651J,IMMUNOGENICITYNA0041765517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1007 10071651J,IMMUNOGENICITYNA0041707119C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1007 10071652J,IMMUNOGENICITYNA0043305584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071652J,IMMUNOGENICITYNA0043305601C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1007 10071652J,IMMUNOGENICITYNA0041739653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1007 10071653J,IMMUNOGENICITYNA0043305139C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071653J,IMMUNOGENICITYNA0042381722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1007 10071653J,IMMUNOGENICITYNA0041706857C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1007 10071654J,IMMUNOGENICITYNA0043305785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1007 10071655J,IMMUNOGENICITYNA0043272007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1007 10071655J,IMMUNOGENICITYNA0042381964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1007 10071656J,IMMUNOGENICITYNA0043317652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1007 10071656J,IMMUNOGENICITYNA0044559347C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B8C4591001ISC4591001 1007 10071656J,IMMUNOGENICITYNA0041706977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1007 10071658J,IMMUNOGENICITYNA0043305815C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1007 10071658J,IMMUNOGENICITYNA0042381742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1007 10071658J,IMMUNOGENICITYNA0041765859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1007 10071659J,IMMUNOGENICITYNA0043305621C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1007 10071659J,IMMUNOGENICITYNA0043317638C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1007 10071659J,IMMUNOGENICITYNA0041708452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1007 10071660J,IMMUNOGENICITYNA0043317471C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1007 10071660J,IMMUNOGENICITYNA0043305807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1007 10071660J,IMMUNOGENICITYNA0045225729C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1007 10071661J,IMMUNOGENICITYNA0043504632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1007 10071661J,IMMUNOGENICITYNA0042381938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1007 10071661J,IMMUNOGENICITYNA0041705226C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1007 10071662J,IMMUNOGENICITYNA0043505234C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1007 10071662J,IMMUNOGENICITYNA0042381933C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1007 10071662J,IMMUNOGENICITYNA0041708292C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-12BC4591001ISC4591001 1008 10081751J,IMMUNOGENICITYNA0040764993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1008 10081751J,IMMUNOGENICITYNA0043271499C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B8C4591001ISC4591001 1008 10081751J,IMMUNOGENICITYNA0043395636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081751J,IMMUNOGENICITYNA0042433725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BqC4591001ISC4591001 1008 10081752J,IMMUNOGENICITYNA0040764984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1008 10081752J,IMMUNOGENICITYNA0040933475C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1008 10081752J,IMMUNOGENICITYNA0043395770C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081752J,IMMUNOGENICITYNA0043260930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BjC4591001ISC4591001 1008 10081753J,IMMUNOGENICITYNA0040764987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1008 10081753J,IMMUNOGENICITYNA0034635645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1008 10081753J,IMMUNOGENICITYNA0042465278C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1008 10081753J,IMMUNOGENICITYNA0043260910C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BjC4591001ISC4591001 1008 10081754J,IMMUNOGENICITYNA0040765951C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1008 10081754J,IMMUNOGENICITYNA0040933459C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B4C4591001ISC4591001 1008 10081754J,IMMUNOGENICITYNA0042465211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1008 10081755J,IMMUNOGENICITYNA0040765974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1008 10081755J,IMMUNOGENICITYNA0040933473C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B3C4591001ISC4591001 1008 10081755J,IMMUNOGENICITYNA0042465316C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1008 10081756J,IMMUNOGENICITYNA0040765937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1008 10081756J,IMMUNOGENICITYNA0034635677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1008 10081756J,IMMUNOGENICITYNA0042362700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-22BC4591001ISC4591001 1008 10081757J,IMMUNOGENICITYNA0040765966C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1008 10081757J,IMMUNOGENICITYNA0034635682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1008 10081757J,IMMUNOGENICITYNA0043395624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081757J,IMMUNOGENICITYNA0044645476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-09BC4591001ISC4591001 1008 10081758J,IMMUNOGENICITYNA0040765954C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1008 10081758J,IMMUNOGENICITYNA0034624954C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B7C4591001ISC4591001 1008 10081758J,IMMUNOGENICITYNA0042464850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1008 10081758J,IMMUNOGENICITYNA0043260540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BdC4591001ISC4591001 1008 10081760J,IMMUNOGENICITYNA0041717921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1008 10081760J,IMMUNOGENICITYNA0034628536C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1008 10081760J,IMMUNOGENICITYNA0042464883C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1008 10081760J,IMMUNOGENICITYNA0043261291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BcC4591001ISC4591001 1008 10081761J,IMMUNOGENICITYNA0041718256C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1008 10081761J,IMMUNOGENICITYNA0034628854C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B6C4591001ISC4591001 1008 10081761J,IMMUNOGENICITYNA0042374048C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-05BxC4591001ISC4591001 1008 10081763J,IMMUNOGENICITYNA0041718103C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1008 10081763J,IMMUNOGENICITYNA0034624936C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1008 10081763J,IMMUNOGENICITYNA0043395402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081763J,IMMUNOGENICITYNA0043261327C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12B`C4591001ISC4591001 1008 10081764J,IMMUNOGENICITYNA0041718065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1008 10081764J,IMMUNOGENICITYNA0034624960C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1008 10081764J,IMMUNOGENICITYNA0042464859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1008 10081764J,IMMUNOGENICITYNA0043261306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12B`C4591001ISC4591001 1008 10081767J,IMMUNOGENICITYNA0040765929C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1008 10081767J,IMMUNOGENICITYNA0034624975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1008 10081767J,IMMUNOGENICITYNA0043395515C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081767J,IMMUNOGENICITYNA0041717758C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BqC4591001ISC4591001 1008 10081768J,IMMUNOGENICITYNA0041718259C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1008 10081768J,IMMUNOGENICITYNA0034628825C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B5C4591001ISC4591001 1008 10081768J,IMMUNOGENICITYNA0042464882C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1008 10081768J,IMMUNOGENICITYNA0043261304C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12B_C4591001ISC4591001 1008 10081769J,IMMUNOGENICITYNA0041718291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1008 10081769J,IMMUNOGENICITYNA0040808464C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23BNC4591001ISC4591001 1008 10081769J,IMMUNOGENICITYNA0041741688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081770J,IMMUNOGENICITYNA0041717936C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1008 10081770J,IMMUNOGENICITYNA0034627609C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1008 10081770J,IMMUNOGENICITYNA0042464862C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1008 10081770J,IMMUNOGENICITYNA0043260542C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11B]C4591001ISC4591001 1008 10081771J,IMMUNOGENICITYNA0041717939C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1008 10081771J,IMMUNOGENICITYNA0034628542C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1008 10081771J,IMMUNOGENICITYNA0042464874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1008 10081771J,IMMUNOGENICITYNA0043260537C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11B]C4591001ISC4591001 1008 10081773J,IMMUNOGENICITYNA0041718010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1008 10081773J,IMMUNOGENICITYNA0034627593C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1008 10081773J,IMMUNOGENICITYNA0043395638C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081773J,IMMUNOGENICITYNA0033124297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24BNC4591001ISC4591001 1008 10081774J,IMMUNOGENICITYNA0041717933C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1008 10081774J,IMMUNOGENICITYNA0034628831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1008 10081774J,IMMUNOGENICITYNA0042464860C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1008 10081774J,IMMUNOGENICITYNA0043309115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BUC4591001ISC4591001 1008 10081775J,IMMUNOGENICITYNA0041718005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1008 10081775J,IMMUNOGENICITYNA0034628860C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1008 10081775J,IMMUNOGENICITYNA0043395400C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1008 10081775J,IMMUNOGENICITYNA0043309114C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BUC4591001ISC4591001 1008 10081777J,IMMUNOGENICITYNA0041717968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1008 10081777J,IMMUNOGENICITYNA0034627599C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1008 10081777J,IMMUNOGENICITYNA0042464849C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1008 10081777J,IMMUNOGENICITYNA0042441962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BcC4591001ISC4591001 1008 10081780J,IMMUNOGENICITYNA0041717976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1008 10081780J,IMMUNOGENICITYNA0034627585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1008 10081780J,IMMUNOGENICITYNA0043395588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081780J,IMMUNOGENICITYNA0043261309C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15B`C4591001ISC4591001 1008 10081781J,IMMUNOGENICITYNA0041717980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1008 10081781J,IMMUNOGENICITYNA0043395571C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B7C4591001ISC4591001 1008 10081781J,IMMUNOGENICITYNA0043395430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1008 10081781J,IMMUNOGENICITYNA0042434620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BcC4591001ISC4591001 1008 10081785J,IMMUNOGENICITYNA0041747208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1008 10081785J,IMMUNOGENICITYNA0043395007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1008 10081785J,IMMUNOGENICITYNA0042464851C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1008 10081785J,IMMUNOGENICITYNA0042433696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BfC4591001ISC4591001 1008 10081788J,IMMUNOGENICITYNA0041747226C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081788J,IMMUNOGENICITYNA0043395043C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1008 10081788J,IMMUNOGENICITYNA0043395735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081788J,IMMUNOGENICITYNA0043260546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BWC4591001ISC4591001 1008 10081789J,IMMUNOGENICITYNA0041747815C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081789J,IMMUNOGENICITYNA0034628469C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B5C4591001ISC4591001 1008 10081789J,IMMUNOGENICITYNA0042464941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081789J,IMMUNOGENICITYNA0043260907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15B\C4591001ISC4591001 1008 10081790J,IMMUNOGENICITYNA0041747200C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081790J,IMMUNOGENICITYNA0034628453C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1008 10081790J,IMMUNOGENICITYNA0043395731C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081790J,IMMUNOGENICITYNA0043260918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B]C4591001ISC4591001 1008 10081791J,IMMUNOGENICITYNA0041747807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081791J,IMMUNOGENICITYNA0043395560C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1008 10081791J,IMMUNOGENICITYNA0041741698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081791J,IMMUNOGENICITYNA0042367147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01BNC4591001ISC4591001 1008 10081792J,IMMUNOGENICITYNA0041756532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081792J,IMMUNOGENICITYNA0043395575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1008 10081792J,IMMUNOGENICITYNA0041741715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081792J,IMMUNOGENICITYNA0042367177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01BNC4591001ISC4591001 1008 10081793J,IMMUNOGENICITYNA0041756551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081793J,IMMUNOGENICITYNA0043395561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1008 10081793J,IMMUNOGENICITYNA0043395772C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081793J,IMMUNOGENICITYNA0042365527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26BKC4591001ISC4591001 1008 10081794J,IMMUNOGENICITYNA0041747795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1008 10081794J,IMMUNOGENICITYNA0043395555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1008 10081794J,IMMUNOGENICITYNA0043395760C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081794J,IMMUNOGENICITYNA0042365534C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26BKC4591001ISC4591001 1008 10081795J,IMMUNOGENICITYNA0041756508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1008 10081795J,IMMUNOGENICITYNA0034628484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B4C4591001ISC4591001 1008 10081795J,IMMUNOGENICITYNA0041741684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1008 10081795J,IMMUNOGENICITYNA0042434637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B]C4591001ISC4591001 1008 10081796J,IMMUNOGENICITYNA0041747816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1008 10081796J,IMMUNOGENICITYNA0034628452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1008 10081796J,IMMUNOGENICITYNA0043395528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081796J,IMMUNOGENICITYNA0042367598C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BVC4591001ISC4591001 1008 10081797J,IMMUNOGENICITYNA0041756518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1008 10081797J,IMMUNOGENICITYNA0034628539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1008 10081797J,IMMUNOGENICITYNA0041741717C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1008 10081797J,IMMUNOGENICITYNA0043309894C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BPC4591001ISC4591001 1008 10081798J,IMMUNOGENICITYNA0041747218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1008 10081798J,IMMUNOGENICITYNA0034628473C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1008 10081798J,IMMUNOGENICITYNA0043395676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081798J,IMMUNOGENICITYNA0042441971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B_C4591001ISC4591001 1008 10081799J,IMMUNOGENICITYNA0040597647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1008 10081799J,IMMUNOGENICITYNA0043395562C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1008 10081799J,IMMUNOGENICITYNA0041704701C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1008 10081799J,IMMUNOGENICITYNA0043309863C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BTC4591001ISC4591001 1008 10081800J,IMMUNOGENICITYNA0040597650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1008 10081800J,IMMUNOGENICITYNA0043395115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1008 10081800J,IMMUNOGENICITYNA0041741686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1008 10081801J,IMMUNOGENICITYNA0039412361C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081801J,IMMUNOGENICITYNA0034628591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1008 10081801J,IMMUNOGENICITYNA0043395596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081802J,IMMUNOGENICITYNA0039412368C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081802J,IMMUNOGENICITYNA0034628455C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1008 10081802J,IMMUNOGENICITYNA0042464885C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1008 10081803J,IMMUNOGENICITYNA0039412348C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081803J,IMMUNOGENICITYNA0034628447C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1008 10081803J,IMMUNOGENICITYNA0042442045C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-19B]C4591001ISC4591001 1008 10081804J,IMMUNOGENICITYNA0039412373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081804J,IMMUNOGENICITYNA0040808495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B9C4591001ISC4591001 1008 10081804J,IMMUNOGENICITYNA0043395742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081804J,IMMUNOGENICITYNA0042434643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B\C4591001ISC4591001 1008 10081805J,IMMUNOGENICITYNA0039412385C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081805J,IMMUNOGENICITYNA0034628600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1008 10081805J,IMMUNOGENICITYNA0042433719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BaC4591001ISC4591001 1008 10081806J,IMMUNOGENICITYNA0039412382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1008 10081806J,IMMUNOGENICITYNA0034628477C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1008 10081806J,IMMUNOGENICITYNA0042465033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1008 10081806J,IMMUNOGENICITYNA0042435142C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BaC4591001ISC4591001 1008 10081807J,IMMUNOGENICITYNA0040600457C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081807J,IMMUNOGENICITYNA0034628594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081807J,IMMUNOGENICITYNA0042357856C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081807J,IMMUNOGENICITYNA0043261285C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BXC4591001ISC4591001 1008 10081808J,IMMUNOGENICITYNA0033126621C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081808J,IMMUNOGENICITYNA0040808484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1008 10081808J,IMMUNOGENICITYNA0043395619C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081808J,IMMUNOGENICITYNA0042442892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BfC4591001ISC4591001 1008 10081809J,IMMUNOGENICITYNA0033126635C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081809J,IMMUNOGENICITYNA0040808600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B6C4591001ISC4591001 1008 10081809J,IMMUNOGENICITYNA0043395486C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081809J,IMMUNOGENICITYNA0042435140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BaC4591001ISC4591001 1008 10081810J,IMMUNOGENICITYNA0033126620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081810J,IMMUNOGENICITYNA0034628483C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081810J,IMMUNOGENICITYNA0041741681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081810J,IMMUNOGENICITYNA0042442885C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BfC4591001ISC4591001 1008 10081811J,IMMUNOGENICITYNA0033126655C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081811J,IMMUNOGENICITYNA0034628487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081811J,IMMUNOGENICITYNA0041741682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081812J,IMMUNOGENICITYNA0033126651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081812J,IMMUNOGENICITYNA0040808602C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1008 10081812J,IMMUNOGENICITYNA0043395491C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081812J,IMMUNOGENICITYNA0043260920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BYC4591001ISC4591001 1008 10081813J,IMMUNOGENICITYNA0040600484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081813J,IMMUNOGENICITYNA0034628612C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B5C4591001ISC4591001 1008 10081813J,IMMUNOGENICITYNA0041741679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1008 10081814J,IMMUNOGENICITYNA0040600495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081814J,IMMUNOGENICITYNA0034628467C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081814J,IMMUNOGENICITYNA0041741708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081814J,IMMUNOGENICITYNA0042377171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-29BC4591001ISC4591001 1008 10081815J,IMMUNOGENICITYNA0040600461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081815J,IMMUNOGENICITYNA0043271463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081815J,IMMUNOGENICITYNA0043395405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1008 10081815J,IMMUNOGENICITYNA0042441966C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B_C4591001ISC4591001 1008 10081816J,IMMUNOGENICITYNA0040600466C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081816J,IMMUNOGENICITYNA0043395539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081816J,IMMUNOGENICITYNA0041741680C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1008 10081816J,IMMUNOGENICITYNA0042433727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B_C4591001ISC4591001 1008 10081817J,IMMUNOGENICITYNA0040600482C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081817J,IMMUNOGENICITYNA0034628670C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1008 10081817J,IMMUNOGENICITYNA0043395653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081817J,IMMUNOGENICITYNA0042442049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B\C4591001ISC4591001 1008 10081818J,IMMUNOGENICITYNA0040600456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1008 10081818J,IMMUNOGENICITYNA0034627600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1008 10081818J,IMMUNOGENICITYNA0042464977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081818J,IMMUNOGENICITYNA0043260534C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BTC4591001ISC4591001 1008 10081819J,IMMUNOGENICITYNA0040600699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081819J,IMMUNOGENICITYNA0040808452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1008 10081819J,IMMUNOGENICITYNA0043395650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081819J,IMMUNOGENICITYNA0042433716C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B\C4591001ISC4591001 1008 10081820J,IMMUNOGENICITYNA0040600723C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081820J,IMMUNOGENICITYNA0040808625C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1008 10081820J,IMMUNOGENICITYNA0043395678C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1008 10081820J,IMMUNOGENICITYNA0043260544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BQC4591001ISC4591001 1008 10081821J,IMMUNOGENICITYNA0040600708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081821J,IMMUNOGENICITYNA0034628621C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1008 10081821J,IMMUNOGENICITYNA0042464970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1008 10081821J,IMMUNOGENICITYNA0043309881C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BNC4591001ISC4591001 1008 10081822J,IMMUNOGENICITYNA0033126653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081822J,IMMUNOGENICITYNA0040808606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1008 10081822J,IMMUNOGENICITYNA0043395661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081822J,IMMUNOGENICITYNA0044645652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-01BfC4591001ISC4591001 1008 10081823J,IMMUNOGENICITYNA0040597657C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081823J,IMMUNOGENICITYNA0034628674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1008 10081823J,IMMUNOGENICITYNA0041741677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1008 10081823J,IMMUNOGENICITYNA0043260928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BUC4591001ISC4591001 1008 10081824J,IMMUNOGENICITYNA0040597668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081824J,IMMUNOGENICITYNA0034628607C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1008 10081824J,IMMUNOGENICITYNA0042425194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1008 10081824J,IMMUNOGENICITYNA0043260935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BVC4591001ISC4591001 1008 10081825J,IMMUNOGENICITYNA0040597622C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081825J,IMMUNOGENICITYNA0040808487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B5C4591001ISC4591001 1008 10081825J,IMMUNOGENICITYNA0043395756C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081826J,IMMUNOGENICITYNA0040597624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081826J,IMMUNOGENICITYNA0034628673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1008 10081826J,IMMUNOGENICITYNA0042464967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081826J,IMMUNOGENICITYNA0042433697C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23B]C4591001ISC4591001 1008 10081827J,IMMUNOGENICITYNA0040600733C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081827J,IMMUNOGENICITYNA0040808461C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1008 10081827J,IMMUNOGENICITYNA0041741706C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1008 10081827J,IMMUNOGENICITYNA0042434618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BWC4591001ISC4591001 1008 10081828J,IMMUNOGENICITYNA0040600707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1008 10081828J,IMMUNOGENICITYNA0042365508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25BCC4591001ISC4591001 1008 10081828J,IMMUNOGENICITYNA0043395660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081829J,IMMUNOGENICITYNA0040600494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081829J,IMMUNOGENICITYNA0040808628C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1008 10081830J,IMMUNOGENICITYNA0040934103C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081830J,IMMUNOGENICITYNA0040808609C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1008 10081830J,IMMUNOGENICITYNA0043394972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081830J,IMMUNOGENICITYNA0043261299C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BQC4591001ISC4591001 1008 10081831J,IMMUNOGENICITYNA0040934116C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081831J,IMMUNOGENICITYNA0034628651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1008 10081831J,IMMUNOGENICITYNA0041741702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1008 10081832J,IMMUNOGENICITYNA0040637909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081832J,IMMUNOGENICITYNA0040808601C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1008 10081832J,IMMUNOGENICITYNA0043304248C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-20BC4591001ISC4591001 1008 10081832J,IMMUNOGENICITYNA0043260563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BOC4591001ISC4591001 1008 10081833J,IMMUNOGENICITYNA0040637925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081833J,IMMUNOGENICITYNA0040808629C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1008 10081833J,IMMUNOGENICITYNA0043395512C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081833J,IMMUNOGENICITYNA0043260527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BOC4591001ISC4591001 1008 10081834J,IMMUNOGENICITYNA0040637892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081834J,IMMUNOGENICITYNA0040808633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1008 10081835J,IMMUNOGENICITYNA0040637929C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081835J,IMMUNOGENICITYNA0040808637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1008 10081835J,IMMUNOGENICITYNA0041741693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1008 10081835J,IMMUNOGENICITYNA0042433694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B[C4591001ISC4591001 1008 10081836J,IMMUNOGENICITYNA0040637906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081836J,IMMUNOGENICITYNA0040808478C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B4C4591001ISC4591001 1008 10081836J,IMMUNOGENICITYNA0043395667C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081837J,IMMUNOGENICITYNA0040637908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081837J,IMMUNOGENICITYNA0040808465C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1008 10081837J,IMMUNOGENICITYNA0043395391C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081837J,IMMUNOGENICITYNA0043261295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BQC4591001ISC4591001 1008 10081838J,IMMUNOGENICITYNA0040934120C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081838J,IMMUNOGENICITYNA0040808497C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1008 10081838J,IMMUNOGENICITYNA0042464935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081838J,IMMUNOGENICITYNA0043261310C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BQC4591001ISC4591001 1008 10081839J,IMMUNOGENICITYNA0040637916C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1008 10081839J,IMMUNOGENICITYNA0034628650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1008 10081839J,IMMUNOGENICITYNA0049355553C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1008 10081839J,IMMUNOGENICITYNA0042434625C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BVC4591001ISC4591001 1008 10081840J,IMMUNOGENICITYNA0040934126C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081840J,IMMUNOGENICITYNA0040808617C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1008 10081840J,IMMUNOGENICITYNA0043395652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081840J,IMMUNOGENICITYNA0042434606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1008 10081841J,IMMUNOGENICITYNA0040934147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081841J,IMMUNOGENICITYNA0040808466C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1008 10081841J,IMMUNOGENICITYNA0042465051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1008 10081842J,IMMUNOGENICITYNA0040934137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081842J,IMMUNOGENICITYNA0033127451C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B;C4591001ISC4591001 1008 10081842J,IMMUNOGENICITYNA0043394968C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081843J,IMMUNOGENICITYNA0040934133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081843J,IMMUNOGENICITYNA0040808636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1008 10081843J,IMMUNOGENICITYNA0041741683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1008 10081843J,IMMUNOGENICITYNA0042374065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BhC4591001ISC4591001 1008 10081844J,IMMUNOGENICITYNA0040934138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081844J,IMMUNOGENICITYNA0040808616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1008 10081844J,IMMUNOGENICITYNA0043394980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081844J,IMMUNOGENICITYNA0042374054C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BhC4591001ISC4591001 1008 10081845J,IMMUNOGENICITYNA0040934104C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081845J,IMMUNOGENICITYNA0040808492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1008 10081845J,IMMUNOGENICITYNA0043395618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081846J,IMMUNOGENICITYNA0040637899C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081846J,IMMUNOGENICITYNA0034628618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1008 10081846J,IMMUNOGENICITYNA0041741711C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081846J,IMMUNOGENICITYNA0042374084C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BhC4591001ISC4591001 1008 10081847J,IMMUNOGENICITYNA0040933931C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081847J,IMMUNOGENICITYNA0040808470C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1008 10081847J,IMMUNOGENICITYNA0041741707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1008 10081847J,IMMUNOGENICITYNA0042434607C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1008 10081848J,IMMUNOGENICITYNA0040933915C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081848J,IMMUNOGENICITYNA0040808453C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1008 10081848J,IMMUNOGENICITYNA0041704668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1008 10081848J,IMMUNOGENICITYNA0042374232C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02BeC4591001ISC4591001 1008 10081849J,IMMUNOGENICITYNA0040933950C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081849J,IMMUNOGENICITYNA0033127427C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B:C4591001ISC4591001 1008 10081849J,IMMUNOGENICITYNA0043395637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081850J,IMMUNOGENICITYNA0040934136C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081850J,IMMUNOGENICITYNA0034628523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B8C4591001ISC4591001 1008 10081850J,IMMUNOGENICITYNA0041704698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1008 10081850J,IMMUNOGENICITYNA0043309861C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BIC4591001ISC4591001 1008 10081851J,IMMUNOGENICITYNA0040933937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081851J,IMMUNOGENICITYNA0033127440C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B:C4591001ISC4591001 1008 10081851J,IMMUNOGENICITYNA0043395633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081852J,IMMUNOGENICITYNA0040933912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1008 10081852J,IMMUNOGENICITYNA0033127439C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B:C4591001ISC4591001 1008 10081852J,IMMUNOGENICITYNA0043394976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081853J,IMMUNOGENICITYNA0040933924C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081853J,IMMUNOGENICITYNA0034628660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1008 10081853J,IMMUNOGENICITYNA0043395598C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081853J,IMMUNOGENICITYNA0042367511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B=C4591001ISC4591001 1008 10081854J,IMMUNOGENICITYNA0040933938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081854J,IMMUNOGENICITYNA0034628656C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1008 10081854J,IMMUNOGENICITYNA0041704678C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1008 10081854J,IMMUNOGENICITYNA0042442057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BRC4591001ISC4591001 1008 10081855J,IMMUNOGENICITYNA0040933918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081855J,IMMUNOGENICITYNA0033124211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B6C4591001ISC4591001 1008 10081855J,IMMUNOGENICITYNA0049614082C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081856J,IMMUNOGENICITYNA0040933936C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081856J,IMMUNOGENICITYNA0033127443C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B6C4591001ISC4591001 1008 10081856J,IMMUNOGENICITYNA0043395404C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081857J,IMMUNOGENICITYNA0040933806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081857J,IMMUNOGENICITYNA0034628530C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B3C4591001ISC4591001 1008 10081857J,IMMUNOGENICITYNA0042465046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1008 10081857J,IMMUNOGENICITYNA0042441964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BRC4591001ISC4591001 1008 10081858J,IMMUNOGENICITYNA0040933797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081858J,IMMUNOGENICITYNA0034628524C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L REPEAT SCREENING 1 2021-02-16B3C4591001ISC4591001 1008 10081859J,IMMUNOGENICITYNA0040933779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081859J,IMMUNOGENICITYNA0033124257C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B6C4591001ISC4591001 1008 10081859J,IMMUNOGENICITYNA0041704670C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1008 10081860J,IMMUNOGENICITYNA0040933927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1008 10081860J,IMMUNOGENICITYNA0034628646C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1008 10081860J,IMMUNOGENICITYNA0049355541C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1008 10081860J,IMMUNOGENICITYNA0043309874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BDC4591001ISC4591001 1008 10081861J,IMMUNOGENICITYNA0040933808C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081861J,IMMUNOGENICITYNA0034628654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1008 10081861J,IMMUNOGENICITYNA0043395645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081862J,IMMUNOGENICITYNA0040933801C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081862J,IMMUNOGENICITYNA0034628527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1008 10081862J,IMMUNOGENICITYNA0043305249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-06BC4591001ISC4591001 1008 10081863J,IMMUNOGENICITYNA0040933796C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081863J,IMMUNOGENICITYNA0034628501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1008 10081863J,IMMUNOGENICITYNA0043395585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081863J,IMMUNOGENICITYNA0040600468C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BNC4591001ISC4591001 1008 10081864J,IMMUNOGENICITYNA0040933803C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081864J,IMMUNOGENICITYNA0034628531C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1008 10081864J,IMMUNOGENICITYNA0049620319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081865J,IMMUNOGENICITYNA0040933795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081865J,IMMUNOGENICITYNA0034628521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1008 10081865J,IMMUNOGENICITYNA0042465036C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1008 10081866J,IMMUNOGENICITYNA0043376932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081866J,IMMUNOGENICITYNA0034628633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1008 10081866J,IMMUNOGENICITYNA0043395511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081867J,IMMUNOGENICITYNA0043376926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081867J,IMMUNOGENICITYNA0034628493C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1008 10081867J,IMMUNOGENICITYNA0043395523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081868J,IMMUNOGENICITYNA0043376943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081868J,IMMUNOGENICITYNA0034628506C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1008 10081868J,IMMUNOGENICITYNA0042464932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1008 10081869J,IMMUNOGENICITYNA0043376939C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081869J,IMMUNOGENICITYNA0033127438C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1008 10081869J,IMMUNOGENICITYNA0043395529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081870J,IMMUNOGENICITYNA0043376970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1008 10081870J,IMMUNOGENICITYNA0033127471C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1008 10081870J,IMMUNOGENICITYNA0041704714C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1008 10081871J,IMMUNOGENICITYNA0040933800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081871J,IMMUNOGENICITYNA0042434640C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-17BNC4591001ISC4591001 1008 10081871J,IMMUNOGENICITYNA0043395755C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081872J,IMMUNOGENICITYNA0043376944C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081872J,IMMUNOGENICITYNA0033124251C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B4C4591001ISC4591001 1008 10081872J,IMMUNOGENICITYNA0044645456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-09BeC4591001ISC4591001 1008 10081873J,IMMUNOGENICITYNA0043376969C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081873J,IMMUNOGENICITYNA0033127435C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1008 10081873J,IMMUNOGENICITYNA0041718048C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1008 10081874J,IMMUNOGENICITYNA0043376958C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081874J,IMMUNOGENICITYNA0034628500C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1008 10081874J,IMMUNOGENICITYNA0042464925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1008 10081874J,IMMUNOGENICITYNA0042367151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B?C4591001ISC4591001 1008 10081875J,IMMUNOGENICITYNA0043376968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081875J,IMMUNOGENICITYNA0034628495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1008 10081875J,IMMUNOGENICITYNA0043395736C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081875J,IMMUNOGENICITYNA0042367150C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B?C4591001ISC4591001 1008 10081876J,IMMUNOGENICITYNA0043376954C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081876J,IMMUNOGENICITYNA0033124278C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1008 10081876J,IMMUNOGENICITYNA0049355530C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081877J,IMMUNOGENICITYNA0043376928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081877J,IMMUNOGENICITYNA0033124279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1008 10081877J,IMMUNOGENICITYNA0043395594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081878J,IMMUNOGENICITYNA0043376963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081878J,IMMUNOGENICITYNA0034628517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1008 10081878J,IMMUNOGENICITYNA0042425197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1008 10081879J,IMMUNOGENICITYNA0043376947C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081879J,IMMUNOGENICITYNA0034628492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1008 10081879J,IMMUNOGENICITYNA0049619719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1008 10081880J,IMMUNOGENICITYNA0041717883C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081880J,IMMUNOGENICITYNA0033127470C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1008 10081880J,IMMUNOGENICITYNA0043394985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081880J,IMMUNOGENICITYNA0043309123C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BAC4591001ISC4591001 1008 10081881J,IMMUNOGENICITYNA0041717877C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1008 10081881J,IMMUNOGENICITYNA0033127446C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1008 10081881J,IMMUNOGENICITYNA0043395005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081881J,IMMUNOGENICITYNA0043309106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BAC4591001ISC4591001 1008 10081882J,IMMUNOGENICITYNA0041717873C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1008 10081882J,IMMUNOGENICITYNA0033127456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B2C4591001ISC4591001 1008 10081882J,IMMUNOGENICITYNA0041704469C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-16BC4591001ISC4591001 1008 10081883J,IMMUNOGENICITYNA0041717907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1008 10081883J,IMMUNOGENICITYNA0042365506C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B9C4591001ISC4591001 1008 10081883J,IMMUNOGENICITYNA0049619734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1008 10081884J,IMMUNOGENICITYNA0041717912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1008 10081884J,IMMUNOGENICITYNA0042441954C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-19BOC4591001ISC4591001 1008 10081884J,IMMUNOGENICITYNA0043395494C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081885J,IMMUNOGENICITYNA0041717908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1008 10081885J,IMMUNOGENICITYNA0033127461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B2C4591001ISC4591001 1008 10081885J,IMMUNOGENICITYNA0049355522C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081886J,IMMUNOGENICITYNA0041717875C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1008 10081886J,IMMUNOGENICITYNA0033127449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B2C4591001ISC4591001 1008 10081886J,IMMUNOGENICITYNA0049355533C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081887J,IMMUNOGENICITYNA0041717909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081887J,IMMUNOGENICITYNA0033124244C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081887J,IMMUNOGENICITYNA0043395510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081888J,IMMUNOGENICITYNA0041717889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081888J,IMMUNOGENICITYNA0033124232C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081888J,IMMUNOGENICITYNA0043395513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081889J,IMMUNOGENICITYNA0041717880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081889J,IMMUNOGENICITYNA0033124222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081889J,IMMUNOGENICITYNA0049614087C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081890J,IMMUNOGENICITYNA0041717895C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081890J,IMMUNOGENICITYNA0033124263C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081890J,IMMUNOGENICITYNA0049614076C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081891J,IMMUNOGENICITYNA0041717878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081891J,IMMUNOGENICITYNA0033124221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081891J,IMMUNOGENICITYNA0043395595C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1008 10081892J,IMMUNOGENICITYNA0040934556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081892J,IMMUNOGENICITYNA0033124224C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081892J,IMMUNOGENICITYNA0043395697C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1008 10081893J,IMMUNOGENICITYNA0040934568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081893J,IMMUNOGENICITYNA0033124240C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081893J,IMMUNOGENICITYNA0049614081C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081894J,IMMUNOGENICITYNA0040934572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081894J,IMMUNOGENICITYNA0043309090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B:C4591001ISC4591001 1008 10081894J,IMMUNOGENICITYNA0049355547C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081895J,IMMUNOGENICITYNA0040933793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081895J,IMMUNOGENICITYNA0033124216C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081895J,IMMUNOGENICITYNA0049355514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1008 10081896J,IMMUNOGENICITYNA0040934545C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1008 10081896J,IMMUNOGENICITYNA0033124217C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1008 10081896J,IMMUNOGENICITYNA0043395641C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081897J,IMMUNOGENICITYNA0040934553C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081897J,IMMUNOGENICITYNA0042367178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B8C4591001ISC4591001 1008 10081897J,IMMUNOGENICITYNA0049355528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1008 10081898J,IMMUNOGENICITYNA0040934561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081898J,IMMUNOGENICITYNA0033124262C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1008 10081898J,IMMUNOGENICITYNA0043395744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081899J,IMMUNOGENICITYNA0040934558C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081899J,IMMUNOGENICITYNA0033124271C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1008 10081899J,IMMUNOGENICITYNA0043395737C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081900J,IMMUNOGENICITYNA0040934551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081900J,IMMUNOGENICITYNA0034628679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1008 10081900J,IMMUNOGENICITYNA0049355531C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1008 10081901J,IMMUNOGENICITYNA0040934575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081901J,IMMUNOGENICITYNA0034628648C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-15B*C4591001ISC4591001 1008 10081902J,IMMUNOGENICITYNA0040934570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081902J,IMMUNOGENICITYNA0033124286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1008 10081902J,IMMUNOGENICITYNA0043395505C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081902J,IMMUNOGENICITYNA0042367588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08B?C4591001ISC4591001 1008 10081903J,IMMUNOGENICITYNA0040934562C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081903J,IMMUNOGENICITYNA0033124293C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1008 10081903J,IMMUNOGENICITYNA0042464890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1008 10081904J,IMMUNOGENICITYNA0040934546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1008 10081904J,IMMUNOGENICITYNA0042365512C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1008 10081904J,IMMUNOGENICITYNA0043395729C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081905J,IMMUNOGENICITYNA0043376852C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081905J,IMMUNOGENICITYNA0043309134C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1008 10081905J,IMMUNOGENICITYNA0041718043C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1008 10081906J,IMMUNOGENICITYNA0043376867C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081906J,IMMUNOGENICITYNA0043309105C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1008 10081906J,IMMUNOGENICITYNA0049355529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081907J,IMMUNOGENICITYNA0043376839C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081907J,IMMUNOGENICITYNA0033124303C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1008 10081907J,IMMUNOGENICITYNA0043395658C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081908J,IMMUNOGENICITYNA0043376831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081908J,IMMUNOGENICITYNA0033124300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1008 10081908J,IMMUNOGENICITYNA0049355512C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1008 10081909J,IMMUNOGENICITYNA0043376848C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081909J,IMMUNOGENICITYNA0042365526C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1008 10081909J,IMMUNOGENICITYNA0043395414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081910J,IMMUNOGENICITYNA0043376857C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081910J,IMMUNOGENICITYNA0033124281C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1008 10081910J,IMMUNOGENICITYNA0049620299C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1008 10081911J,IMMUNOGENICITYNA0043376872C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081911J,IMMUNOGENICITYNA0042367476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1008 10081911J,IMMUNOGENICITYNA0043395496C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081911J,IMMUNOGENICITYNA0043260529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B@C4591001ISC4591001 1008 10081912J,IMMUNOGENICITYNA0043376844C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081912J,IMMUNOGENICITYNA0042367485C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1008 10081912J,IMMUNOGENICITYNA0049355559C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1008 10081913J,IMMUNOGENICITYNA0043376861C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081913J,IMMUNOGENICITYNA0042365515C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1008 10081913J,IMMUNOGENICITYNA0043395620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081914J,IMMUNOGENICITYNA0043376875C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1008 10081914J,IMMUNOGENICITYNA0043261301C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-12BBC4591001ISC4591001 1008 10081914J,IMMUNOGENICITYNA0043395728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1008 10081915J,IMMUNOGENICITYNA0043376847C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081915J,IMMUNOGENICITYNA0042367513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1008 10081915J,IMMUNOGENICITYNA0049355520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1008 10081916J,IMMUNOGENICITYNA0043376855C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081916J,IMMUNOGENICITYNA0042367497C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1008 10081916J,IMMUNOGENICITYNA0049355539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1008 10081917J,IMMUNOGENICITYNA0043376862C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081917J,IMMUNOGENICITYNA0042367488C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1008 10081917J,IMMUNOGENICITYNA0043394994C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081918J,IMMUNOGENICITYNA0040934665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081918J,IMMUNOGENICITYNA0042367498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1008 10081918J,IMMUNOGENICITYNA0049355548C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1008 10081919J,IMMUNOGENICITYNA0040934652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081919J,IMMUNOGENICITYNA0042365540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1008 10081919J,IMMUNOGENICITYNA0043394998C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081920J,IMMUNOGENICITYNA0040934657C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081920J,IMMUNOGENICITYNA0042367161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1008 10081920J,IMMUNOGENICITYNA0049614070C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081921J,IMMUNOGENICITYNA0040934676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1008 10081921J,IMMUNOGENICITYNA0043309121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B7C4591001ISC4591001 1008 10081921J,IMMUNOGENICITYNA0042442691C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-26BnC4591001ISC4591001 1008 10081922J,IMMUNOGENICITYNA0040600705C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081922J,IMMUNOGENICITYNA0042365520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081922J,IMMUNOGENICITYNA0049355518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1008 10081923J,IMMUNOGENICITYNA0040600701C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081923J,IMMUNOGENICITYNA0042367496C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081923J,IMMUNOGENICITYNA0043395749C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B~C4591001ISC4591001 1008 10081924J,IMMUNOGENICITYNA0040600724C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081924J,IMMUNOGENICITYNA0042367484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081924J,IMMUNOGENICITYNA0043395506C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081925J,IMMUNOGENICITYNA0040600732C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081925J,IMMUNOGENICITYNA0042365524C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081925J,IMMUNOGENICITYNA0049620311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1008 10081926J,IMMUNOGENICITYNA0040600718C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081926J,IMMUNOGENICITYNA0042365544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081926J,IMMUNOGENICITYNA0043395626C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1008 10081927J,IMMUNOGENICITYNA0040934649C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081927J,IMMUNOGENICITYNA0042365541C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081927J,IMMUNOGENICITYNA0042443020C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1008 10081928J,IMMUNOGENICITYNA0040934667C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081928J,IMMUNOGENICITYNA0042365552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1008 10081928J,IMMUNOGENICITYNA0041718051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1008 10081929J,IMMUNOGENICITYNA0040600715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1008 10081929J,IMMUNOGENICITYNA0043309118C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1008 10081929J,IMMUNOGENICITYNA0049614063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1008 10081930J,IMMUNOGENICITYNA0040600710C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081930J,IMMUNOGENICITYNA0042367144C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081930J,IMMUNOGENICITYNA0043395768C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B{C4591001ISC4591001 1008 10081931J,IMMUNOGENICITYNA0040934650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081931J,IMMUNOGENICITYNA0042367143C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081931J,IMMUNOGENICITYNA0043394964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081931J,IMMUNOGENICITYNA0042441975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BDC4591001ISC4591001 1008 10081932J,IMMUNOGENICITYNA0040934630C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081932J,IMMUNOGENICITYNA0042367141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081932J,IMMUNOGENICITYNA0043394959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1008 10081933J,IMMUNOGENICITYNA0039408694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081933J,IMMUNOGENICITYNA0042367168C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1008 10081933J,IMMUNOGENICITYNA0043395582C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081934J,IMMUNOGENICITYNA0039408652C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081934J,IMMUNOGENICITYNA0042367146C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081934J,IMMUNOGENICITYNA0049614095C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1008 10081935J,IMMUNOGENICITYNA0039408653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081935J,IMMUNOGENICITYNA0043309096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L REPEAT SCREENING 1 2021-03-03B4C4591001ISC4591001 1008 10081935J,IMMUNOGENICITYNA0043304240C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-13BC4591001ISC4591001 1008 10081936J,IMMUNOGENICITYNA0039408671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081936J,IMMUNOGENICITYNA0042367172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081936J,IMMUNOGENICITYNA0043395664C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B|C4591001ISC4591001 1008 10081937J,IMMUNOGENICITYNA0039408677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081937J,IMMUNOGENICITYNA0042367173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1008 10081937J,IMMUNOGENICITYNA0049614049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1008 10081938J,IMMUNOGENICITYNA0039408686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1008 10081938J,IMMUNOGENICITYNA0043309098C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1008 10081938J,IMMUNOGENICITYNA0043395605C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1008 10081940J,IMMUNOGENICITYNA0040600739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1008 10081940J,IMMUNOGENICITYNA0043309112C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1008 10081940J,IMMUNOGENICITYNA0049614057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1008 10081941J,IMMUNOGENICITYNA0040934666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1008 10081941J,IMMUNOGENICITYNA0042367138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1008 10081941J,IMMUNOGENICITYNA0043395002C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B{C4591001ISC4591001 1008 10081942J,IMMUNOGENICITYNA0039408696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1008 10081942J,IMMUNOGENICITYNA0042367179C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1008 10081942J,IMMUNOGENICITYNA0043395000C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B{C4591001ISC4591001 1008 10081943J,IMMUNOGENICITYNA0039408659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1008 10081943J,IMMUNOGENICITYNA0043309094C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B3C4591001ISC4591001 1008 10081943J,IMMUNOGENICITYNA0043305274C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1009 10091204J,IMMUNOGENICITYNA0039414092C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1009 10091204J,IMMUNOGENICITYNA0040809747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-03B2C4591001ISC4591001 1009 10091204J,IMMUNOGENICITYNA0044660764C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-30BC4591001ISC4591001 1009 10091204J,IMMUNOGENICITYNA0042505207C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-02C@C4591001ISC4591001 1009 10091204J,IMMUNOGENICITYNA0038262162C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BC4591001ISC4591001 1009 10091205J,IMMUNOGENICITYNA0039414119C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1009 10091205J,IMMUNOGENICITYNA0040808543C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B3C4591001ISC4591001 1009 10091205J,IMMUNOGENICITYNA0044660528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-04-30BC4591001ISC4591001 1009 10091205J,IMMUNOGENICITYNA0045270963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BC4591001ISC4591001 1009 10091208J,IMMUNOGENICITYNA0039414080C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1009 10091208J,IMMUNOGENICITYNA0040808518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B3C4591001ISC4591001 1009 10091208J,IMMUNOGENICITYNA0042358663C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-05BC4591001ISC4591001 1009 10091209J,IMMUNOGENICITYNA0039413950C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1009 10091209J,IMMUNOGENICITYNA0033140336C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-02B1C4591001ISC4591001 1009 10091209J,IMMUNOGENICITYNA0044578455C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-28BC4591001ISC4591001 1009 10091209J,IMMUNOGENICITYNA0044634324C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BC4591001ISC4591001 1009 10091212J,IMMUNOGENICITYNA0039413956C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1009 10091212J,IMMUNOGENICITYNA0040825823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-18B@C4591001ISC4591001 1009 10091212J,IMMUNOGENICITYNA0042502223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1009 10091212J,IMMUNOGENICITYNA0044579108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BC4591001ISC4591001 1009 10091213J,IMMUNOGENICITYNA0039413957C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1009 10091213J,IMMUNOGENICITYNA0040809914C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-16B>C4591001ISC4591001 1009 10091213J,IMMUNOGENICITYNA0033141522C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-22BC4591001ISC4591001 1009 10091216J,IMMUNOGENICITYNA0039413931C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1009 10091216J,IMMUNOGENICITYNA0040808505C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B2C4591001ISC4591001 1009 10091216J,IMMUNOGENICITYNA0044636035C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1009 10091218J,IMMUNOGENICITYNA0039413942C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1009 10091218J,IMMUNOGENICITYNA0040808544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B2C4591001ISC4591001 1009 10091218J,IMMUNOGENICITYNA0044660520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1009 10091220J,IMMUNOGENICITYNA0031355616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1009 10091220J,IMMUNOGENICITYNA0034587655C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B5C4591001ISC4591001 1009 10091220J,IMMUNOGENICITYNA0041604989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-14BC4591001ISC4591001 1009 10091220J,IMMUNOGENICITYNA0044578823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-09BC4591001ISC4591001 1009 10091221J,IMMUNOGENICITYNA0031355595C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1009 10091221J,IMMUNOGENICITYNA0034587683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B5C4591001ISC4591001 1009 10091221J,IMMUNOGENICITYNA0041604993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-14BC4591001ISC4591001 1009 10091221J,IMMUNOGENICITYNA0044578782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-09BC4591001ISC4591001 1009 10091223J,IMMUNOGENICITYNA0031355592C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1009 10091223J,IMMUNOGENICITYNA0040809750C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B3C4591001ISC4591001 1009 10091223J,IMMUNOGENICITYNA0044660762C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-04BC4591001ISC4591001 1009 10091226J,IMMUNOGENICITYNA0031355614C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1009 10091226J,IMMUNOGENICITYNA0034587941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B1C4591001ISC4591001 1009 10091226J,IMMUNOGENICITYNA0041706193C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-13BC4591001ISC4591001 1009 10091226J,IMMUNOGENICITYNA0042502226C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1009 10091226J,IMMUNOGENICITYNA0044579087C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BC4591001ISC4591001 1009 10091227J,IMMUNOGENICITYNA0031355617C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1009 10091227J,IMMUNOGENICITYNA0040808680C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B3C4591001ISC4591001 1009 10091227J,IMMUNOGENICITYNA0044578487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-11BC4591001ISC4591001 1009 10091229J,IMMUNOGENICITYNA0031355413C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1009 10091229J,IMMUNOGENICITYNA0040825997C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-21B?C4591001ISC4591001 1009 10091229J,IMMUNOGENICITYNA0042502410C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1009 10091231J,IMMUNOGENICITYNA0031355404C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1009 10091231J,IMMUNOGENICITYNA0034587694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B4C4591001ISC4591001 1009 10091231J,IMMUNOGENICITYNA0044660540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-05BC4591001ISC4591001 1009 10091233J,IMMUNOGENICITYNA0031355408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1009 10091233J,IMMUNOGENICITYNA0034587674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B7C4591001ISC4591001 1009 10091233J,IMMUNOGENICITYNA0044660558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-06BC4591001ISC4591001 1009 10091233J,IMMUNOGENICITYNA0044581903C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1009 10091234J,IMMUNOGENICITYNA0031355457C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1009 10091234J,IMMUNOGENICITYNA0040809913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-16B9C4591001ISC4591001 1009 10091234J,IMMUNOGENICITYNA0041604240C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-19BC4591001ISC4591001 1009 10091234J,IMMUNOGENICITYNA0044579106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BC4591001ISC4591001 1009 10091237J,IMMUNOGENICITYNA0031355455C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1009 10091237J,IMMUNOGENICITYNA0033141782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B7C4591001ISC4591001 1009 10091237J,IMMUNOGENICITYNA0041604879C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-11BC4591001ISC4591001 1009 10091238J,IMMUNOGENICITYNA0031355488C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1009 10091238J,IMMUNOGENICITYNA0042437167C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B1C4591001ISC4591001 1009 10091238J,IMMUNOGENICITYNA0044578477C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-26BC4591001ISC4591001 1009 10091240J,IMMUNOGENICITYNA0031355494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1009 10091240J,IMMUNOGENICITYNA0034587944C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B0C4591001ISC4591001 1009 10091240J,IMMUNOGENICITYNA0044660555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-06BC4591001ISC4591001 1009 10091246J,IMMUNOGENICITYNA0031355463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1009 10091246J,IMMUNOGENICITYNA0033141698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B6C4591001ISC4591001 1009 10091246J,IMMUNOGENICITYNA0044660765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-04BC4591001ISC4591001 1009 10091246J,IMMUNOGENICITYNA0041706166C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1009 10091246J,IMMUNOGENICITYNA0044634325C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BC4591001ISC4591001 1009 10091247J,IMMUNOGENICITYNA0031355492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1009 10091247J,IMMUNOGENICITYNA0034587481C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B1C4591001ISC4591001 1009 10091247J,IMMUNOGENICITYNA0041605117C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-19BC4591001ISC4591001 1009 10091247J,IMMUNOGENICITYNA0044578490C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BC4591001ISC4591001 1009 10091249J,IMMUNOGENICITYNA0031355388C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1009 10091249J,IMMUNOGENICITYNA0033141788C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-11B3C4591001ISC4591001 1009 10091249J,IMMUNOGENICITYNA0041706202C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1009 10091249J,IMMUNOGENICITYNA0044636197C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BC4591001ISC4591001 1009 10091250J,IMMUNOGENICITYNA0031355373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1009 10091250J,IMMUNOGENICITYNA0033141808C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-11B3C4591001ISC4591001 1009 10091250J,IMMUNOGENICITYNA0042611616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-18BC4591001ISC4591001 1009 10091250J,IMMUNOGENICITYNA0044636228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BC4591001ISC4591001 1009 10091265J,IMMUNOGENICITYNA0033140363C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1009 10091265J,IMMUNOGENICITYNA0044571012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1009 10091265J,IMMUNOGENICITYNA0049613941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091266J,IMMUNOGENICITYNA0033141206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1009 10091266J,IMMUNOGENICITYNA0042414674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1009 10091266J,IMMUNOGENICITYNA0042393319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-04B^C4591001ISC4591001 1009 10091267J,IMMUNOGENICITYNA0033141214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1009 10091267J,IMMUNOGENICITYNA0042414642C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1009 10091267J,IMMUNOGENICITYNA0041605024C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1009 10091267J,IMMUNOGENICITYNA0044634352C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BrC4591001ISC4591001 1009 10091269J,IMMUNOGENICITYNA0033140330C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1009 10091269J,IMMUNOGENICITYNA0042414676C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1009 10091269J,IMMUNOGENICITYNA0041705029C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1009 10091269J,IMMUNOGENICITYNA0045270973C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BpC4591001ISC4591001 1009 10091270J,IMMUNOGENICITYNA0033141225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1009 10091270J,IMMUNOGENICITYNA0044571039C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1009 10091270J,IMMUNOGENICITYNA0041705028C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1009 10091270J,IMMUNOGENICITYNA0045270974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BpC4591001ISC4591001 1009 10091272J,IMMUNOGENICITYNA0033140339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1009 10091272J,IMMUNOGENICITYNA0044571022C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1009 10091272J,IMMUNOGENICITYNA0042505102C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1009 10091273J,IMMUNOGENICITYNA0033140353C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1009 10091273J,IMMUNOGENICITYNA0044571042C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1009 10091273J,IMMUNOGENICITYNA0042502395C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1009 10091274J,IMMUNOGENICITYNA0040809791C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1009 10091274J,IMMUNOGENICITYNA0044570503C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B9C4591001ISC4591001 1009 10091274J,IMMUNOGENICITYNA0049612085C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-02BC4591001ISC4591001 1009 10091274J,IMMUNOGENICITYNA0044578688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BlC4591001ISC4591001 1009 10091275J,IMMUNOGENICITYNA0040809777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1009 10091275J,IMMUNOGENICITYNA0044570497C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B9C4591001ISC4591001 1009 10091275J,IMMUNOGENICITYNA0049612112C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-02BC4591001ISC4591001 1009 10091275J,IMMUNOGENICITYNA0044578696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BlC4591001ISC4591001 1009 10091277J,IMMUNOGENICITYNA0040809760C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091277J,IMMUNOGENICITYNA0044571331C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B9C4591001ISC4591001 1009 10091277J,IMMUNOGENICITYNA0041704651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-09BC4591001ISC4591001 1009 10091277J,IMMUNOGENICITYNA0042611709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BC4591001ISC4591001 1009 10091280J,IMMUNOGENICITYNA0040809765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091280J,IMMUNOGENICITYNA0044571583C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B3C4591001ISC4591001 1009 10091280J,IMMUNOGENICITYNA0042505794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1009 10091280J,IMMUNOGENICITYNA0044634311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BpC4591001ISC4591001 1009 10091281J,IMMUNOGENICITYNA0040809754C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091281J,IMMUNOGENICITYNA0044571626C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B3C4591001ISC4591001 1009 10091281J,IMMUNOGENICITYNA0042505826C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1009 10091281J,IMMUNOGENICITYNA0043288841C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05B|C4591001ISC4591001 1009 10091282J,IMMUNOGENICITYNA0040809771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091282J,IMMUNOGENICITYNA0044571605C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B3C4591001ISC4591001 1009 10091282J,IMMUNOGENICITYNA0044576306C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1009 10091282J,IMMUNOGENICITYNA0044582978C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-21BC4591001ISC4591001 1009 10091282J,IMMUNOGENICITYNA0044636217C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BuC4591001ISC4591001 1009 10091283J,IMMUNOGENICITYNA0034587263C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091283J,IMMUNOGENICITYNA0044570331C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B8C4591001ISC4591001 1009 10091283J,IMMUNOGENICITYNA0044573474C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1009 10091283J,IMMUNOGENICITYNA0041704343C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-23BC4591001ISC4591001 1009 10091284J,IMMUNOGENICITYNA0034587294C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1009 10091284J,IMMUNOGENICITYNA0042414659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B8C4591001ISC4591001 1009 10091284J,IMMUNOGENICITYNA0044573480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-06-18BC4591001ISC4591001 1009 10091284J,IMMUNOGENICITYNA0044636212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BvC4591001ISC4591001 1009 10091287J,IMMUNOGENICITYNA0040808540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1009 10091287J,IMMUNOGENICITYNA0044571622C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1009 10091287J,IMMUNOGENICITYNA0044573460C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1009 10091288J,IMMUNOGENICITYNA0040808509C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1009 10091288J,IMMUNOGENICITYNA0044571604C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1009 10091288J,IMMUNOGENICITYNA0044573472C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1009 10091288J,IMMUNOGENICITYNA0044578730C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BqC4591001ISC4591001 1009 10091289J,IMMUNOGENICITYNA0034587292C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1009 10091289J,IMMUNOGENICITYNA0044571594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1009 10091289J,IMMUNOGENICITYNA0041704339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091292J,IMMUNOGENICITYNA0034587298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1009 10091292J,IMMUNOGENICITYNA0044571599C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1009 10091292J,IMMUNOGENICITYNA0043288468C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-02BxC4591001ISC4591001 1009 10091293J,IMMUNOGENICITYNA0034587270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1009 10091293J,IMMUNOGENICITYNA0044571624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B5C4591001ISC4591001 1009 10091293J,IMMUNOGENICITYNA0041605118C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1009 10091293J,IMMUNOGENICITYNA0044634320C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BoC4591001ISC4591001 1009 10091294J,IMMUNOGENICITYNA0034587283C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091294J,IMMUNOGENICITYNA0044571585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1009 10091294J,IMMUNOGENICITYNA0043288837C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-06ByC4591001ISC4591001 1009 10091295J,IMMUNOGENICITYNA0034587954C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091295J,IMMUNOGENICITYNA0044570286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1009 10091295J,IMMUNOGENICITYNA0044582999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091295J,IMMUNOGENICITYNA0044578700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BgC4591001ISC4591001 1009 10091296J,IMMUNOGENICITYNA0034587935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091296J,IMMUNOGENICITYNA0044570322C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1009 10091296J,IMMUNOGENICITYNA0044582969C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091296J,IMMUNOGENICITYNA0041681703C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-24BC4591001ISC4591001 1009 10091296J,IMMUNOGENICITYNA0044578718C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BgC4591001ISC4591001 1009 10091297J,IMMUNOGENICITYNA0034587970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091297J,IMMUNOGENICITYNA0044570311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1009 10091297J,IMMUNOGENICITYNA0044582997C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1009 10091297J,IMMUNOGENICITYNA0042611633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BC4591001ISC4591001 1009 10091298J,IMMUNOGENICITYNA0034587974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091298J,IMMUNOGENICITYNA0044570289C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1009 10091298J,IMMUNOGENICITYNA0049613746C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091298J,IMMUNOGENICITYNA0045270981C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BkC4591001ISC4591001 1009 10091300J,IMMUNOGENICITYNA0034587951C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091300J,IMMUNOGENICITYNA0044571297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1009 10091300J,IMMUNOGENICITYNA0044582981C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1009 10091300J,IMMUNOGENICITYNA0044634314C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BmC4591001ISC4591001 1009 10091301J,IMMUNOGENICITYNA0034587965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1009 10091301J,IMMUNOGENICITYNA0044571309C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1009 10091301J,IMMUNOGENICITYNA0042505262C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1009 10091301J,IMMUNOGENICITYNA0044634338C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BmC4591001ISC4591001 1009 10091303J,IMMUNOGENICITYNA0034587948C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1009 10091303J,IMMUNOGENICITYNA0044571295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B5C4591001ISC4591001 1009 10091303J,IMMUNOGENICITYNA0044582983C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-21BC4591001ISC4591001 1009 10091303J,IMMUNOGENICITYNA0044578724C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BfC4591001ISC4591001 1009 10091304J,IMMUNOGENICITYNA0042437188C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1009 10091304J,IMMUNOGENICITYNA0044571303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1009 10091304J,IMMUNOGENICITYNA0041681722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1009 10091305J,IMMUNOGENICITYNA0042437152C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1009 10091305J,IMMUNOGENICITYNA0044570476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1009 10091305J,IMMUNOGENICITYNA0044578714C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-19BfC4591001ISC4591001 1009 10091306J,IMMUNOGENICITYNA0042437169C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1009 10091306J,IMMUNOGENICITYNA0044570484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1009 10091306J,IMMUNOGENICITYNA0041604222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1009 10091306J,IMMUNOGENICITYNA0043298235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BmC4591001ISC4591001 1009 10091307J,IMMUNOGENICITYNA0042437163C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091307J,IMMUNOGENICITYNA0044571590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1009 10091307J,IMMUNOGENICITYNA0049613728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091307J,IMMUNOGENICITYNA0044634340C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1009 10091308J,IMMUNOGENICITYNA0042437190C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091308J,IMMUNOGENICITYNA0044570306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1009 10091308J,IMMUNOGENICITYNA0049613726C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091308J,IMMUNOGENICITYNA0044634321C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1009 10091309J,IMMUNOGENICITYNA0042437162C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091309J,IMMUNOGENICITYNA0044570284C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B1C4591001ISC4591001 1009 10091309J,IMMUNOGENICITYNA0044582988C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091310J,IMMUNOGENICITYNA0042437155C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091310J,IMMUNOGENICITYNA0034563360C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1009 10091310J,IMMUNOGENICITYNA0041681699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1009 10091311J,IMMUNOGENICITYNA0040808674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091311J,IMMUNOGENICITYNA0044571600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1009 10091311J,IMMUNOGENICITYNA0041605010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1009 10091312J,IMMUNOGENICITYNA0040808676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091312J,IMMUNOGENICITYNA0044571292C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B8C4591001ISC4591001 1009 10091312J,IMMUNOGENICITYNA0042505271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1009 10091312J,IMMUNOGENICITYNA0042611623C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-16BC4591001ISC4591001 1009 10091313J,IMMUNOGENICITYNA0040808647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091313J,IMMUNOGENICITYNA0044570521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B8C4591001ISC4591001 1009 10091313J,IMMUNOGENICITYNA0049613913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1009 10091314J,IMMUNOGENICITYNA0040808667C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091314J,IMMUNOGENICITYNA0034563339C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1009 10091314J,IMMUNOGENICITYNA0049613938C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091314J,IMMUNOGENICITYNA0049612083C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-06BC4591001ISC4591001 1009 10091314J,IMMUNOGENICITYNA0043298167C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BvC4591001ISC4591001 1009 10091315J,IMMUNOGENICITYNA0034587471C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091315J,IMMUNOGENICITYNA0044571306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B4C4591001ISC4591001 1009 10091315J,IMMUNOGENICITYNA0044582971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1009 10091315J,IMMUNOGENICITYNA0043298231C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BlC4591001ISC4591001 1009 10091316J,IMMUNOGENICITYNA0034587480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1009 10091316J,IMMUNOGENICITYNA0044571569C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B4C4591001ISC4591001 1009 10091316J,IMMUNOGENICITYNA0038262178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-17BcC4591001ISC4591001 1009 10091317J,IMMUNOGENICITYNA0034587456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091317J,IMMUNOGENICITYNA0044570294C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1009 10091317J,IMMUNOGENICITYNA0044582972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091317J,IMMUNOGENICITYNA0041681679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-25BC4591001ISC4591001 1009 10091317J,IMMUNOGENICITYNA0044578727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BiC4591001ISC4591001 1009 10091318J,IMMUNOGENICITYNA0034587463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091318J,IMMUNOGENICITYNA0044570287C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1009 10091318J,IMMUNOGENICITYNA0042505463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091318J,IMMUNOGENICITYNA0044579096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BjC4591001ISC4591001 1009 10091319J,IMMUNOGENICITYNA0034587681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091319J,IMMUNOGENICITYNA0034563345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B7C4591001ISC4591001 1009 10091319J,IMMUNOGENICITYNA0042505814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1009 10091319J,IMMUNOGENICITYNA0045270965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BgC4591001ISC4591001 1009 10091320J,IMMUNOGENICITYNA0034587669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091320J,IMMUNOGENICITYNA0044571539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B3C4591001ISC4591001 1009 10091320J,IMMUNOGENICITYNA0044581920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1009 10091320J,IMMUNOGENICITYNA0044634358C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BiC4591001ISC4591001 1009 10091321J,IMMUNOGENICITYNA0034587677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091321J,IMMUNOGENICITYNA0044571335C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B3C4591001ISC4591001 1009 10091321J,IMMUNOGENICITYNA0041681690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1009 10091321J,IMMUNOGENICITYNA0043298149C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BuC4591001ISC4591001 1009 10091322J,IMMUNOGENICITYNA0034587684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091322J,IMMUNOGENICITYNA0044571323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1009 10091322J,IMMUNOGENICITYNA0049613919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1009 10091322J,IMMUNOGENICITYNA0043288606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BpC4591001ISC4591001 1009 10091323J,IMMUNOGENICITYNA0034587676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1009 10091323J,IMMUNOGENICITYNA0044571330C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B2C4591001ISC4591001 1009 10091323J,IMMUNOGENICITYNA0049613921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1009 10091323J,IMMUNOGENICITYNA0049612091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-06BC4591001ISC4591001 1009 10091323J,IMMUNOGENICITYNA0043288612C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BpC4591001ISC4591001 1009 10091324J,IMMUNOGENICITYNA0034587666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091324J,IMMUNOGENICITYNA0034563352C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B5C4591001ISC4591001 1009 10091324J,IMMUNOGENICITYNA0041681687C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1009 10091324J,IMMUNOGENICITYNA0051279473C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-29BC4591001ISC4591001 1009 10091324J,IMMUNOGENICITYNA0043298236C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BjC4591001ISC4591001 1009 10091325J,IMMUNOGENICITYNA0034587650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091325J,IMMUNOGENICITYNA0034563357C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B5C4591001ISC4591001 1009 10091325J,IMMUNOGENICITYNA0041681684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1009 10091325J,IMMUNOGENICITYNA0043298234C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BjC4591001ISC4591001 1009 10091326J,IMMUNOGENICITYNA0034587680C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091326J,IMMUNOGENICITYNA0044571319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091326J,IMMUNOGENICITYNA0042505485C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1009 10091326J,IMMUNOGENICITYNA0038262161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1009 10091328J,IMMUNOGENICITYNA0033141793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091328J,IMMUNOGENICITYNA0034563329C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B6C4591001ISC4591001 1009 10091328J,IMMUNOGENICITYNA0049614045C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1009 10091329J,IMMUNOGENICITYNA0033141792C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091329J,IMMUNOGENICITYNA0034563319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B6C4591001ISC4591001 1009 10091329J,IMMUNOGENICITYNA0042505279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1009 10091330J,IMMUNOGENICITYNA0033141773C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091330J,IMMUNOGENICITYNA0034563324C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B6C4591001ISC4591001 1009 10091330J,IMMUNOGENICITYNA0049612088C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1009 10091330J,IMMUNOGENICITYNA0049614020C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-07BC4591001ISC4591001 1009 10091331J,IMMUNOGENICITYNA0033141721C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091331J,IMMUNOGENICITYNA0044571556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091331J,IMMUNOGENICITYNA0041681693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1009 10091331J,IMMUNOGENICITYNA0043298223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BjC4591001ISC4591001 1009 10091332J,IMMUNOGENICITYNA0033141780C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091332J,IMMUNOGENICITYNA0044571576C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091332J,IMMUNOGENICITYNA0041681676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1009 10091333J,IMMUNOGENICITYNA0033141715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091333J,IMMUNOGENICITYNA0044571574C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091333J,IMMUNOGENICITYNA0041704368C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1009 10091333J,IMMUNOGENICITYNA0044634339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BhC4591001ISC4591001 1009 10091334J,IMMUNOGENICITYNA0033141790C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091334J,IMMUNOGENICITYNA0044571575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091334J,IMMUNOGENICITYNA0041605091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1009 10091334J,IMMUNOGENICITYNA0044634349C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BgC4591001ISC4591001 1009 10091335J,IMMUNOGENICITYNA0033141700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091335J,IMMUNOGENICITYNA0044571533C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091335J,IMMUNOGENICITYNA0049613940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091336J,IMMUNOGENICITYNA0033141707C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1009 10091336J,IMMUNOGENICITYNA0044571552C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1009 10091336J,IMMUNOGENICITYNA0049613914C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091336J,IMMUNOGENICITYNA0043288362C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-16BC4591001ISC4591001 1009 10091336J,IMMUNOGENICITYNA0042611652C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-16BC4591001ISC4591001 1009 10091337J,IMMUNOGENICITYNA0033141710C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091337J,IMMUNOGENICITYNA0034563314C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1009 10091337J,IMMUNOGENICITYNA0041604995C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1009 10091338J,IMMUNOGENICITYNA0033141687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091338J,IMMUNOGENICITYNA0043397447C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B@C4591001ISC4591001 1009 10091338J,IMMUNOGENICITYNA0044747750C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-20BC4591001ISC4591001 1009 10091338J,IMMUNOGENICITYNA0044578708C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B`C4591001ISC4591001 1009 10091339J,IMMUNOGENICITYNA0033141696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091339J,IMMUNOGENICITYNA0043397469C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B@C4591001ISC4591001 1009 10091339J,IMMUNOGENICITYNA0044747758C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1009 10091339J,IMMUNOGENICITYNA0045270992C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B`C4591001ISC4591001 1009 10091340J,IMMUNOGENICITYNA0033141774C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091340J,IMMUNOGENICITYNA0043398828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B9C4591001ISC4591001 1009 10091340J,IMMUNOGENICITYNA0049613757C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1009 10091340J,IMMUNOGENICITYNA0045270964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BfC4591001ISC4591001 1009 10091341J,IMMUNOGENICITYNA0033141701C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091341J,IMMUNOGENICITYNA0031429628C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B6C4591001ISC4591001 1009 10091341J,IMMUNOGENICITYNA0041681716C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1009 10091341J,IMMUNOGENICITYNA0049612105C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-02BC4591001ISC4591001 1009 10091341J,IMMUNOGENICITYNA0043298210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BgC4591001ISC4591001 1009 10091342J,IMMUNOGENICITYNA0033141691C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1009 10091342J,IMMUNOGENICITYNA0031429638C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B6C4591001ISC4591001 1009 10091342J,IMMUNOGENICITYNA0041681723C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1009 10091342J,IMMUNOGENICITYNA0043298225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BgC4591001ISC4591001 1009 10091343J,IMMUNOGENICITYNA0033141683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091343J,IMMUNOGENICITYNA0031429610C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1009 10091343J,IMMUNOGENICITYNA0049613733C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1009 10091343J,IMMUNOGENICITYNA0038262180C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BeC4591001ISC4591001 1009 10091344J,IMMUNOGENICITYNA0033141676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091344J,IMMUNOGENICITYNA0034563336C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1009 10091344J,IMMUNOGENICITYNA0042359199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-01BMC4591001ISC4591001 1009 10091345J,IMMUNOGENICITYNA0034587672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091345J,IMMUNOGENICITYNA0031429818C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1009 10091345J,IMMUNOGENICITYNA0049613739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1009 10091345J,IMMUNOGENICITYNA0038262160C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B_C4591001ISC4591001 1009 10091346J,IMMUNOGENICITYNA0033141801C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091346J,IMMUNOGENICITYNA0031429630C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1009 10091346J,IMMUNOGENICITYNA0044579086C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-18B^C4591001ISC4591001 1009 10091347J,IMMUNOGENICITYNA0040809814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091347J,IMMUNOGENICITYNA0031429601C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1009 10091347J,IMMUNOGENICITYNA0041681681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1009 10091347J,IMMUNOGENICITYNA0041681719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-09BC4591001ISC4591001 1009 10091347J,IMMUNOGENICITYNA0043298211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BiC4591001ISC4591001 1009 10091348J,IMMUNOGENICITYNA0040809799C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091348J,IMMUNOGENICITYNA0031429606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1009 10091348J,IMMUNOGENICITYNA0049613735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1009 10091348J,IMMUNOGENICITYNA0044636221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BiC4591001ISC4591001 1009 10091349J,IMMUNOGENICITYNA0040809907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1009 10091349J,IMMUNOGENICITYNA0031429607C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B4C4591001ISC4591001 1009 10091349J,IMMUNOGENICITYNA0041605011C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1009 10091349J,IMMUNOGENICITYNA0044635513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BqC4591001ISC4591001 1009 10091350J,IMMUNOGENICITYNA0040809892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091350J,IMMUNOGENICITYNA0044570478C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1009 10091350J,IMMUNOGENICITYNA0049612080C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1009 10091350J,IMMUNOGENICITYNA0049612126C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-14BC4591001ISC4591001 1009 10091350J,IMMUNOGENICITYNA0044578716C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BjC4591001ISC4591001 1009 10091351J,IMMUNOGENICITYNA0040809938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091351J,IMMUNOGENICITYNA0044570323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1009 10091351J,IMMUNOGENICITYNA0049613908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1009 10091353J,IMMUNOGENICITYNA0040809909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091353J,IMMUNOGENICITYNA0044571551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1009 10091353J,IMMUNOGENICITYNA0044747700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1009 10091354J,IMMUNOGENICITYNA0040809893C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091354J,IMMUNOGENICITYNA0044570511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1009 10091354J,IMMUNOGENICITYNA0049614010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1009 10091354J,IMMUNOGENICITYNA0044634322C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BdC4591001ISC4591001 1009 10091355J,IMMUNOGENICITYNA0040809899C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091355J,IMMUNOGENICITYNA0031429797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B:C4591001ISC4591001 1009 10091355J,IMMUNOGENICITYNA0041681708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1009 10091355J,IMMUNOGENICITYNA0038262152C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BeC4591001ISC4591001 1009 10091356J,IMMUNOGENICITYNA0040809929C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1009 10091356J,IMMUNOGENICITYNA0031429645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1009 10091356J,IMMUNOGENICITYNA0041605006C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1009 10091356J,IMMUNOGENICITYNA0043288613C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BjC4591001ISC4591001 1009 10091357J,IMMUNOGENICITYNA0040809797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091357J,IMMUNOGENICITYNA0034563353C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1009 10091357J,IMMUNOGENICITYNA0044579111C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-16BZC4591001ISC4591001 1009 10091358J,IMMUNOGENICITYNA0040809928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091358J,IMMUNOGENICITYNA0031429812C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1009 10091358J,IMMUNOGENICITYNA0049614015C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1009 10091358J,IMMUNOGENICITYNA0043298227C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BgC4591001ISC4591001 1009 10091359J,IMMUNOGENICITYNA0040809804C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091359J,IMMUNOGENICITYNA0044570481C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1009 10091359J,IMMUNOGENICITYNA0041604985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1009 10091359J,IMMUNOGENICITYNA0044636211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BhC4591001ISC4591001 1009 10091360J,IMMUNOGENICITYNA0040809801C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091360J,IMMUNOGENICITYNA0044570513C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1009 10091360J,IMMUNOGENICITYNA0044747708C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1009 10091360J,IMMUNOGENICITYNA0044636198C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BhC4591001ISC4591001 1009 10091361J,IMMUNOGENICITYNA0040809816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091361J,IMMUNOGENICITYNA0044571577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1009 10091361J,IMMUNOGENICITYNA0041605012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1009 10091361J,IMMUNOGENICITYNA0044636216C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BhC4591001ISC4591001 1009 10091362J,IMMUNOGENICITYNA0040809812C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091362J,IMMUNOGENICITYNA0043398805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1009 10091362J,IMMUNOGENICITYNA0044747706C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1009 10091362J,IMMUNOGENICITYNA0042611727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BwC4591001ISC4591001 1009 10091363J,IMMUNOGENICITYNA0040809821C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091363J,IMMUNOGENICITYNA0043398811C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B7C4591001ISC4591001 1009 10091363J,IMMUNOGENICITYNA0043288398C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1009 10091363J,IMMUNOGENICITYNA0051279481C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1009 10091363J,IMMUNOGENICITYNA0042611739C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BwC4591001ISC4591001 1009 10091364J,IMMUNOGENICITYNA0040809826C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091364J,IMMUNOGENICITYNA0038261932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B>C4591001ISC4591001 1009 10091364J,IMMUNOGENICITYNA0044660185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1009 10091364J,IMMUNOGENICITYNA0044634350C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BbC4591001ISC4591001 1009 10091365J,IMMUNOGENICITYNA0040809839C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091365J,IMMUNOGENICITYNA0043398001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B>C4591001ISC4591001 1009 10091365J,IMMUNOGENICITYNA0044660206C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-20BC4591001ISC4591001 1009 10091366J,IMMUNOGENICITYNA0040809922C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1009 10091366J,IMMUNOGENICITYNA0031429837C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1009 10091366J,IMMUNOGENICITYNA0042505069C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-10BC4591001ISC4591001 1009 10091366J,IMMUNOGENICITYNA0038262140C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BdC4591001ISC4591001 1009 10091369J,IMMUNOGENICITYNA0040825814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1009 10091369J,IMMUNOGENICITYNA0031429816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1009 10091369J,IMMUNOGENICITYNA0042502215C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1009 10091369J,IMMUNOGENICITYNA0043288616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BhC4591001ISC4591001 1009 10091370J,IMMUNOGENICITYNA0040825811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1009 10091370J,IMMUNOGENICITYNA0031429603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1009 10091370J,IMMUNOGENICITYNA0049613725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1009 10091370J,IMMUNOGENICITYNA0043288859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BmC4591001ISC4591001 1009 10091371J,IMMUNOGENICITYNA0040825821C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1009 10091371J,IMMUNOGENICITYNA0031429611C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1009 10091371J,IMMUNOGENICITYNA0049614035C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1009 10091371J,IMMUNOGENICITYNA0043298224C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BcC4591001ISC4591001 1009 10091372J,IMMUNOGENICITYNA0040825792C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1009 10091372J,IMMUNOGENICITYNA0031429810C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B8C4591001ISC4591001 1009 10091372J,IMMUNOGENICITYNA0041681712C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1009 10091372J,IMMUNOGENICITYNA0043288615C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BhC4591001ISC4591001 1009 10091373J,IMMUNOGENICITYNA0040826012C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1009 10091373J,IMMUNOGENICITYNA0031429642C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1009 10091373J,IMMUNOGENICITYNA0041681677C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1009 10091373J,IMMUNOGENICITYNA0041705817C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-16BC4591001ISC4591001 1009 10091373J,IMMUNOGENICITYNA0044636189C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BgC4591001ISC4591001 1009 10091374J,IMMUNOGENICITYNA0040825796C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1009 10091374J,IMMUNOGENICITYNA0043398804C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1009 10091374J,IMMUNOGENICITYNA0041705651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1009 10091374J,IMMUNOGENICITYNA0043298212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BcC4591001ISC4591001 1009 10091375J,IMMUNOGENICITYNA0040825999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1009 10091375J,IMMUNOGENICITYNA0043398824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1009 10091375J,IMMUNOGENICITYNA0044747703C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1009 10091375J,IMMUNOGENICITYNA0043298222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BcC4591001ISC4591001 1009 10091376J,IMMUNOGENICITYNA0040826011C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1009 10091376J,IMMUNOGENICITYNA0043397452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1009 10091376J,IMMUNOGENICITYNA0049614001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1009 10091376J,IMMUNOGENICITYNA0043288635C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BeC4591001ISC4591001 1009 10091377J,IMMUNOGENICITYNA0040826001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1009 10091377J,IMMUNOGENICITYNA0043397480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1009 10091377J,IMMUNOGENICITYNA0049614009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1009 10091377J,IMMUNOGENICITYNA0044641253C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02BgC4591001ISC4591001 1009 10091378J,IMMUNOGENICITYNA0040825976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1009 10091378J,IMMUNOGENICITYNA0043397461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1009 10091378J,IMMUNOGENICITYNA0041705047C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1009 10091378J,IMMUNOGENICITYNA0051279740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-26BC4591001ISC4591001 1009 10091378J,IMMUNOGENICITYNA0044641223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02BgC4591001ISC4591001 1009 10091379J,IMMUNOGENICITYNA0040825977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1009 10091379J,IMMUNOGENICITYNA0043398574C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1009 10091379J,IMMUNOGENICITYNA0041605093C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1009 10091380J,IMMUNOGENICITYNA0040826767C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1009 10091380J,IMMUNOGENICITYNA0033141514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1009 10091380J,IMMUNOGENICITYNA0041704369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-23BC4591001ISC4591001 1009 10091380J,IMMUNOGENICITYNA0044635551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BcC4591001ISC4591001 1009 10091381J,IMMUNOGENICITYNA0040826748C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1009 10091381J,IMMUNOGENICITYNA0043397487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B0C4591001ISC4591001 1009 10091381J,IMMUNOGENICITYNA0044747684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1009 10091381J,IMMUNOGENICITYNA0044641260C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02B]C4591001ISC4591001 1009 10091382J,IMMUNOGENICITYNA0040809715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1009 10091382J,IMMUNOGENICITYNA0038260111C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1009 10091382J,IMMUNOGENICITYNA0041706173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1009 10091382J,IMMUNOGENICITYNA0043288846C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-07B^C4591001ISC4591001 1009 10091383J,IMMUNOGENICITYNA0040809702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1009 10091383J,IMMUNOGENICITYNA0042359181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B8C4591001ISC4591001 1009 10091383J,IMMUNOGENICITYNA0041705790C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-19BC4591001ISC4591001 1009 10091384J,IMMUNOGENICITYNA0040809736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1009 10091384J,IMMUNOGENICITYNA0033141492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-02-23B2C4591001ISC4591001 1009 10091385J,IMMUNOGENICITYNA0040809743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1009 10091385J,IMMUNOGENICITYNA0033141524C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1009 10091385J,IMMUNOGENICITYNA0041705630C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1009 10091385J,IMMUNOGENICITYNA0043288855C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05B[C4591001ISC4591001 1009 10091386J,IMMUNOGENICITYNA0040809746C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1009 10091386J,IMMUNOGENICITYNA0042359011C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1009 10091386J,IMMUNOGENICITYNA0049355536C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1009 10091386J,IMMUNOGENICITYNA0044578755C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-13BbC4591001ISC4591001 1009 10091387J,IMMUNOGENICITYNA0040809744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1009 10091387J,IMMUNOGENICITYNA0042358673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B;C4591001ISC4591001 1009 10091387J,IMMUNOGENICITYNA0044747762C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1009 10091388J,IMMUNOGENICITYNA0040809738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1009 10091388J,IMMUNOGENICITYNA0033141305C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1009 10091388J,IMMUNOGENICITYNA0041605100C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1009 10091388J,IMMUNOGENICITYNA0044578777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-13BbC4591001ISC4591001 1009 10091389J,IMMUNOGENICITYNA0040809728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1009 10091389J,IMMUNOGENICITYNA0038260070C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1009 10091389J,IMMUNOGENICITYNA0031429974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-28BC4591001ISC4591001 1009 10091390J,IMMUNOGENICITYNA0040809733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091390J,IMMUNOGENICITYNA0042359010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1009 10091390J,IMMUNOGENICITYNA0051279717C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1009 10091390J,IMMUNOGENICITYNA0043288627C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BTC4591001ISC4591001 1009 10091391J,IMMUNOGENICITYNA0042414643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091391J,IMMUNOGENICITYNA0042359018C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1009 10091391J,IMMUNOGENICITYNA0042505221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1009 10091391J,IMMUNOGENICITYNA0043298233C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BOC4591001ISC4591001 1009 10091392J,IMMUNOGENICITYNA0040809741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091392J,IMMUNOGENICITYNA0042359175C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1009 10091392J,IMMUNOGENICITYNA0049613734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-01BC4591001ISC4591001 1009 10091392J,IMMUNOGENICITYNA0043298214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BOC4591001ISC4591001 1009 10091393J,IMMUNOGENICITYNA0040826768C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091393J,IMMUNOGENICITYNA0042359216C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1009 10091393J,IMMUNOGENICITYNA0049355524C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1009 10091393J,IMMUNOGENICITYNA0043288617C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BTC4591001ISC4591001 1009 10091394J,IMMUNOGENICITYNA0040617340C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091394J,IMMUNOGENICITYNA0042358997C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1009 10091394J,IMMUNOGENICITYNA0042505372C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1009 10091394J,IMMUNOGENICITYNA0038262136C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BOC4591001ISC4591001 1009 10091395J,IMMUNOGENICITYNA0031429891C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091395J,IMMUNOGENICITYNA0042359185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1009 10091395J,IMMUNOGENICITYNA0042505697C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1009 10091395J,IMMUNOGENICITYNA0038262154C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BOC4591001ISC4591001 1009 10091396J,IMMUNOGENICITYNA0031429893C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091396J,IMMUNOGENICITYNA0043398996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1009 10091396J,IMMUNOGENICITYNA0042505563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-11BC4591001ISC4591001 1009 10091398J,IMMUNOGENICITYNA0031429903C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1009 10091398J,IMMUNOGENICITYNA0042358987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1009 10091398J,IMMUNOGENICITYNA0051279700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1009 10091399J,IMMUNOGENICITYNA0031429900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091399J,IMMUNOGENICITYNA0042358986C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091399J,IMMUNOGENICITYNA0051279489C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1009 10091399J,IMMUNOGENICITYNA0044636196C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BRC4591001ISC4591001 1009 10091400J,IMMUNOGENICITYNA0031429887C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091400J,IMMUNOGENICITYNA0044579120C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-12B@C4591001ISC4591001 1009 10091400J,IMMUNOGENICITYNA0042505092C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-06BC4591001ISC4591001 1009 10091400J,IMMUNOGENICITYNA0041679232C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-30BC4591001ISC4591001 1009 10091400J,IMMUNOGENICITYNA0044635549C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BYC4591001ISC4591001 1009 10091401J,IMMUNOGENICITYNA0031429894C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091401J,IMMUNOGENICITYNA0042359008C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091401J,IMMUNOGENICITYNA0049355525C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091401J,IMMUNOGENICITYNA0044578732C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-12B_C4591001ISC4591001 1009 10091402J,IMMUNOGENICITYNA0031429888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091402J,IMMUNOGENICITYNA0042358994C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091402J,IMMUNOGENICITYNA0049355555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091402J,IMMUNOGENICITYNA0044578769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-12B_C4591001ISC4591001 1009 10091403J,IMMUNOGENICITYNA0042414672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091403J,IMMUNOGENICITYNA0033141523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-24B0C4591001ISC4591001 1009 10091404J,IMMUNOGENICITYNA0031429909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091404J,IMMUNOGENICITYNA0038262517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091404J,IMMUNOGENICITYNA0049355544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1009 10091404J,IMMUNOGENICITYNA0042611651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-20BgC4591001ISC4591001 1009 10091405J,IMMUNOGENICITYNA0031429912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091405J,IMMUNOGENICITYNA0043399001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091405J,IMMUNOGENICITYNA0049355551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091405J,IMMUNOGENICITYNA0042611738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-16BcC4591001ISC4591001 1009 10091406J,IMMUNOGENICITYNA0031429897C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1009 10091406J,IMMUNOGENICITYNA0038260106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1009 10091406J,IMMUNOGENICITYNA0049355532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091406J,IMMUNOGENICITYNA0044578774C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-16BcC4591001ISC4591001 1009 10091407J,IMMUNOGENICITYNA0040617305C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1009 10091407J,IMMUNOGENICITYNA0042359025C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B2C4591001ISC4591001 1009 10091407J,IMMUNOGENICITYNA0042505380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1009 10091407J,IMMUNOGENICITYNA0042611745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14B^C4591001ISC4591001 1009 10091408J,IMMUNOGENICITYNA0040617333C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1009 10091408J,IMMUNOGENICITYNA0042359208C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1009 10091408J,IMMUNOGENICITYNA0042505072C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-06BC4591001ISC4591001 1009 10091408J,IMMUNOGENICITYNA0044660533C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04BrC4591001ISC4591001 1009 10091409J,IMMUNOGENICITYNA0040617315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1009 10091409J,IMMUNOGENICITYNA0042359191C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1009 10091409J,IMMUNOGENICITYNA0042505096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-06BC4591001ISC4591001 1009 10091409J,IMMUNOGENICITYNA0044660560C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04BrC4591001ISC4591001 1009 10091410J,IMMUNOGENICITYNA0040617300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1009 10091410J,IMMUNOGENICITYNA0042359195C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B1C4591001ISC4591001 1009 10091410J,IMMUNOGENICITYNA0049355537C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091410J,IMMUNOGENICITYNA0044636207C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BMC4591001ISC4591001 1009 10091411J,IMMUNOGENICITYNA0040617323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1009 10091411J,IMMUNOGENICITYNA0042358680C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B5C4591001ISC4591001 1009 10091411J,IMMUNOGENICITYNA0041605106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1009 10091411J,IMMUNOGENICITYNA0042611615C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BdC4591001ISC4591001 1009 10091412J,IMMUNOGENICITYNA0042414667C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1009 10091412J,IMMUNOGENICITYNA0044579105C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-15B?C4591001ISC4591001 1009 10091412J,IMMUNOGENICITYNA0049355519C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1009 10091412J,IMMUNOGENICITYNA0044747752C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-30BC4591001ISC4591001 1009 10091413J,IMMUNOGENICITYNA0042414668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1009 10091413J,IMMUNOGENICITYNA0042358644C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B5C4591001ISC4591001 1009 10091413J,IMMUNOGENICITYNA0042505095C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-09BC4591001ISC4591001 1009 10091413J,IMMUNOGENICITYNA0043297631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-05BTC4591001ISC4591001 1009 10091414J,IMMUNOGENICITYNA0044570131C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1009 10091414J,IMMUNOGENICITYNA0042358688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B5C4591001ISC4591001 1009 10091414J,IMMUNOGENICITYNA0051279501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1009 10091414J,IMMUNOGENICITYNA0042611620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-16B_C4591001ISC4591001 1013 10131821J,IMMUNOGENICITYNA0042421989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1013 10131821J,IMMUNOGENICITYNA0044571252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1013 10131821J,IMMUNOGENICITYNA0042479600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1013 10131821J,IMMUNOGENICITYNA0044578421C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-01-27B;C4591001ISC4591001 1013 10131822J,IMMUNOGENICITYNA0042421998C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1013 10131822J,IMMUNOGENICITYNA0044571278C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1013 10131822J,IMMUNOGENICITYNA0042479593C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1013 10131822J,IMMUNOGENICITYNA0044578402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-01-27B;C4591001ISC4591001 1013 10131823J,IMMUNOGENICITYNA0042421940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1013 10131823J,IMMUNOGENICITYNA0044570265C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1013 10131823J,IMMUNOGENICITYNA0042479618C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L OPEN LABEL TREATMENT2021-06-23BC4591001ISC4591001 1013 10131824J,IMMUNOGENICITYNA0042421958C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1013 10131824J,IMMUNOGENICITYNA0044570260C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1013 10131824J,IMMUNOGENICITYNA0042479579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1013 10131826J,IMMUNOGENICITYNA0042421832C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1013 10131826J,IMMUNOGENICITYNA0044578507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1013 10131826J,IMMUNOGENICITYNA0049629823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1013 10131828J,IMMUNOGENICITYNA0042421278C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131828J,IMMUNOGENICITYNA0044578425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B:C4591001ISC4591001 1013 10131828J,IMMUNOGENICITYNA0044611538C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-09BC4591001ISC4591001 1013 10131830J,IMMUNOGENICITYNA0042421794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131830J,IMMUNOGENICITYNA0044569970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B0C4591001ISC4591001 1013 10131830J,IMMUNOGENICITYNA0044578432C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-01-28B:C4591001ISC4591001 1013 10131835J,IMMUNOGENICITYNA0042421286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131835J,IMMUNOGENICITYNA0044570269C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1013 10131835J,IMMUNOGENICITYNA0041762786C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1013 10131836J,IMMUNOGENICITYNA0034570558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131836J,IMMUNOGENICITYNA0044570266C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1013 10131836J,IMMUNOGENICITYNA0049629819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1013 10131839J,IMMUNOGENICITYNA0034570532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131839J,IMMUNOGENICITYNA0044570244C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1013 10131839J,IMMUNOGENICITYNA0042480722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1013 10131841J,IMMUNOGENICITYNA0034570038C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131841J,IMMUNOGENICITYNA0044578516C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1013 10131841J,IMMUNOGENICITYNA0049628689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1013 10131842J,IMMUNOGENICITYNA0034570033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131842J,IMMUNOGENICITYNA0044578514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1013 10131842J,IMMUNOGENICITYNA0049628704C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-17BC4591001ISC4591001 1013 10131843J,IMMUNOGENICITYNA0042421270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131843J,IMMUNOGENICITYNA0044578406C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B9C4591001ISC4591001 1013 10131843J,IMMUNOGENICITYNA0042480695C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1013 10131844J,IMMUNOGENICITYNA0042421292C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1013 10131844J,IMMUNOGENICITYNA0044578410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B9C4591001ISC4591001 1013 10131844J,IMMUNOGENICITYNA0042479602C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-24BC4591001ISC4591001 1013 10131845J,IMMUNOGENICITYNA0034570065C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1013 10131845J,IMMUNOGENICITYNA0044750221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B2C4591001ISC4591001 1013 10131845J,IMMUNOGENICITYNA0049628730C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1013 10131846J,IMMUNOGENICITYNA0034570051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1013 10131846J,IMMUNOGENICITYNA0044578502C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B1C4591001ISC4591001 1013 10131848J,IMMUNOGENICITYNA0034570062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1013 10131848J,IMMUNOGENICITYNA0044578503C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B1C4591001ISC4591001 1013 10131850J,IMMUNOGENICITYNA0034570003C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1013 10131850J,IMMUNOGENICITYNA0044750229C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B6C4591001ISC4591001 1013 10131850J,IMMUNOGENICITYNA0042479587C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1013 10131851J,IMMUNOGENICITYNA0034570258C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1013 10131851J,IMMUNOGENICITYNA0044744589C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1013 10131851J,IMMUNOGENICITYNA0049628727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-21BC4591001ISC4591001 1013 10131852J,IMMUNOGENICITYNA0034570233C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1013 10131852J,IMMUNOGENICITYNA0044745149C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1013 10131852J,IMMUNOGENICITYNA0041762765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1013 10131852J,IMMUNOGENICITYNA0044619326C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-07BzC4591001ISC4591001 1013 10131855J,IMMUNOGENICITYNA0041756741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1013 10131855J,IMMUNOGENICITYNA0042479585C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1013 10131855J,IMMUNOGENICITYNA0044578403C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-01-27B3C4591001ISC4591001 1013 10131856J,IMMUNOGENICITYNA0043270374C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1013 10131856J,IMMUNOGENICITYNA0041776682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B>C4591001ISC4591001 1013 10131858J,IMMUNOGENICITYNA0043270358C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1013 10131858J,IMMUNOGENICITYNA0044745154C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B1C4591001ISC4591001 1013 10131858J,IMMUNOGENICITYNA0039441235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1013 10131859J,IMMUNOGENICITYNA0043270397C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1013 10131859J,IMMUNOGENICITYNA0042480821C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1013 10131859J,IMMUNOGENICITYNA0041773204C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-02B8C4591001ISC4591001 1013 10131860J,IMMUNOGENICITYNA0043273407C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1013 10131860J,IMMUNOGENICITYNA0044578398C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1013 10131860J,IMMUNOGENICITYNA0041762745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1013 10131861J,IMMUNOGENICITYNA0043273536C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1013 10131861J,IMMUNOGENICITYNA0041733110C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B@C4591001ISC4591001 1013 10131861J,IMMUNOGENICITYNA0042515994C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-25C0C4591001ISC4591001 1013 10131862J,IMMUNOGENICITYNA0043273544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1013 10131862J,IMMUNOGENICITYNA0044578428C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1013 10131863J,IMMUNOGENICITYNA0043272259C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1013 10131863J,IMMUNOGENICITYNA0044578414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1013 10131863J,IMMUNOGENICITYNA0044618090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1013 10131865J,IMMUNOGENICITYNA0043273570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1013 10131865J,IMMUNOGENICITYNA0041773193C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1013 10131865J,IMMUNOGENICITYNA0042479617C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1013 10131865J,IMMUNOGENICITYNA0041733097C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-10B;C4591001ISC4591001 1013 10131866J,IMMUNOGENICITYNA0043273566C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1013 10131866J,IMMUNOGENICITYNA0041773170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1013 10131866J,IMMUNOGENICITYNA0042480816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1013 10131866J,IMMUNOGENICITYNA0041775818C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-10B;C4591001ISC4591001 1013 10131867J,IMMUNOGENICITYNA0033812259C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1013 10131867J,IMMUNOGENICITYNA0041773178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1013 10131867J,IMMUNOGENICITYNA0049628095C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1013 10131868J,IMMUNOGENICITYNA0043273255C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1013 10131868J,IMMUNOGENICITYNA0041733118C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B5C4591001ISC4591001 1013 10131869J,IMMUNOGENICITYNA0043273268C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1013 10131869J,IMMUNOGENICITYNA0042410295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1013 10131870J,IMMUNOGENICITYNA0043273266C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1013 10131870J,IMMUNOGENICITYNA0042410308C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1013 10131871J,IMMUNOGENICITYNA0041608069C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1013 10131871J,IMMUNOGENICITYNA0041776517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1013 10131871J,IMMUNOGENICITYNA0042480776C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1013 10131872J,IMMUNOGENICITYNA0041608060C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1013 10131872J,IMMUNOGENICITYNA0042480781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1013 10131872J,IMMUNOGENICITYNA0041776478C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1013 10131873J,IMMUNOGENICITYNA0041609582C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1013 10131873J,IMMUNOGENICITYNA0041773172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B,C4591001ISC4591001 1013 10131873J,IMMUNOGENICITYNA0041727156C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-20BC4591001ISC4591001 1013 10131874J,IMMUNOGENICITYNA0041609566C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1013 10131874J,IMMUNOGENICITYNA0041773194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B,C4591001ISC4591001 1013 10131874J,IMMUNOGENICITYNA0041727161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-20BC4591001ISC4591001 1013 10131875J,IMMUNOGENICITYNA0041609572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1013 10131875J,IMMUNOGENICITYNA0041775846C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1013 10131875J,IMMUNOGENICITYNA0044618091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1013 10131876J,IMMUNOGENICITYNA0041609565C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1013 10131876J,IMMUNOGENICITYNA0044578597C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B9C4591001ISC4591001 1013 10131876J,IMMUNOGENICITYNA0042480797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1013 10131877J,IMMUNOGENICITYNA0041613356C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1013 10131877J,IMMUNOGENICITYNA0041774462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01BEC4591001ISC4591001 1013 10131877J,IMMUNOGENICITYNA0042480250C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1013 10131878J,IMMUNOGENICITYNA0041613364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1013 10131878J,IMMUNOGENICITYNA0044578631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B8C4591001ISC4591001 1013 10131879J,IMMUNOGENICITYNA0041613332C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1013 10131879J,IMMUNOGENICITYNA0041776491C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B0C4591001ISC4591001 1013 10131879J,IMMUNOGENICITYNA0044611285C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-28BC4591001ISC4591001 1013 10131880J,IMMUNOGENICITYNA0041613329C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1013 10131880J,IMMUNOGENICITYNA0041776471C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B0C4591001ISC4591001 1013 10131880J,IMMUNOGENICITYNA0042480801C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1013 10131881J,IMMUNOGENICITYNA0041613215C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1013 10131881J,IMMUNOGENICITYNA0044578296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1013 10131881J,IMMUNOGENICITYNA0042480696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1013 10131881J,IMMUNOGENICITYNA0044578519C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-20BC4591001ISC4591001 1013 10131882J,IMMUNOGENICITYNA0041613212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1013 10131882J,IMMUNOGENICITYNA0042410399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1013 10131882J,IMMUNOGENICITYNA0039441234C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1013 10131882J,IMMUNOGENICITYNA0041613338C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-19BC4591001ISC4591001 1013 10131883J,IMMUNOGENICITYNA0041613289C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1013 10131883J,IMMUNOGENICITYNA0041776400C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B8C4591001ISC4591001 1013 10131883J,IMMUNOGENICITYNA0041761124C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1013 10131884J,IMMUNOGENICITYNA0042384488C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1013 10131884J,IMMUNOGENICITYNA0041776579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1013 10131884J,IMMUNOGENICITYNA0044848522C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-18BC4591001ISC4591001 1013 10131884J,IMMUNOGENICITYNA0044583477C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-28BC4591001ISC4591001 1013 10131885J,IMMUNOGENICITYNA0042384493C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1013 10131885J,IMMUNOGENICITYNA0041776662C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1013 10131885J,IMMUNOGENICITYNA0049628067C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1013 10131886J,IMMUNOGENICITYNA0042384466C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1013 10131886J,IMMUNOGENICITYNA0041776391C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1013 10131886J,IMMUNOGENICITYNA0037527934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1013 10131886J,IMMUNOGENICITYNA0041776068C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-02-01BC4591001ISC4591001 1016 10161307J,IMMUNOGENICITYNA0034639459C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1016 10161307J,IMMUNOGENICITYNA0043508758C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-03B2C4591001ISC4591001 1016 10161307J,IMMUNOGENICITYNA0044561587C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-30BC4591001ISC4591001 1016 10161307J,IMMUNOGENICITYNA0042410051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1016 10161307J,IMMUNOGENICITYNA0044745556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BpC4591001ISC4591001 1016 10161308J,IMMUNOGENICITYNA0034639447C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1016 10161308J,IMMUNOGENICITYNA0043508858C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B6C4591001ISC4591001 1016 10161308J,IMMUNOGENICITYNA0034631033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-03BC4591001ISC4591001 1016 10161308J,IMMUNOGENICITYNA0044688064C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1016 10161308J,IMMUNOGENICITYNA0044745494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-01-28BjC4591001ISC4591001 1016 10161309J,IMMUNOGENICITYNA0034639444C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1016 10161309J,IMMUNOGENICITYNA0043298309C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-16B?C4591001ISC4591001 1016 10161309J,IMMUNOGENICITYNA0043509136C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-05-13BC4591001ISC4591001 1016 10161309J,IMMUNOGENICITYNA0042432386C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-04BqC4591001ISC4591001 1016 10161310J,IMMUNOGENICITYNA0034639439C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1016 10161310J,IMMUNOGENICITYNA0043508740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-02B1C4591001ISC4591001 1016 10161310J,IMMUNOGENICITYNA0044561579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-29BC4591001ISC4591001 1016 10161310J,IMMUNOGENICITYNA0042432381C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-04BqC4591001ISC4591001 1016 10161311J,IMMUNOGENICITYNA0034639445C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-15AC4591001ISC4591001 1016 10161311J,IMMUNOGENICITYNA0043508737C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-02B1C4591001ISC4591001 1016 10161311J,IMMUNOGENICITYNA0044561572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-04-29BC4591001ISC4591001 1016 10161314J,IMMUNOGENICITYNA0031384205C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1016 10161314J,IMMUNOGENICITYNA0043508721C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B2C4591001ISC4591001 1016 10161314J,IMMUNOGENICITYNA0044567323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-30BC4591001ISC4591001 1016 10161314J,IMMUNOGENICITYNA0044745508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BoC4591001ISC4591001 1016 10161315J,IMMUNOGENICITYNA0031384210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1016 10161315J,IMMUNOGENICITYNA0043508726C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B2C4591001ISC4591001 1016 10161315J,IMMUNOGENICITYNA0044561555C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-03BC4591001ISC4591001 1016 10161315J,IMMUNOGENICITYNA0043475218C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1016 10161315J,IMMUNOGENICITYNA0042432374C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BqC4591001ISC4591001 1016 10161316J,IMMUNOGENICITYNA0031384215C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1016 10161316J,IMMUNOGENICITYNA0043298292C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B<C4591001ISC4591001 1016 10161316J,IMMUNOGENICITYNA0042393165C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-25BC4591001ISC4591001 1016 10161318J,IMMUNOGENICITYNA0031384236C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1016 10161318J,IMMUNOGENICITYNA0043508900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-04B2C4591001ISC4591001 1016 10161318J,IMMUNOGENICITYNA0044687294C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-03BC4591001ISC4591001 1016 10161318J,IMMUNOGENICITYNA0049627498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-10BC4591001ISC4591001 1016 10161318J,IMMUNOGENICITYNA0042432370C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-04BpC4591001ISC4591001 1016 10161319J,IMMUNOGENICITYNA0031384206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-16AC4591001ISC4591001 1016 10161319J,IMMUNOGENICITYNA0043508748C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-02B0C4591001ISC4591001 1016 10161319J,IMMUNOGENICITYNA0044561556C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-04-29BC4591001ISC4591001 1016 10161319J,IMMUNOGENICITYNA0044688024C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1016 10161320J,IMMUNOGENICITYNA0034639649C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161320J,IMMUNOGENICITYNA0043508867C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B1C4591001ISC4591001 1016 10161320J,IMMUNOGENICITYNA0044687290C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-04BC4591001ISC4591001 1016 10161322J,IMMUNOGENICITYNA0031384212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1016 10161322J,IMMUNOGENICITYNA0043508741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B2C4591001ISC4591001 1016 10161322J,IMMUNOGENICITYNA0044687272C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-04BC4591001ISC4591001 1016 10161322J,IMMUNOGENICITYNA0042432364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BnC4591001ISC4591001 1016 10161323J,IMMUNOGENICITYNA0031384199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1016 10161323J,IMMUNOGENICITYNA0043508873C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B2C4591001ISC4591001 1016 10161323J,IMMUNOGENICITYNA0044559302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-12BC4591001ISC4591001 1016 10161323J,IMMUNOGENICITYNA0042354784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-09BrC4591001ISC4591001 1016 10161324J,IMMUNOGENICITYNA0031384243C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1016 10161324J,IMMUNOGENICITYNA0043508878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B2C4591001ISC4591001 1016 10161324J,IMMUNOGENICITYNA0044559333C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-12BC4591001ISC4591001 1016 10161324J,IMMUNOGENICITYNA0042410157C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1016 10161324J,IMMUNOGENICITYNA0042354804C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-09BrC4591001ISC4591001 1016 10161325J,IMMUNOGENICITYNA0040905382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-19AC4591001ISC4591001 1016 10161325J,IMMUNOGENICITYNA0043508902C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B3C4591001ISC4591001 1016 10161325J,IMMUNOGENICITYNA0044687255C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-05BC4591001ISC4591001 1016 10161325J,IMMUNOGENICITYNA0042354783C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BnC4591001ISC4591001 1016 10161326J,IMMUNOGENICITYNA0034639443C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1016 10161326J,IMMUNOGENICITYNA0043508862C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B2C4591001ISC4591001 1016 10161326J,IMMUNOGENICITYNA0044559306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1016 10161326J,IMMUNOGENICITYNA0044745551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BkC4591001ISC4591001 1016 10161327J,IMMUNOGENICITYNA0034639451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1016 10161327J,IMMUNOGENICITYNA0043508886C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-08B2C4591001ISC4591001 1016 10161327J,IMMUNOGENICITYNA0044559321C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1016 10161327J,IMMUNOGENICITYNA0042410162C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1016 10161327J,IMMUNOGENICITYNA0044745532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BkC4591001ISC4591001 1016 10161329J,IMMUNOGENICITYNA0034639640C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1016 10161329J,IMMUNOGENICITYNA0043298303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-14B8C4591001ISC4591001 1016 10161329J,IMMUNOGENICITYNA0044559295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1016 10161329J,IMMUNOGENICITYNA0042410078C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1016 10161329J,IMMUNOGENICITYNA0044745509C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-02BjC4591001ISC4591001 1016 10161330J,IMMUNOGENICITYNA0034639647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1016 10161330J,IMMUNOGENICITYNA0041774889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-11B5C4591001ISC4591001 1016 10161330J,IMMUNOGENICITYNA0044559318C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-11BC4591001ISC4591001 1016 10161330J,IMMUNOGENICITYNA0042432350C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-04BlC4591001ISC4591001 1016 10161331J,IMMUNOGENICITYNA0034639668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-20AC4591001ISC4591001 1016 10161331J,IMMUNOGENICITYNA0041774909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B3C4591001ISC4591001 1016 10161331J,IMMUNOGENICITYNA0044559311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-06BC4591001ISC4591001 1016 10161331J,IMMUNOGENICITYNA0042410164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1016 10161331J,IMMUNOGENICITYNA0044745071C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-01BiC4591001ISC4591001 1016 10161332J,IMMUNOGENICITYNA0031384853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161332J,IMMUNOGENICITYNA0043508903C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-07B0C4591001ISC4591001 1016 10161332J,IMMUNOGENICITYNA0044559339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-12BC4591001ISC4591001 1016 10161332J,IMMUNOGENICITYNA0042354800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-09BpC4591001ISC4591001 1016 10161334J,IMMUNOGENICITYNA0031384850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161334J,IMMUNOGENICITYNA0041774931C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B3C4591001ISC4591001 1016 10161334J,IMMUNOGENICITYNA0044559301C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-07BC4591001ISC4591001 1016 10161334J,IMMUNOGENICITYNA0042410171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1016 10161335J,IMMUNOGENICITYNA0031384820C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161335J,IMMUNOGENICITYNA0040926472C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B2C4591001ISC4591001 1016 10161335J,IMMUNOGENICITYNA0044559328C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-12BC4591001ISC4591001 1016 10161335J,IMMUNOGENICITYNA0042393146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26BC4591001ISC4591001 1016 10161336J,IMMUNOGENICITYNA0031384857C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161336J,IMMUNOGENICITYNA0043508743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B2C4591001ISC4591001 1016 10161336J,IMMUNOGENICITYNA0044559332C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-12BC4591001ISC4591001 1016 10161336J,IMMUNOGENICITYNA0049627502C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-06C0C4591001ISC4591001 1016 10161336J,IMMUNOGENICITYNA0044567156C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26BC4591001ISC4591001 1016 10161337J,IMMUNOGENICITYNA0031384859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-21AC4591001ISC4591001 1016 10161337J,IMMUNOGENICITYNA0041774918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B2C4591001ISC4591001 1016 10161337J,IMMUNOGENICITYNA0044561594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-19BC4591001ISC4591001 1016 10161337J,IMMUNOGENICITYNA0044745555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-01BhC4591001ISC4591001 1016 10161338J,IMMUNOGENICITYNA0031384845C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1016 10161338J,IMMUNOGENICITYNA0043297991C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-28BDC4591001ISC4591001 1016 10161338J,IMMUNOGENICITYNA0044687279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-04BC4591001ISC4591001 1016 10161338J,IMMUNOGENICITYNA0042432361C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BkC4591001ISC4591001 1016 10161339J,IMMUNOGENICITYNA0031384849C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1016 10161339J,IMMUNOGENICITYNA0040926494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B1C4591001ISC4591001 1016 10161339J,IMMUNOGENICITYNA0044687293C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-05BC4591001ISC4591001 1016 10161339J,IMMUNOGENICITYNA0044745062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BiC4591001ISC4591001 1016 10161340J,IMMUNOGENICITYNA0031384865C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1016 10161340J,IMMUNOGENICITYNA0043508718C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-09B1C4591001ISC4591001 1016 10161340J,IMMUNOGENICITYNA0044687263C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-05BC4591001ISC4591001 1016 10161340J,IMMUNOGENICITYNA0044688047C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1016 10161340J,IMMUNOGENICITYNA0044745054C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BiC4591001ISC4591001 1016 10161343J,IMMUNOGENICITYNA0031384826C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1016 10161343J,IMMUNOGENICITYNA0041774926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-11B3C4591001ISC4591001 1016 10161343J,IMMUNOGENICITYNA0044559340C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-11BC4591001ISC4591001 1016 10161343J,IMMUNOGENICITYNA0042432395C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BkC4591001ISC4591001 1016 10161344J,IMMUNOGENICITYNA0031384837C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-10-22AC4591001ISC4591001 1016 10161344J,IMMUNOGENICITYNA0041774896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2020-12-10B2C4591001ISC4591001 1016 10161344J,IMMUNOGENICITYNA0044559307C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-05-06BC4591001ISC4591001 1016 10161344J,IMMUNOGENICITYNA0043509138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1016 10161344J,IMMUNOGENICITYNA0044745074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03BiC4591001ISC4591001 1016 10161350J,IMMUNOGENICITYNA0043508917C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1016 10161350J,IMMUNOGENICITYNA0031384719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1016 10161350J,IMMUNOGENICITYNA0049627521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1016 10161350J,IMMUNOGENICITYNA0044745547C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-02BAC4591001ISC4591001 1016 10161351J,IMMUNOGENICITYNA0043508949C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1016 10161351J,IMMUNOGENICITYNA0031384676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1016 10161351J,IMMUNOGENICITYNA0049627507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-14BC4591001ISC4591001 1016 10161351J,IMMUNOGENICITYNA0042431541C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-12BKC4591001ISC4591001 1016 10161352J,IMMUNOGENICITYNA0043508912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1016 10161352J,IMMUNOGENICITYNA0043297896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B4C4591001ISC4591001 1016 10161352J,IMMUNOGENICITYNA0042410177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1016 10161353J,IMMUNOGENICITYNA0043508929C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1016 10161353J,IMMUNOGENICITYNA0043298093C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B4C4591001ISC4591001 1016 10161353J,IMMUNOGENICITYNA0044688020C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1016 10161353J,IMMUNOGENICITYNA0042432382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-04BCC4591001ISC4591001 1016 10161354J,IMMUNOGENICITYNA0043508943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1016 10161354J,IMMUNOGENICITYNA0041774711C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B3C4591001ISC4591001 1016 10161354J,IMMUNOGENICITYNA0049627499C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1016 10161354J,IMMUNOGENICITYNA0042432355C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-03B@C4591001ISC4591001 1016 10161356J,IMMUNOGENICITYNA0040926885C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1016 10161356J,IMMUNOGENICITYNA0041774712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B3C4591001ISC4591001 1016 10161356J,IMMUNOGENICITYNA0049627530C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1016 10161356J,IMMUNOGENICITYNA0044745550C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05BBC4591001ISC4591001 1016 10161357J,IMMUNOGENICITYNA0043508759C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1016 10161357J,IMMUNOGENICITYNA0041774733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B3C4591001ISC4591001 1016 10161357J,IMMUNOGENICITYNA0049627496C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1016 10161357J,IMMUNOGENICITYNA0042354799C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-16BMC4591001ISC4591001 1016 10161358J,IMMUNOGENICITYNA0043508738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1016 10161358J,IMMUNOGENICITYNA0041774735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B2C4591001ISC4591001 1016 10161358J,IMMUNOGENICITYNA0049627495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1016 10161358J,IMMUNOGENICITYNA0042354782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-09BEC4591001ISC4591001 1016 10161361J,IMMUNOGENICITYNA0040641785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1016 10161361J,IMMUNOGENICITYNA0043298061C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1016 10161361J,IMMUNOGENICITYNA0043509142C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1016 10161362J,IMMUNOGENICITYNA0043508898C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1016 10161362J,IMMUNOGENICITYNA0044745330C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B6C4591001ISC4591001 1016 10161362J,IMMUNOGENICITYNA0044688022C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1016 10161362J,IMMUNOGENICITYNA0042354762C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-09BDC4591001ISC4591001 1016 10161363J,IMMUNOGENICITYNA0043508714C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1016 10161363J,IMMUNOGENICITYNA0044745345C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1016 10161363J,IMMUNOGENICITYNA0049627490C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1016 10161364J,IMMUNOGENICITYNA0041774901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1016 10161364J,IMMUNOGENICITYNA0042432387C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B:C4591001ISC4591001 1016 10161364J,IMMUNOGENICITYNA0042410165C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1016 10161365J,IMMUNOGENICITYNA0041774892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1016 10161365J,IMMUNOGENICITYNA0044745462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1016 10161365J,IMMUNOGENICITYNA0043509140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1016 10161366J,IMMUNOGENICITYNA0043298298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1016 10161366J,IMMUNOGENICITYNA0044566693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17BAC4591001ISC4591001 1016 10161366J,IMMUNOGENICITYNA0042410069C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1016 10161367J,IMMUNOGENICITYNA0043297995C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1016 10161367J,IMMUNOGENICITYNA0044552779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1016 10161367J,IMMUNOGENICITYNA0044688042C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1016 10161367J,IMMUNOGENICITYNA0042431552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-02-12B.C4591001ISC4591001 1016 10161368J,IMMUNOGENICITYNA0043508990C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1016 10161368J,IMMUNOGENICITYNA0044566180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B4C4591001ISC4591001 1016 10161368J,IMMUNOGENICITYNA0042410080C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1016 10161369J,IMMUNOGENICITYNA0043508985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1016 10161369J,IMMUNOGENICITYNA0044566452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B@C4591001ISC4591001 1016 10161369J,IMMUNOGENICITYNA0051357902C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1016 10161370J,IMMUNOGENICITYNA0043508980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1016 10161370J,IMMUNOGENICITYNA0040926291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1016 10161370J,IMMUNOGENICITYNA0051357433C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1016 10161370J,IMMUNOGENICITYNA0044745344C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-25BC4591001ISC4591001 1016 10161371J,IMMUNOGENICITYNA0043508978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1016 10161371J,IMMUNOGENICITYNA0042393057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B3C4591001ISC4591001 1016 10161371J,IMMUNOGENICITYNA0044688039C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1016 10161371J,IMMUNOGENICITYNA0044745317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-26BC4591001ISC4591001 1016 10161372J,IMMUNOGENICITYNA0043508961C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1016 10161372J,IMMUNOGENICITYNA0042393147C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1016 10161372J,IMMUNOGENICITYNA0043509115C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1016 10161373J,IMMUNOGENICITYNA0043508996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1016 10161373J,IMMUNOGENICITYNA0042393171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1016 10161373J,IMMUNOGENICITYNA0049634334C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1016 10161373J,IMMUNOGENICITYNA0044745329C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-27BC4591001ISC4591001 1016 10161374J,IMMUNOGENICITYNA0043309904C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1016 10161374J,IMMUNOGENICITYNA0040926309C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1016 10161374J,IMMUNOGENICITYNA0042432007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1016 10161374J,IMMUNOGENICITYNA0044745480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-28BC4591001ISC4591001 1016 10161375J,IMMUNOGENICITYNA0043309910C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1016 10161375J,IMMUNOGENICITYNA0042393083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1016 10161375J,IMMUNOGENICITYNA0043509131C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1016 10161375J,IMMUNOGENICITYNA0044745498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-27BC4591001ISC4591001 1016 10161376J,IMMUNOGENICITYNA0043309916C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1016 10161376J,IMMUNOGENICITYNA0044567013C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B0C4591001ISC4591001 1016 10161376J,IMMUNOGENICITYNA0041739894C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1016 10161376J,IMMUNOGENICITYNA0044745350C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-26BC4591001ISC4591001 1016 10161377J,IMMUNOGENICITYNA0043309933C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1016 10161377J,IMMUNOGENICITYNA0044567014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B0C4591001ISC4591001 1016 10161377J,IMMUNOGENICITYNA0051357874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1016 10161377J,IMMUNOGENICITYNA0044745333C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-26BC4591001ISC4591001 1016 10161378J,IMMUNOGENICITYNA0043309942C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1016 10161378J,IMMUNOGENICITYNA0042393067C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B0C4591001ISC4591001 1016 10161378J,IMMUNOGENICITYNA0051357915C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-23BC4591001ISC4591001 1016 10161378J,IMMUNOGENICITYNA0042431996C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-04BC4591001ISC4591001 1016 10161379J,IMMUNOGENICITYNA0043309941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1016 10161379J,IMMUNOGENICITYNA0042393124C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-10B?C4591001ISC4591001 1016 10161379J,IMMUNOGENICITYNA0042410139C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1016 10161381J,IMMUNOGENICITYNA0043309913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161381J,IMMUNOGENICITYNA0042393182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B1C4591001ISC4591001 1016 10161381J,IMMUNOGENICITYNA0042431975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1016 10161381J,IMMUNOGENICITYNA0044745506C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-28BC4591001ISC4591001 1016 10161382J,IMMUNOGENICITYNA0043309914C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161382J,IMMUNOGENICITYNA0040926304C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1016 10161382J,IMMUNOGENICITYNA0051278011C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1016 10161382J,IMMUNOGENICITYNA0043298084C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-28BC4591001ISC4591001 1016 10161383J,IMMUNOGENICITYNA0043309935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161383J,IMMUNOGENICITYNA0040926306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1016 10161383J,IMMUNOGENICITYNA0043509108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B~C4591001ISC4591001 1016 10161383J,IMMUNOGENICITYNA0044745477C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-28BC4591001ISC4591001 1016 10161384J,IMMUNOGENICITYNA0043309929C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161384J,IMMUNOGENICITYNA0042393085C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B0C4591001ISC4591001 1016 10161384J,IMMUNOGENICITYNA0051357920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1016 10161384J,IMMUNOGENICITYNA0044745338C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-27BC4591001ISC4591001 1016 10161385J,IMMUNOGENICITYNA0043309949C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161385J,IMMUNOGENICITYNA0042393176C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1016 10161385J,IMMUNOGENICITYNA0049629219C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1016 10161385J,IMMUNOGENICITYNA0044745035C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-29BC4591001ISC4591001 1016 10161386J,IMMUNOGENICITYNA0043309938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161386J,IMMUNOGENICITYNA0042393181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B1C4591001ISC4591001 1016 10161386J,IMMUNOGENICITYNA0043509141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B~C4591001ISC4591001 1016 10161387J,IMMUNOGENICITYNA0043309919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1016 10161387J,IMMUNOGENICITYNA0042393093C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B0C4591001ISC4591001 1016 10161387J,IMMUNOGENICITYNA0049634304C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1016 10161387J,IMMUNOGENICITYNA0044745495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-01-27BC4591001ISC4591001 1016 10161388J,IMMUNOGENICITYNA0043508983C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1016 10161388J,IMMUNOGENICITYNA0044566480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1016 10161388J,IMMUNOGENICITYNA0044687287C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-05BsC4591001ISC4591001 1016 10161388J,IMMUNOGENICITYNA0044745517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT VACCINATION 2021-02-02BC4591001ISC4591001 1039 10391246J,IMMUNOGENICITYNA0040670269C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1039 10391246J,IMMUNOGENICITYNA0041774845C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1039 10391246J,IMMUNOGENICITYNA0042359244C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-26BXC4591001ISC4591001 1039 10391247J,IMMUNOGENICITYNA0043489722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1039 10391247J,IMMUNOGENICITYNA0041774858C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1039 10391247J,IMMUNOGENICITYNA0044643337C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1039 10391247J,IMMUNOGENICITYNA0042426252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BlC4591001ISC4591001 1039 10391250J,IMMUNOGENICITYNA0040808376C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1039 10391250J,IMMUNOGENICITYNA0040808292C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B7C4591001ISC4591001 1039 10391250J,IMMUNOGENICITYNA0044586831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1039 10391251J,IMMUNOGENICITYNA0040808359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391251J,IMMUNOGENICITYNA0040808306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-02-02B:C4591001ISC4591001 1039 10391252J,IMMUNOGENICITYNA0040808365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391252J,IMMUNOGENICITYNA0041775147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1039 10391252J,IMMUNOGENICITYNA0042426249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-25BmC4591001ISC4591001 1039 10391253J,IMMUNOGENICITYNA0040808410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391253J,IMMUNOGENICITYNA0040808286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1039 10391253J,IMMUNOGENICITYNA0042426229C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BfC4591001ISC4591001 1039 10391255J,IMMUNOGENICITYNA0040808356C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391255J,IMMUNOGENICITYNA0041775146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1039 10391255J,IMMUNOGENICITYNA0041605385C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1039 10391256J,IMMUNOGENICITYNA0040808422C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391256J,IMMUNOGENICITYNA0041775173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1039 10391256J,IMMUNOGENICITYNA0042536642C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391258J,IMMUNOGENICITYNA0040890249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391258J,IMMUNOGENICITYNA0040808278C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1039 10391258J,IMMUNOGENICITYNA0042536666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391259J,IMMUNOGENICITYNA0040808370C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391259J,IMMUNOGENICITYNA0041775154C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1039 10391259J,IMMUNOGENICITYNA0044558164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391260J,IMMUNOGENICITYNA0040808433C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1039 10391260J,IMMUNOGENICITYNA0041775127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1039 10391260J,IMMUNOGENICITYNA0044559151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1039 10391262J,IMMUNOGENICITYNA0040808447C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391262J,IMMUNOGENICITYNA0041775135C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1039 10391262J,IMMUNOGENICITYNA0041604914C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1039 10391263J,IMMUNOGENICITYNA0040808417C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391263J,IMMUNOGENICITYNA0040808260C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1039 10391263J,IMMUNOGENICITYNA0041604912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1039 10391264J,IMMUNOGENICITYNA0040879527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391264J,IMMUNOGENICITYNA0042359027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01BTC4591001ISC4591001 1039 10391264J,IMMUNOGENICITYNA0041702702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1039 10391265J,IMMUNOGENICITYNA0040890281C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391265J,IMMUNOGENICITYNA0042359032C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01BTC4591001ISC4591001 1039 10391265J,IMMUNOGENICITYNA0041605399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1039 10391266J,IMMUNOGENICITYNA0040808448C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391266J,IMMUNOGENICITYNA0041775130C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1039 10391267J,IMMUNOGENICITYNA0040669976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391267J,IMMUNOGENICITYNA0041775182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1039 10391267J,IMMUNOGENICITYNA0041604898C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1039 10391268J,IMMUNOGENICITYNA0040890563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391268J,IMMUNOGENICITYNA0041775208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1039 10391268J,IMMUNOGENICITYNA0042536768C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391269J,IMMUNOGENICITYNA0040808418C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1039 10391269J,IMMUNOGENICITYNA0041775185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1039 10391269J,IMMUNOGENICITYNA0044586806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1039 10391270J,IMMUNOGENICITYNA0040890276C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1039 10391270J,IMMUNOGENICITYNA0041775197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1039 10391270J,IMMUNOGENICITYNA0044643853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391271J,IMMUNOGENICITYNA0040669549C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1039 10391271J,IMMUNOGENICITYNA0041775215C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1039 10391271J,IMMUNOGENICITYNA0044758170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391272J,IMMUNOGENICITYNA0040808421C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1039 10391272J,IMMUNOGENICITYNA0041775184C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1039 10391272J,IMMUNOGENICITYNA0044586818C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1039 10391273J,IMMUNOGENICITYNA0040808403C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1039 10391273J,IMMUNOGENICITYNA0041775189C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1039 10391273J,IMMUNOGENICITYNA0044758136C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391274J,IMMUNOGENICITYNA0041608260C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391274J,IMMUNOGENICITYNA0041775174C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1039 10391274J,IMMUNOGENICITYNA0044758172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391275J,IMMUNOGENICITYNA0042404797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391275J,IMMUNOGENICITYNA0041775166C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1039 10391275J,IMMUNOGENICITYNA0044559192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1039 10391276J,IMMUNOGENICITYNA0042404781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391276J,IMMUNOGENICITYNA0041771410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B4C4591001ISC4591001 1039 10391276J,IMMUNOGENICITYNA0041605409C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1039 10391277J,IMMUNOGENICITYNA0041607855C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391277J,IMMUNOGENICITYNA0041771408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B4C4591001ISC4591001 1039 10391277J,IMMUNOGENICITYNA0044758176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391278J,IMMUNOGENICITYNA0041607833C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391278J,IMMUNOGENICITYNA0041771425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B8C4591001ISC4591001 1039 10391278J,IMMUNOGENICITYNA0044586835C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1039 10391279J,IMMUNOGENICITYNA0041607840C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1039 10391279J,IMMUNOGENICITYNA0040808194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1039 10391279J,IMMUNOGENICITYNA0041775171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1039 10391280J,IMMUNOGENICITYNA0042404772C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1039 10391280J,IMMUNOGENICITYNA0040808293C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1039 10391280J,IMMUNOGENICITYNA0042536684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391281J,IMMUNOGENICITYNA0041608286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1039 10391281J,IMMUNOGENICITYNA0040808272C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1039 10391281J,IMMUNOGENICITYNA0041604911C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1039 10391282J,IMMUNOGENICITYNA0042404785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391282J,IMMUNOGENICITYNA0041771411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391282J,IMMUNOGENICITYNA0041605516C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1039 10391283J,IMMUNOGENICITYNA0041608255C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391283J,IMMUNOGENICITYNA0041775213C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B1C4591001ISC4591001 1039 10391283J,IMMUNOGENICITYNA0044558585C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391284J,IMMUNOGENICITYNA0041608246C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391284J,IMMUNOGENICITYNA0040808276C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B1C4591001ISC4591001 1039 10391284J,IMMUNOGENICITYNA0044586814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1039 10391285J,IMMUNOGENICITYNA0042404784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391285J,IMMUNOGENICITYNA0041771396C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391285J,IMMUNOGENICITYNA0042536682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391285J,IMMUNOGENICITYNA0044583314C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BcC4591001ISC4591001 1039 10391286J,IMMUNOGENICITYNA0041608252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391286J,IMMUNOGENICITYNA0040806389C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391286J,IMMUNOGENICITYNA0044586807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1039 10391286J,IMMUNOGENICITYNA0044767391C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BcC4591001ISC4591001 1039 10391287J,IMMUNOGENICITYNA0041608267C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391287J,IMMUNOGENICITYNA0040806425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B5C4591001ISC4591001 1039 10391287J,IMMUNOGENICITYNA0044758149C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391289J,IMMUNOGENICITYNA0040776813C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391289J,IMMUNOGENICITYNA0040808174C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391289J,IMMUNOGENICITYNA0041605386C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1039 10391290J,IMMUNOGENICITYNA0041607825C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391290J,IMMUNOGENICITYNA0040806426C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391290J,IMMUNOGENICITYNA0044559179C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1039 10391291J,IMMUNOGENICITYNA0042404802C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391291J,IMMUNOGENICITYNA0041771405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391291J,IMMUNOGENICITYNA0042425817C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-26BcC4591001ISC4591001 1039 10391292J,IMMUNOGENICITYNA0041607860C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1039 10391292J,IMMUNOGENICITYNA0041771384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1039 10391292J,IMMUNOGENICITYNA0044758140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391293J,IMMUNOGENICITYNA0042404763C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1039 10391293J,IMMUNOGENICITYNA0040806414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1039 10391293J,IMMUNOGENICITYNA0041605405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1039 10391294J,IMMUNOGENICITYNA0042404782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1039 10391294J,IMMUNOGENICITYNA0041771409C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1039 10391294J,IMMUNOGENICITYNA0042536669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391295J,IMMUNOGENICITYNA0042404789C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391295J,IMMUNOGENICITYNA0041775153C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1039 10391295J,IMMUNOGENICITYNA0041605384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1039 10391296J,IMMUNOGENICITYNA0040777460C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391296J,IMMUNOGENICITYNA0040806427C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1039 10391296J,IMMUNOGENICITYNA0033098771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391297J,IMMUNOGENICITYNA0041608277C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391297J,IMMUNOGENICITYNA0041702481C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1039 10391298J,IMMUNOGENICITYNA0041608268C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391298J,IMMUNOGENICITYNA0040806398C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1039 10391298J,IMMUNOGENICITYNA0041605382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1039 10391299J,IMMUNOGENICITYNA0040777487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391299J,IMMUNOGENICITYNA0040806433C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1039 10391299J,IMMUNOGENICITYNA0042536661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391300J,IMMUNOGENICITYNA0041608273C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391300J,IMMUNOGENICITYNA0041605441C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1039 10391301J,IMMUNOGENICITYNA0041608276C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391301J,IMMUNOGENICITYNA0040806432C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1039 10391301J,IMMUNOGENICITYNA0042536676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391302J,IMMUNOGENICITYNA0042404795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391302J,IMMUNOGENICITYNA0040806402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1039 10391302J,IMMUNOGENICITYNA0051278058C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1039 10391303J,IMMUNOGENICITYNA0041608257C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391303J,IMMUNOGENICITYNA0040806430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1039 10391303J,IMMUNOGENICITYNA0044758141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1039 10391304J,IMMUNOGENICITYNA0041607853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1039 10391304J,IMMUNOGENICITYNA0042358760C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B:C4591001ISC4591001 1039 10391304J,IMMUNOGENICITYNA0044559181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1039 10391305J,IMMUNOGENICITYNA0043489501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1039 10391305J,IMMUNOGENICITYNA0040806392C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B0C4591001ISC4591001 1039 10391305J,IMMUNOGENICITYNA0044558176C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391306J,IMMUNOGENICITYNA0043489513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1039 10391306J,IMMUNOGENICITYNA0041771421C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B0C4591001ISC4591001 1039 10391306J,IMMUNOGENICITYNA0041697834C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1039 10391307J,IMMUNOGENICITYNA0043489499C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1039 10391307J,IMMUNOGENICITYNA0042358777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1039 10391307J,IMMUNOGENICITYNA0044558146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391308J,IMMUNOGENICITYNA0043489510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1039 10391308J,IMMUNOGENICITYNA0042359235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1039 10391308J,IMMUNOGENICITYNA0041702708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1039 10391309J,IMMUNOGENICITYNA0044586747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391309J,IMMUNOGENICITYNA0042358784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1039 10391309J,IMMUNOGENICITYNA0042536681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1039 10391310J,IMMUNOGENICITYNA0043489511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391310J,IMMUNOGENICITYNA0040808164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B0C4591001ISC4591001 1039 10391310J,IMMUNOGENICITYNA0044758164C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391311J,IMMUNOGENICITYNA0043489480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391311J,IMMUNOGENICITYNA0042358739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1039 10391311J,IMMUNOGENICITYNA0044559180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1039 10391312J,IMMUNOGENICITYNA0043489504C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391312J,IMMUNOGENICITYNA0042358753C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1039 10391312J,IMMUNOGENICITYNA0044757585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1039 10391313J,IMMUNOGENICITYNA0043489471C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391313J,IMMUNOGENICITYNA0042358836C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B7C4591001ISC4591001 1039 10391313J,IMMUNOGENICITYNA0044558170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391314J,IMMUNOGENICITYNA0044584715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391314J,IMMUNOGENICITYNA0042359232C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1039 10391314J,IMMUNOGENICITYNA0044643377C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1039 10391315J,IMMUNOGENICITYNA0044586735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391315J,IMMUNOGENICITYNA0042359248C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1039 10391315J,IMMUNOGENICITYNA0041604919C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1039 10391316J,IMMUNOGENICITYNA0043489514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391316J,IMMUNOGENICITYNA0042358771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1039 10391316J,IMMUNOGENICITYNA0044558151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1039 10391317J,IMMUNOGENICITYNA0043489484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391317J,IMMUNOGENICITYNA0042359074C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1039 10391317J,IMMUNOGENICITYNA0042536645C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1039 10391318J,IMMUNOGENICITYNA0043489507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1039 10391318J,IMMUNOGENICITYNA0042359057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1039 10391318J,IMMUNOGENICITYNA0051278043C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-09BC4591001ISC4591001 1039 10391319J,IMMUNOGENICITYNA0043489496C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391319J,IMMUNOGENICITYNA0042359031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1039 10391319J,IMMUNOGENICITYNA0041702388C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1039 10391320J,IMMUNOGENICITYNA0044584731C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391320J,IMMUNOGENICITYNA0042358744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1039 10391320J,IMMUNOGENICITYNA0044582935C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-23BC4591001ISC4591001 1039 10391321J,IMMUNOGENICITYNA0043489487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391321J,IMMUNOGENICITYNA0042358759C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1039 10391321J,IMMUNOGENICITYNA0044558187C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1039 10391322J,IMMUNOGENICITYNA0044586707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391322J,IMMUNOGENICITYNA0042358768C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1039 10391322J,IMMUNOGENICITYNA0041605390C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1039 10391323J,IMMUNOGENICITYNA0044586726C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391323J,IMMUNOGENICITYNA0042358740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1039 10391323J,IMMUNOGENICITYNA0044643835C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1039 10391324J,IMMUNOGENICITYNA0044586895C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1039 10391324J,IMMUNOGENICITYNA0042359033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1039 10391324J,IMMUNOGENICITYNA0044559190C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1039 10391325J,IMMUNOGENICITYNA0044586934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391325J,IMMUNOGENICITYNA0042359151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B5C4591001ISC4591001 1039 10391325J,IMMUNOGENICITYNA0042536679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B{C4591001ISC4591001 1039 10391326J,IMMUNOGENICITYNA0044586914C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391326J,IMMUNOGENICITYNA0042359228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B5C4591001ISC4591001 1039 10391326J,IMMUNOGENICITYNA0041697812C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-09BC4591001ISC4591001 1039 10391327J,IMMUNOGENICITYNA0044586922C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391327J,IMMUNOGENICITYNA0042358869C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1039 10391327J,IMMUNOGENICITYNA0051278032C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1039 10391328J,IMMUNOGENICITYNA0044586930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391328J,IMMUNOGENICITYNA0042359225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1039 10391328J,IMMUNOGENICITYNA0042536660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B|C4591001ISC4591001 1039 10391329J,IMMUNOGENICITYNA0044586901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391329J,IMMUNOGENICITYNA0042358774C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B3C4591001ISC4591001 1039 10391329J,IMMUNOGENICITYNA0041702727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1039 10391330J,IMMUNOGENICITYNA0044584712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1039 10391330J,IMMUNOGENICITYNA0042359028C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1039 10391330J,IMMUNOGENICITYNA0041697807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1039 10391331J,IMMUNOGENICITYNA0043489476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391331J,IMMUNOGENICITYNA0042359224C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1039 10391331J,IMMUNOGENICITYNA0044558591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1039 10391332J,IMMUNOGENICITYNA0044586921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391332J,IMMUNOGENICITYNA0042359063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1039 10391333J,IMMUNOGENICITYNA0044584696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391333J,IMMUNOGENICITYNA0042359036C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1039 10391333J,IMMUNOGENICITYNA0041702704C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1039 10391334J,IMMUNOGENICITYNA0044584695C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391334J,IMMUNOGENICITYNA0042359041C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1039 10391334J,IMMUNOGENICITYNA0041702712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1039 10391335J,IMMUNOGENICITYNA0044586744C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391335J,IMMUNOGENICITYNA0042359153C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L REPEAT SCREENING 1 2021-03-04B4C4591001ISC4591001 1039 10391335J,IMMUNOGENICITYNA0044582936C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1039 10391336J,IMMUNOGENICITYNA0044586905C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391336J,IMMUNOGENICITYNA0042359231C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B4C4591001ISC4591001 1039 10391336J,IMMUNOGENICITYNA0044582950C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1039 10391337J,IMMUNOGENICITYNA0044586899C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391337J,IMMUNOGENICITYNA0042359140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1039 10391337J,IMMUNOGENICITYNA0042536665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B{C4591001ISC4591001 1039 10391338J,IMMUNOGENICITYNA0044584690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391338J,IMMUNOGENICITYNA0042359260C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B4C4591001ISC4591001 1039 10391338J,IMMUNOGENICITYNA0051278057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1039 10391339J,IMMUNOGENICITYNA0044586924C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1039 10391339J,IMMUNOGENICITYNA0042359138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B4C4591001ISC4591001 1039 10391339J,IMMUNOGENICITYNA0044758142C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1044 10441251J,IMMUNOGENICITYNA0041687177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1044 10441251J,IMMUNOGENICITYNA0033150414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B3C4591001ISC4591001 1044 10441251J,IMMUNOGENICITYNA0049580770C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1044 10441251J,IMMUNOGENICITYNA0041614947C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-03BC4591001ISC4591001 1044 10441252J,IMMUNOGENICITYNA0041687171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1044 10441252J,IMMUNOGENICITYNA0033150434C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1044 10441252J,IMMUNOGENICITYNA0041614646C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441252J,IMMUNOGENICITYNA0041714688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BC4591001ISC4591001 1044 10441253J,IMMUNOGENICITYNA0041687173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1044 10441253J,IMMUNOGENICITYNA0033150413C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1044 10441253J,IMMUNOGENICITYNA0049580826C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1044 10441253J,IMMUNOGENICITYNA0041714664C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BC4591001ISC4591001 1044 10441255J,IMMUNOGENICITYNA0041687151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441255J,IMMUNOGENICITYNA0033150411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B1C4591001ISC4591001 1044 10441255J,IMMUNOGENICITYNA0049580750C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1044 10441255J,IMMUNOGENICITYNA0041614546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BC4591001ISC4591001 1044 10441256J,IMMUNOGENICITYNA0041687157C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441256J,IMMUNOGENICITYNA0033150410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B1C4591001ISC4591001 1044 10441256J,IMMUNOGENICITYNA0041614648C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441256J,IMMUNOGENICITYNA0041614554C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BC4591001ISC4591001 1044 10441257J,IMMUNOGENICITYNA0041687181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441257J,IMMUNOGENICITYNA0033150454C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1044 10441257J,IMMUNOGENICITYNA0041739149C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1044 10441257J,IMMUNOGENICITYNA0041614924C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04BC4591001ISC4591001 1044 10441259J,IMMUNOGENICITYNA0041687166C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441259J,IMMUNOGENICITYNA0033150430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1044 10441259J,IMMUNOGENICITYNA0049580817C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1044 10441259J,IMMUNOGENICITYNA0041714690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BC4591001ISC4591001 1044 10441260J,IMMUNOGENICITYNA0041687187C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441260J,IMMUNOGENICITYNA0033150450C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1044 10441260J,IMMUNOGENICITYNA0041614676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441261J,IMMUNOGENICITYNA0041687154C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1044 10441261J,IMMUNOGENICITYNA0033150446C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B1C4591001ISC4591001 1044 10441261J,IMMUNOGENICITYNA0044627363C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441261J,IMMUNOGENICITYNA0042611594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-27BC4591001ISC4591001 1044 10441263J,IMMUNOGENICITYNA0040752900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1044 10441263J,IMMUNOGENICITYNA0041745685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1044 10441263J,IMMUNOGENICITYNA0049580773C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1044 10441263J,IMMUNOGENICITYNA0044626221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-30BC4591001ISC4591001 1044 10441264J,IMMUNOGENICITYNA0040752468C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1044 10441264J,IMMUNOGENICITYNA0041745659C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B9C4591001ISC4591001 1044 10441264J,IMMUNOGENICITYNA0041739173C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-06-28BC4591001ISC4591001 1044 10441264J,IMMUNOGENICITYNA0041739841C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-26BC4591001ISC4591001 1044 10441264J,IMMUNOGENICITYNA0044627720C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BC4591001ISC4591001 1044 10441265J,IMMUNOGENICITYNA0040752909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1044 10441265J,IMMUNOGENICITYNA0041746133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1044 10441265J,IMMUNOGENICITYNA0044627391C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441265J,IMMUNOGENICITYNA0041614890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BC4591001ISC4591001 1044 10441266J,IMMUNOGENICITYNA0040752906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441266J,IMMUNOGENICITYNA0041745681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B5C4591001ISC4591001 1044 10441266J,IMMUNOGENICITYNA0041739130C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1044 10441266J,IMMUNOGENICITYNA0042611610C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BC4591001ISC4591001 1044 10441267J,IMMUNOGENICITYNA0040752897C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441267J,IMMUNOGENICITYNA0041745695C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1044 10441267J,IMMUNOGENICITYNA0044627369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441267J,IMMUNOGENICITYNA0042611573C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BC4591001ISC4591001 1044 10441268J,IMMUNOGENICITYNA0040752920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441268J,IMMUNOGENICITYNA0041746097C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1044 10441268J,IMMUNOGENICITYNA0041739170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1044 10441268J,IMMUNOGENICITYNA0041714672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BC4591001ISC4591001 1044 10441270J,IMMUNOGENICITYNA0040752921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441270J,IMMUNOGENICITYNA0041745658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1044 10441270J,IMMUNOGENICITYNA0041739134C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1044 10441270J,IMMUNOGENICITYNA0041714679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BC4591001ISC4591001 1044 10441271J,IMMUNOGENICITYNA0040752901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441271J,IMMUNOGENICITYNA0041745693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B5C4591001ISC4591001 1044 10441271J,IMMUNOGENICITYNA0049580813C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-26BC4591001ISC4591001 1044 10441273J,IMMUNOGENICITYNA0040752904C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441273J,IMMUNOGENICITYNA0041746120C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1044 10441273J,IMMUNOGENICITYNA0041739172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1044 10441273J,IMMUNOGENICITYNA0041614875C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BC4591001ISC4591001 1044 10441274J,IMMUNOGENICITYNA0040752889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1044 10441274J,IMMUNOGENICITYNA0041746099C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1044 10441274J,IMMUNOGENICITYNA0041745668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-17BHC4591001ISC4591001 1044 10441275J,IMMUNOGENICITYNA0041687040C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441275J,IMMUNOGENICITYNA0041745673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B4C4591001ISC4591001 1044 10441275J,IMMUNOGENICITYNA0041614623C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441275J,IMMUNOGENICITYNA0041614544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BC4591001ISC4591001 1044 10441276J,IMMUNOGENICITYNA0041687027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441276J,IMMUNOGENICITYNA0041746125C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1044 10441276J,IMMUNOGENICITYNA0041739162C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1044 10441276J,IMMUNOGENICITYNA0044626339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BC4591001ISC4591001 1044 10441277J,IMMUNOGENICITYNA0041687025C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441277J,IMMUNOGENICITYNA0041746124C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1044 10441277J,IMMUNOGENICITYNA0041614637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441277J,IMMUNOGENICITYNA0044627730C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05BC4591001ISC4591001 1044 10441278J,IMMUNOGENICITYNA0040752888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441278J,IMMUNOGENICITYNA0042516880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1044 10441278J,IMMUNOGENICITYNA0041739137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1044 10441278J,IMMUNOGENICITYNA0041714663C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BC4591001ISC4591001 1044 10441279J,IMMUNOGENICITYNA0040752914C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441279J,IMMUNOGENICITYNA0041746128C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1044 10441279J,IMMUNOGENICITYNA0041739160C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1044 10441280J,IMMUNOGENICITYNA0041687005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441280J,IMMUNOGENICITYNA0041746094C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-01-28B3C4591001ISC4591001 1044 10441281J,IMMUNOGENICITYNA0040752910C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441281J,IMMUNOGENICITYNA0041746101C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1044 10441281J,IMMUNOGENICITYNA0041739177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1044 10441281J,IMMUNOGENICITYNA0041714677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BC4591001ISC4591001 1044 10441282J,IMMUNOGENICITYNA0041687029C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1044 10441282J,IMMUNOGENICITYNA0041746109C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1044 10441282J,IMMUNOGENICITYNA0041745948C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-03BUC4591001ISC4591001 1044 10441283J,IMMUNOGENICITYNA0041687041C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1044 10441283J,IMMUNOGENICITYNA0041745698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B3C4591001ISC4591001 1044 10441283J,IMMUNOGENICITYNA0041739167C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1044 10441284J,IMMUNOGENICITYNA0040752926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1044 10441284J,IMMUNOGENICITYNA0041745701C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B0C4591001ISC4591001 1044 10441284J,IMMUNOGENICITYNA0044626301C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1044 10441285J,IMMUNOGENICITYNA0041687004C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1044 10441285J,IMMUNOGENICITYNA0041745688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B3C4591001ISC4591001 1044 10441285J,IMMUNOGENICITYNA0041739158C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1044 10441285J,IMMUNOGENICITYNA0041714681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BC4591001ISC4591001 1044 10441286J,IMMUNOGENICITYNA0041771533C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1044 10441286J,IMMUNOGENICITYNA0041746108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B0C4591001ISC4591001 1044 10441286J,IMMUNOGENICITYNA0041614629C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441288J,IMMUNOGENICITYNA0041771543C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1044 10441288J,IMMUNOGENICITYNA0044750715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1044 10441288J,IMMUNOGENICITYNA0049580796C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1044 10441288J,IMMUNOGENICITYNA0041713830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-26BC4591001ISC4591001 1044 10441289J,IMMUNOGENICITYNA0041771527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1044 10441289J,IMMUNOGENICITYNA0044750738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1044 10441290J,IMMUNOGENICITYNA0033150689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441290J,IMMUNOGENICITYNA0042380934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1044 10441290J,IMMUNOGENICITYNA0044627287C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441290J,IMMUNOGENICITYNA0041714884C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-26BmC4591001ISC4591001 1044 10441291J,IMMUNOGENICITYNA0040752725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1044 10441291J,IMMUNOGENICITYNA0041745677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1044 10441291J,IMMUNOGENICITYNA0041739138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1044 10441291J,IMMUNOGENICITYNA0044626331C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-11BC4591001ISC4591001 1044 10441292J,IMMUNOGENICITYNA0041771567C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1044 10441292J,IMMUNOGENICITYNA0044750920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1044 10441292J,IMMUNOGENICITYNA0041744559C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-10BTC4591001ISC4591001 1044 10441293J,IMMUNOGENICITYNA0041771563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1044 10441293J,IMMUNOGENICITYNA0044750736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1044 10441293J,IMMUNOGENICITYNA0041614672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441294J,IMMUNOGENICITYNA0041771552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1044 10441294J,IMMUNOGENICITYNA0044750735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1044 10441294J,IMMUNOGENICITYNA0041614689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441295J,IMMUNOGENICITYNA0040752720C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1044 10441295J,IMMUNOGENICITYNA0044750894C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1044 10441295J,IMMUNOGENICITYNA0041739813C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1044 10441295J,IMMUNOGENICITYNA0042611590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BC4591001ISC4591001 1044 10441296J,IMMUNOGENICITYNA0042517932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1044 10441296J,IMMUNOGENICITYNA0044750709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1044 10441296J,IMMUNOGENICITYNA0041739747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1044 10441297J,IMMUNOGENICITYNA0042517925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1044 10441297J,IMMUNOGENICITYNA0044750734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1044 10441297J,IMMUNOGENICITYNA0041739727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1044 10441297J,IMMUNOGENICITYNA0041714665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BzC4591001ISC4591001 1044 10441298J,IMMUNOGENICITYNA0041771566C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1044 10441298J,IMMUNOGENICITYNA0044750927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1044 10441298J,IMMUNOGENICITYNA0041739783C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1044 10441298J,IMMUNOGENICITYNA0041713827C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-26B}C4591001ISC4591001 1044 10441299J,IMMUNOGENICITYNA0040753218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1044 10441299J,IMMUNOGENICITYNA0044750890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B3C4591001ISC4591001 1044 10441299J,IMMUNOGENICITYNA0044626296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1044 10441299J,IMMUNOGENICITYNA0042611576C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BzC4591001ISC4591001 1044 10441300J,IMMUNOGENICITYNA0042517938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1044 10441300J,IMMUNOGENICITYNA0044750926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1044 10441300J,IMMUNOGENICITYNA0041739826C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1044 10441300J,IMMUNOGENICITYNA0041713795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-26BxC4591001ISC4591001 1044 10441301J,IMMUNOGENICITYNA0042516898C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1044 10441301J,IMMUNOGENICITYNA0044750913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B1C4591001ISC4591001 1044 10441301J,IMMUNOGENICITYNA0041739719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1044 10441302J,IMMUNOGENICITYNA0042516909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1044 10441302J,IMMUNOGENICITYNA0041745662C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1044 10441302J,IMMUNOGENICITYNA0041614633C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441303J,IMMUNOGENICITYNA0042516912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1044 10441303J,IMMUNOGENICITYNA0041745663C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B8C4591001ISC4591001 1044 10441303J,IMMUNOGENICITYNA0042518016C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-20BqC4591001ISC4591001 1044 10441304J,IMMUNOGENICITYNA0042516878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1044 10441304J,IMMUNOGENICITYNA0044747975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B9C4591001ISC4591001 1044 10441304J,IMMUNOGENICITYNA0041739735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1044 10441304J,IMMUNOGENICITYNA0042517990C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BrC4591001ISC4591001 1044 10441306J,IMMUNOGENICITYNA0042516892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1044 10441306J,IMMUNOGENICITYNA0041745666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1044 10441306J,IMMUNOGENICITYNA0041739720C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1044 10441306J,IMMUNOGENICITYNA0041714666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BsC4591001ISC4591001 1044 10441307J,IMMUNOGENICITYNA0042516890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1044 10441307J,IMMUNOGENICITYNA0041745674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1044 10441307J,IMMUNOGENICITYNA0041739726C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1044 10441307J,IMMUNOGENICITYNA0043248891C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-17BC4591001ISC4591001 1044 10441307J,IMMUNOGENICITYNA0041714684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BsC4591001ISC4591001 1044 10441308J,IMMUNOGENICITYNA0042516902C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1044 10441308J,IMMUNOGENICITYNA0044747968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1044 10441308J,IMMUNOGENICITYNA0041614661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441308J,IMMUNOGENICITYNA0044627721C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05BC4591001ISC4591001 1044 10441309J,IMMUNOGENICITYNA0042516900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1044 10441309J,IMMUNOGENICITYNA0044750726C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B0C4591001ISC4591001 1044 10441309J,IMMUNOGENICITYNA0041739723C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1044 10441309J,IMMUNOGENICITYNA0041615284C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-29ByC4591001ISC4591001 1044 10441310J,IMMUNOGENICITYNA0042516887C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1044 10441310J,IMMUNOGENICITYNA0041745678C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1044 10441310J,IMMUNOGENICITYNA0041739846C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1044 10441310J,IMMUNOGENICITYNA0042611591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BxC4591001ISC4591001 1044 10441311J,IMMUNOGENICITYNA0042516869C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441311J,IMMUNOGENICITYNA0041745699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1044 10441311J,IMMUNOGENICITYNA0041739717C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1044 10441311J,IMMUNOGENICITYNA0044646076C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07B|C4591001ISC4591001 1044 10441312J,IMMUNOGENICITYNA0042516893C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441312J,IMMUNOGENICITYNA0044747967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1044 10441312J,IMMUNOGENICITYNA0044627373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441312J,IMMUNOGENICITYNA0044646099C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05BzC4591001ISC4591001 1044 10441313J,IMMUNOGENICITYNA0042516882C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441313J,IMMUNOGENICITYNA0044747971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1044 10441313J,IMMUNOGENICITYNA0041739824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L OPEN LABEL TREATMENT2021-07-26BC4591001ISC4591001 1044 10441313J,IMMUNOGENICITYNA0041739829C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-26BC4591001ISC4591001 1044 10441313J,IMMUNOGENICITYNA0044646103C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07B|C4591001ISC4591001 1044 10441314J,IMMUNOGENICITYNA0033150651C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441314J,IMMUNOGENICITYNA0044748003C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1044 10441314J,IMMUNOGENICITYNA0043398031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441314J,IMMUNOGENICITYNA0041614889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BsC4591001ISC4591001 1044 10441315J,IMMUNOGENICITYNA0033150654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441315J,IMMUNOGENICITYNA0044747978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1044 10441315J,IMMUNOGENICITYNA0041614669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441315J,IMMUNOGENICITYNA0041614884C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BsC4591001ISC4591001 1044 10441316J,IMMUNOGENICITYNA0033150649C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441316J,IMMUNOGENICITYNA0044747960C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B3C4591001ISC4591001 1044 10441316J,IMMUNOGENICITYNA0041739132C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1044 10441316J,IMMUNOGENICITYNA0044626317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-12BC4591001ISC4591001 1044 10441317J,IMMUNOGENICITYNA0033150661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1044 10441317J,IMMUNOGENICITYNA0044747979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1044 10441317J,IMMUNOGENICITYNA0044627389C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441317J,IMMUNOGENICITYNA0044627728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05BzC4591001ISC4591001 1044 10441318J,IMMUNOGENICITYNA0033150677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441318J,IMMUNOGENICITYNA0042380949C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B5C4591001ISC4591001 1044 10441318J,IMMUNOGENICITYNA0044615172C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441318J,IMMUNOGENICITYNA0041714652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BmC4591001ISC4591001 1044 10441319J,IMMUNOGENICITYNA0033150678C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441319J,IMMUNOGENICITYNA0042380933C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B5C4591001ISC4591001 1044 10441319J,IMMUNOGENICITYNA0043398046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441319J,IMMUNOGENICITYNA0041714689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BmC4591001ISC4591001 1044 10441320J,IMMUNOGENICITYNA0033150663C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441320J,IMMUNOGENICITYNA0041745964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B9C4591001ISC4591001 1044 10441320J,IMMUNOGENICITYNA0044627372C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441321J,IMMUNOGENICITYNA0033150658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441321J,IMMUNOGENICITYNA0044748002C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1044 10441321J,IMMUNOGENICITYNA0041714805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1044 10441321J,IMMUNOGENICITYNA0041713793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-27BqC4591001ISC4591001 1044 10441322J,IMMUNOGENICITYNA0033150665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441323J,IMMUNOGENICITYNA0033150662C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441323J,IMMUNOGENICITYNA0044747962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1044 10441323J,IMMUNOGENICITYNA0041614628C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441323J,IMMUNOGENICITYNA0041614899C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BrC4591001ISC4591001 1044 10441324J,IMMUNOGENICITYNA0033150657C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441324J,IMMUNOGENICITYNA0044747984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B1C4591001ISC4591001 1044 10441324J,IMMUNOGENICITYNA0041614671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441324J,IMMUNOGENICITYNA0044646095C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05ByC4591001ISC4591001 1044 10441325J,IMMUNOGENICITYNA0033150655C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1044 10441325J,IMMUNOGENICITYNA0044747996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1044 10441325J,IMMUNOGENICITYNA0041739811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1044 10441325J,IMMUNOGENICITYNA0041614888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-30BtC4591001ISC4591001 1044 10441326J,IMMUNOGENICITYNA0033150687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441326J,IMMUNOGENICITYNA0044747985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B1C4591001ISC4591001 1044 10441326J,IMMUNOGENICITYNA0044627383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441326J,IMMUNOGENICITYNA0041614562C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BzC4591001ISC4591001 1044 10441327J,IMMUNOGENICITYNA0033150676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441327J,IMMUNOGENICITYNA0044747972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B1C4591001ISC4591001 1044 10441327J,IMMUNOGENICITYNA0044626316C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441327J,IMMUNOGENICITYNA0041614541C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BzC4591001ISC4591001 1044 10441328J,IMMUNOGENICITYNA0033150675C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441328J,IMMUNOGENICITYNA0044747993C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B1C4591001ISC4591001 1044 10441328J,IMMUNOGENICITYNA0041714813C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1044 10441328J,IMMUNOGENICITYNA0041713806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-26BoC4591001ISC4591001 1044 10441329J,IMMUNOGENICITYNA0033150668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441329J,IMMUNOGENICITYNA0041745980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1044 10441329J,IMMUNOGENICITYNA0043248868C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-10BC4591001ISC4591001 1044 10441330J,IMMUNOGENICITYNA0033150660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441330J,IMMUNOGENICITYNA0044747992C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1044 10441330J,IMMUNOGENICITYNA0044626306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441330J,IMMUNOGENICITYNA0044627380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441331J,IMMUNOGENICITYNA0033150653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441331J,IMMUNOGENICITYNA0041745958C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B8C4591001ISC4591001 1044 10441331J,IMMUNOGENICITYNA0041739822C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1044 10441331J,IMMUNOGENICITYNA0041614923C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04BwC4591001ISC4591001 1044 10441332J,IMMUNOGENICITYNA0033150688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441332J,IMMUNOGENICITYNA0041745953C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B8C4591001ISC4591001 1044 10441332J,IMMUNOGENICITYNA0044627393C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1044 10441332J,IMMUNOGENICITYNA0044627704C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04BwC4591001ISC4591001 1044 10441333J,IMMUNOGENICITYNA0033150669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1044 10441333J,IMMUNOGENICITYNA0041745984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1044 10441333J,IMMUNOGENICITYNA0041739839C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1044 10441333J,IMMUNOGENICITYNA0041714685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-21BjC4591001ISC4591001 1044 10441334J,IMMUNOGENICITYNA0033150666C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1044 10441334J,IMMUNOGENICITYNA0041744573C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B:C4591001ISC4591001 1044 10441334J,IMMUNOGENICITYNA0041714831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1044 10441335J,IMMUNOGENICITYNA0033150674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1044 10441335J,IMMUNOGENICITYNA0041744594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B:C4591001ISC4591001 1044 10441335J,IMMUNOGENICITYNA0041612930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1044 10441336J,IMMUNOGENICITYNA0033150673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1044 10441336J,IMMUNOGENICITYNA0044747983C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1044 10441336J,IMMUNOGENICITYNA0044627290C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1044 10441336J,IMMUNOGENICITYNA0044626323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-11B}C4591001ISC4591001 1044 10441337J,IMMUNOGENICITYNA0033150659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441337J,IMMUNOGENICITYNA0044748001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1044 10441337J,IMMUNOGENICITYNA0044626328C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441338J,IMMUNOGENICITYNA0033150693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441338J,IMMUNOGENICITYNA0044747957C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1044 10441338J,IMMUNOGENICITYNA0041739837C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1044 10441339J,IMMUNOGENICITYNA0033150685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441339J,IMMUNOGENICITYNA0042380923C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1044 10441339J,IMMUNOGENICITYNA0041714830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1044 10441339J,IMMUNOGENICITYNA0041714662C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BjC4591001ISC4591001 1044 10441340J,IMMUNOGENICITYNA0033150686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441340J,IMMUNOGENICITYNA0041745947C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1044 10441340J,IMMUNOGENICITYNA0044627365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B~C4591001ISC4591001 1044 10441341J,IMMUNOGENICITYNA0033150691C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1044 10441341J,IMMUNOGENICITYNA0041745963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1044 10441341J,IMMUNOGENICITYNA0044627397C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B~C4591001ISC4591001 1044 10441341J,IMMUNOGENICITYNA0041714671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BjC4591001ISC4591001 1044 10441342J,IMMUNOGENICITYNA0033150670C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441342J,IMMUNOGENICITYNA0041745968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B4C4591001ISC4591001 1044 10441342J,IMMUNOGENICITYNA0041739806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1044 10441342J,IMMUNOGENICITYNA0044626332C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-10BzC4591001ISC4591001 1044 10441343J,IMMUNOGENICITYNA0033150694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441343J,IMMUNOGENICITYNA0044747969C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B1C4591001ISC4591001 1044 10441343J,IMMUNOGENICITYNA0043398027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441343J,IMMUNOGENICITYNA0041614904C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BnC4591001ISC4591001 1044 10441344J,IMMUNOGENICITYNA0042516870C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441344J,IMMUNOGENICITYNA0041745697C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-19B*C4591001ISC4591001 1044 10441345J,IMMUNOGENICITYNA0033150684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441345J,IMMUNOGENICITYNA0041745982C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B5C4591001ISC4591001 1044 10441345J,IMMUNOGENICITYNA0041614626C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441345J,IMMUNOGENICITYNA0042611606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-27BmC4591001ISC4591001 1044 10441346J,IMMUNOGENICITYNA0033150505C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441346J,IMMUNOGENICITYNA0041745985C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B5C4591001ISC4591001 1044 10441346J,IMMUNOGENICITYNA0041739805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1044 10441346J,IMMUNOGENICITYNA0041714686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BiC4591001ISC4591001 1044 10441347J,IMMUNOGENICITYNA0033150511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441347J,IMMUNOGENICITYNA0042380920C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B6C4591001ISC4591001 1044 10441348J,IMMUNOGENICITYNA0033150506C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441348J,IMMUNOGENICITYNA0044747980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B0C4591001ISC4591001 1044 10441348J,IMMUNOGENICITYNA0041614670C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441348J,IMMUNOGENICITYNA0041714654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-23BiC4591001ISC4591001 1044 10441349J,IMMUNOGENICITYNA0033150705C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441349J,IMMUNOGENICITYNA0044747989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B1C4591001ISC4591001 1044 10441349J,IMMUNOGENICITYNA0043398062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441349J,IMMUNOGENICITYNA0041614560C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BwC4591001ISC4591001 1044 10441350J,IMMUNOGENICITYNA0033150744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-09AC4591001ISC4591001 1044 10441350J,IMMUNOGENICITYNA0044747977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B1C4591001ISC4591001 1044 10441350J,IMMUNOGENICITYNA0041739832C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1044 10441351J,IMMUNOGENICITYNA0033150727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441351J,IMMUNOGENICITYNA0042380946C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B6C4591001ISC4591001 1044 10441351J,IMMUNOGENICITYNA0044627271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441351J,IMMUNOGENICITYNA0041714819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-03BC4591001ISC4591001 1044 10441351J,IMMUNOGENICITYNA0044646096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT REPEAT SCREENING 1 2021-05-07BvC4591001ISC4591001 1044 10441352J,IMMUNOGENICITYNA0033150717C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441352J,IMMUNOGENICITYNA0041745952C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B4C4591001ISC4591001 1044 10441352J,IMMUNOGENICITYNA0041714798C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-05BC4591001ISC4591001 1044 10441352J,IMMUNOGENICITYNA0044626201C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-30BoC4591001ISC4591001 1044 10441353J,IMMUNOGENICITYNA0033150709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441353J,IMMUNOGENICITYNA0042380911C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B3C4591001ISC4591001 1044 10441353J,IMMUNOGENICITYNA0044627303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441353J,IMMUNOGENICITYNA0041714698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BgC4591001ISC4591001 1044 10441354J,IMMUNOGENICITYNA0033150520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441354J,IMMUNOGENICITYNA0044747999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B0C4591001ISC4591001 1044 10441354J,IMMUNOGENICITYNA0044627359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1044 10441355J,IMMUNOGENICITYNA0033150524C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441355J,IMMUNOGENICITYNA0041745976C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B0C4591001ISC4591001 1044 10441355J,IMMUNOGENICITYNA0041739833C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1044 10441356J,IMMUNOGENICITYNA0033150537C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441356J,IMMUNOGENICITYNA0041744555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B:C4591001ISC4591001 1044 10441356J,IMMUNOGENICITYNA0043398047C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441357J,IMMUNOGENICITYNA0033150712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441357J,IMMUNOGENICITYNA0041744596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B7C4591001ISC4591001 1044 10441357J,IMMUNOGENICITYNA0041614660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1044 10441358J,IMMUNOGENICITYNA0033150541C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-10AC4591001ISC4591001 1044 10441358J,IMMUNOGENICITYNA0042380954C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B7C4591001ISC4591001 1044 10441358J,IMMUNOGENICITYNA0041714840C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-09BC4591001ISC4591001 1044 10441358J,IMMUNOGENICITYNA0041614558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BvC4591001ISC4591001 1044 10441359J,IMMUNOGENICITYNA0033150545C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441359J,IMMUNOGENICITYNA0042382247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-25BJC4591001ISC4591001 1044 10441359J,IMMUNOGENICITYNA0043248857C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-23BC4591001ISC4591001 1044 10441359J,IMMUNOGENICITYNA0041714660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BfC4591001ISC4591001 1044 10441360J,IMMUNOGENICITYNA0033150548C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441360J,IMMUNOGENICITYNA0042382228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-25BJC4591001ISC4591001 1044 10441360J,IMMUNOGENICITYNA0041614636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1044 10441360J,IMMUNOGENICITYNA0041714661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BfC4591001ISC4591001 1044 10441361J,IMMUNOGENICITYNA0033150742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441361J,IMMUNOGENICITYNA0041744587C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B:C4591001ISC4591001 1044 10441361J,IMMUNOGENICITYNA0044627277C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1044 10441361J,IMMUNOGENICITYNA0044646106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BuC4591001ISC4591001 1044 10441362J,IMMUNOGENICITYNA0033150732C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441362J,IMMUNOGENICITYNA0041745987C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B5C4591001ISC4591001 1044 10441362J,IMMUNOGENICITYNA0044626320C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B{C4591001ISC4591001 1044 10441362J,IMMUNOGENICITYNA0041614865C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441363J,IMMUNOGENICITYNA0033150522C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441363J,IMMUNOGENICITYNA0041745992C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1044 10441363J,IMMUNOGENICITYNA0041614681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14B|C4591001ISC4591001 1044 10441363J,IMMUNOGENICITYNA0042611609C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441364J,IMMUNOGENICITYNA0033150724C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441364J,IMMUNOGENICITYNA0042380912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B5C4591001ISC4591001 1044 10441364J,IMMUNOGENICITYNA0041714839C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1044 10441364J,IMMUNOGENICITYNA0042611600C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-27BkC4591001ISC4591001 1044 10441365J,IMMUNOGENICITYNA0033150523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441365J,IMMUNOGENICITYNA0042380956C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1044 10441365J,IMMUNOGENICITYNA0044626337C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13B{C4591001ISC4591001 1044 10441365J,IMMUNOGENICITYNA0042611603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441366J,IMMUNOGENICITYNA0033150517C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441366J,IMMUNOGENICITYNA0041745974C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1044 10441366J,IMMUNOGENICITYNA0043398033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441366J,IMMUNOGENICITYNA0042611604C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441367J,IMMUNOGENICITYNA0033150542C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441367J,IMMUNOGENICITYNA0041744565C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B:C4591001ISC4591001 1044 10441367J,IMMUNOGENICITYNA0041739843C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1044 10441368J,IMMUNOGENICITYNA0033150531C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441368J,IMMUNOGENICITYNA0041744563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-03-09B:C4591001ISC4591001 1044 10441368J,IMMUNOGENICITYNA0041744567C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-09B:C4591001ISC4591001 1044 10441369J,IMMUNOGENICITYNA0033150738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441369J,IMMUNOGENICITYNA0041745960C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1044 10441369J,IMMUNOGENICITYNA0041714810C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1044 10441369J,IMMUNOGENICITYNA0041614896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441370J,IMMUNOGENICITYNA0033150707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441370J,IMMUNOGENICITYNA0042380937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1044 10441370J,IMMUNOGENICITYNA0041739781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1044 10441370J,IMMUNOGENICITYNA0041614887C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BlC4591001ISC4591001 1044 10441371J,IMMUNOGENICITYNA0033150512C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441371J,IMMUNOGENICITYNA0041745977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1044 10441372J,IMMUNOGENICITYNA0033150540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1044 10441372J,IMMUNOGENICITYNA0041745972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1044 10441373J,IMMUNOGENICITYNA0033150735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441373J,IMMUNOGENICITYNA0041744570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1044 10441373J,IMMUNOGENICITYNA0041614632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17B~C4591001ISC4591001 1044 10441373J,IMMUNOGENICITYNA0044646083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BtC4591001ISC4591001 1044 10441374J,IMMUNOGENICITYNA0033150551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441374J,IMMUNOGENICITYNA0041745961C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B3C4591001ISC4591001 1044 10441374J,IMMUNOGENICITYNA0044627284C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1044 10441374J,IMMUNOGENICITYNA0049639404C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-20BC4591001ISC4591001 1044 10441374J,IMMUNOGENICITYNA0041614878C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-28BkC4591001ISC4591001 1044 10441375J,IMMUNOGENICITYNA0033150539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441375J,IMMUNOGENICITYNA0042380943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1044 10441375J,IMMUNOGENICITYNA0043398064C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441376J,IMMUNOGENICITYNA0033150543C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441376J,IMMUNOGENICITYNA0041745981C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1044 10441376J,IMMUNOGENICITYNA0043398032C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441376J,IMMUNOGENICITYNA0044646090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-07BtC4591001ISC4591001 1044 10441377J,IMMUNOGENICITYNA0041745702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-02-01AC4591001ISC4591001 1044 10441377J,IMMUNOGENICITYNA0043398063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-22B2C4591001ISC4591001 1044 10441377J,IMMUNOGENICITYNA0050870325C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-25BC4591001ISC4591001 1044 10441377J,IMMUNOGENICITYNA0044627732C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-05B^C4591001ISC4591001 1044 10441378J,IMMUNOGENICITYNA0033150718C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441378J,IMMUNOGENICITYNA0041744572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B8C4591001ISC4591001 1044 10441378J,IMMUNOGENICITYNA0043398025C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441379J,IMMUNOGENICITYNA0033150528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441379J,IMMUNOGENICITYNA0041744575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B8C4591001ISC4591001 1044 10441379J,IMMUNOGENICITYNA0043398060C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1044 10441380J,IMMUNOGENICITYNA0033150518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441380J,IMMUNOGENICITYNA0042380926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B4C4591001ISC4591001 1044 10441380J,IMMUNOGENICITYNA0044626318C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BzC4591001ISC4591001 1044 10441380J,IMMUNOGENICITYNA0042611593C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-27BjC4591001ISC4591001 1044 10441381J,IMMUNOGENICITYNA0033150530C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441381J,IMMUNOGENICITYNA0041745967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B5C4591001ISC4591001 1044 10441381J,IMMUNOGENICITYNA0041614631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17B~C4591001ISC4591001 1044 10441381J,IMMUNOGENICITYNA0044626222C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-30BmC4591001ISC4591001 1044 10441382J,IMMUNOGENICITYNA0033150734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441382J,IMMUNOGENICITYNA0041744581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B8C4591001ISC4591001 1044 10441382J,IMMUNOGENICITYNA0044627367C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BzC4591001ISC4591001 1044 10441382J,IMMUNOGENICITYNA0041614534C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BsC4591001ISC4591001 1044 10441383J,IMMUNOGENICITYNA0033150533C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441383J,IMMUNOGENICITYNA0041744592C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B8C4591001ISC4591001 1044 10441383J,IMMUNOGENICITYNA0044627281C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1044 10441383J,IMMUNOGENICITYNA0041614556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-06BsC4591001ISC4591001 1044 10441384J,IMMUNOGENICITYNA0033150546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1044 10441384J,IMMUNOGENICITYNA0042380925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B4C4591001ISC4591001 1044 10441384J,IMMUNOGENICITYNA0044642319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1044 10441384J,IMMUNOGENICITYNA0041714676C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-22BeC4591001ISC4591001 1057 10571376J,IMMUNOGENICITYNA0041763414C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1057 10571376J,IMMUNOGENICITYNA0043263597C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B9C4591001ISC4591001 1057 10571376J,IMMUNOGENICITYNA0041602806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1057 10571377J,IMMUNOGENICITYNA0041579539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1057 10571377J,IMMUNOGENICITYNA0043382525C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1057 10571378J,IMMUNOGENICITYNA0031393990C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1057 10571378J,IMMUNOGENICITYNA0043383433C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1057 10571379J,IMMUNOGENICITYNA0042388538C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1057 10571379J,IMMUNOGENICITYNA0043382707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1057 10571379J,IMMUNOGENICITYNA0044726700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1057 10571379J,IMMUNOGENICITYNA0042442579C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BdC4591001ISC4591001 1057 10571380J,IMMUNOGENICITYNA0043398764C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571380J,IMMUNOGENICITYNA0043383779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B<C4591001ISC4591001 1057 10571380J,IMMUNOGENICITYNA0041602807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1057 10571382J,IMMUNOGENICITYNA0033812242C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571382J,IMMUNOGENICITYNA0043383784C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B9C4591001ISC4591001 1057 10571382J,IMMUNOGENICITYNA0041602786C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1057 10571383J,IMMUNOGENICITYNA0039408928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571383J,IMMUNOGENICITYNA0043382686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1057 10571383J,IMMUNOGENICITYNA0041615894C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571384J,IMMUNOGENICITYNA0041687365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571384J,IMMUNOGENICITYNA0043382315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1057 10571384J,IMMUNOGENICITYNA0041602777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-29BC4591001ISC4591001 1057 10571385J,IMMUNOGENICITYNA0033812236C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571385J,IMMUNOGENICITYNA0044743652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1057 10571385J,IMMUNOGENICITYNA0041602787C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1057 10571386J,IMMUNOGENICITYNA0041763374C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1057 10571386J,IMMUNOGENICITYNA0043382651C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1057 10571386J,IMMUNOGENICITYNA0041602821C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1057 10571387J,IMMUNOGENICITYNA0041687375C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571387J,IMMUNOGENICITYNA0043383406C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1057 10571387J,IMMUNOGENICITYNA0044723819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1057 10571388J,IMMUNOGENICITYNA0033812227C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571388J,IMMUNOGENICITYNA0044743638C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B9C4591001ISC4591001 1057 10571388J,IMMUNOGENICITYNA0049635081C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1057 10571388J,IMMUNOGENICITYNA0045170581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1057 10571389J,IMMUNOGENICITYNA0041579544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571389J,IMMUNOGENICITYNA0043383480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B9C4591001ISC4591001 1057 10571389J,IMMUNOGENICITYNA0049634855C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1057 10571389J,IMMUNOGENICITYNA0045170555C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1057 10571390J,IMMUNOGENICITYNA0043399988C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571390J,IMMUNOGENICITYNA0043383456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1057 10571390J,IMMUNOGENICITYNA0041602802C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1057 10571391J,IMMUNOGENICITYNA0043400022C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571391J,IMMUNOGENICITYNA0043383494C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1057 10571391J,IMMUNOGENICITYNA0044743654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-24BNC4591001ISC4591001 1057 10571392J,IMMUNOGENICITYNA0041579363C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571392J,IMMUNOGENICITYNA0043383420C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1057 10571392J,IMMUNOGENICITYNA0041602818C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1057 10571393J,IMMUNOGENICITYNA0034622688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571393J,IMMUNOGENICITYNA0044743659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B4C4591001ISC4591001 1057 10571393J,IMMUNOGENICITYNA0044575794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1057 10571394J,IMMUNOGENICITYNA0043398773C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571394J,IMMUNOGENICITYNA0044743004C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B1C4591001ISC4591001 1057 10571394J,IMMUNOGENICITYNA0044724518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571395J,IMMUNOGENICITYNA0043398737C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1057 10571395J,IMMUNOGENICITYNA0040529128C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17BGC4591001ISC4591001 1057 10571395J,IMMUNOGENICITYNA0042361096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-25BOC4591001ISC4591001 1057 10571396J,IMMUNOGENICITYNA0041579212C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1057 10571396J,IMMUNOGENICITYNA0043382665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B6C4591001ISC4591001 1057 10571396J,IMMUNOGENICITYNA0041602822C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-21BC4591001ISC4591001 1057 10571396J,IMMUNOGENICITYNA0042410925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02BSC4591001ISC4591001 1057 10571397J,IMMUNOGENICITYNA0041579177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1057 10571397J,IMMUNOGENICITYNA0043383588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1057 10571397J,IMMUNOGENICITYNA0041602815C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1057 10571398J,IMMUNOGENICITYNA0041765477C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1057 10571398J,IMMUNOGENICITYNA0043383436C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1057 10571398J,IMMUNOGENICITYNA0044723832C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571399J,IMMUNOGENICITYNA0033812244C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1057 10571399J,IMMUNOGENICITYNA0043383430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1057 10571399J,IMMUNOGENICITYNA0041602805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1057 10571400J,IMMUNOGENICITYNA0033812234C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1057 10571400J,IMMUNOGENICITYNA0043382730C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B5C4591001ISC4591001 1057 10571400J,IMMUNOGENICITYNA0044723630C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571401J,IMMUNOGENICITYNA0043400005C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1057 10571401J,IMMUNOGENICITYNA0043382317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B1C4591001ISC4591001 1057 10571401J,IMMUNOGENICITYNA0041615569C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1057 10571402J,IMMUNOGENICITYNA0033812248C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1057 10571402J,IMMUNOGENICITYNA0044748824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1057 10571402J,IMMUNOGENICITYNA0042413787C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-03BPC4591001ISC4591001 1057 10571403J,IMMUNOGENICITYNA0043398771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1057 10571403J,IMMUNOGENICITYNA0043383744C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1057 10571403J,IMMUNOGENICITYNA0041602800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1057 10571404J,IMMUNOGENICITYNA0041579396C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1057 10571404J,IMMUNOGENICITYNA0042414529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B?C4591001ISC4591001 1057 10571404J,IMMUNOGENICITYNA0041602797C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-28BC4591001ISC4591001 1057 10571404J,IMMUNOGENICITYNA0043383785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24BGC4591001ISC4591001 1057 10571405J,IMMUNOGENICITYNA0041579390C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1057 10571405J,IMMUNOGENICITYNA0043383751C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B1C4591001ISC4591001 1057 10571405J,IMMUNOGENICITYNA0041602794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1057 10571406J,IMMUNOGENICITYNA0041579542C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1057 10571406J,IMMUNOGENICITYNA0043272074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B1C4591001ISC4591001 1057 10571406J,IMMUNOGENICITYNA0041615877C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571407J,IMMUNOGENICITYNA0040865188C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571407J,IMMUNOGENICITYNA0044743006C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1057 10571407J,IMMUNOGENICITYNA0034622585C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-12BVC4591001ISC4591001 1057 10571408J,IMMUNOGENICITYNA0043398779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571408J,IMMUNOGENICITYNA0044742988C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1057 10571408J,IMMUNOGENICITYNA0041615900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1057 10571408J,IMMUNOGENICITYNA0042442596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B[C4591001ISC4591001 1057 10571409J,IMMUNOGENICITYNA0034622963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571409J,IMMUNOGENICITYNA0044742972C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1057 10571409J,IMMUNOGENICITYNA0041602813C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1057 10571409J,IMMUNOGENICITYNA0042380420C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B[C4591001ISC4591001 1057 10571410J,IMMUNOGENICITYNA0040918073C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571410J,IMMUNOGENICITYNA0044742966C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1057 10571410J,IMMUNOGENICITYNA0041615916C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1057 10571411J,IMMUNOGENICITYNA0040688781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571411J,IMMUNOGENICITYNA0044743204C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1057 10571411J,IMMUNOGENICITYNA0041602791C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1057 10571412J,IMMUNOGENICITYNA0043238575C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1057 10571412J,IMMUNOGENICITYNA0040529116C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1057 10571412J,IMMUNOGENICITYNA0044724722C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1057 10571412J,IMMUNOGENICITYNA0042380567C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B\C4591001ISC4591001 1057 10571414J,IMMUNOGENICITYNA0041579182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1057 10571414J,IMMUNOGENICITYNA0044748855C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1057 10571415J,IMMUNOGENICITYNA0043262346C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1057 10571415J,IMMUNOGENICITYNA0042379402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-12BRC4591001ISC4591001 1057 10571415J,IMMUNOGENICITYNA0044566683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-03BC4591001ISC4591001 1057 10571416J,IMMUNOGENICITYNA0043262354C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1057 10571416J,IMMUNOGENICITYNA0042442577C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-19BYC4591001ISC4591001 1057 10571416J,IMMUNOGENICITYNA0049634799C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1057 10571417J,IMMUNOGENICITYNA0043261439C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1057 10571417J,IMMUNOGENICITYNA0042361411C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B:C4591001ISC4591001 1057 10571417J,IMMUNOGENICITYNA0044723850C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571418J,IMMUNOGENICITYNA0043263589C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1057 10571418J,IMMUNOGENICITYNA0043238821C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B1C4591001ISC4591001 1057 10571419J,IMMUNOGENICITYNA0043263129C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1057 10571419J,IMMUNOGENICITYNA0042413822C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B9C4591001ISC4591001 1057 10571420J,IMMUNOGENICITYNA0043238811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1057 10571421J,IMMUNOGENICITYNA0043263150C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1057 10571421J,IMMUNOGENICITYNA0043382316C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B0C4591001ISC4591001 1057 10571422J,IMMUNOGENICITYNA0041579211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1057 10571422J,IMMUNOGENICITYNA0043383029C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1057 10571422J,IMMUNOGENICITYNA0049635010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1057 10571423J,IMMUNOGENICITYNA0043263110C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571423J,IMMUNOGENICITYNA0042361098C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B3C4591001ISC4591001 1057 10571423J,IMMUNOGENICITYNA0049635108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1057 10571424J,IMMUNOGENICITYNA0043263147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571424J,IMMUNOGENICITYNA0042361137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B3C4591001ISC4591001 1057 10571424J,IMMUNOGENICITYNA0044726702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1057 10571425J,IMMUNOGENICITYNA0043262382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571425J,IMMUNOGENICITYNA0042361121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B7C4591001ISC4591001 1057 10571426J,IMMUNOGENICITYNA0043238820C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571426J,IMMUNOGENICITYNA0044743175C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B?C4591001ISC4591001 1057 10571427J,IMMUNOGENICITYNA0043262355C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571427J,IMMUNOGENICITYNA0043383760C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B?C4591001ISC4591001 1057 10571427J,IMMUNOGENICITYNA0044723668C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1057 10571427J,IMMUNOGENICITYNA0042361388C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BFC4591001ISC4591001 1057 10571428J,IMMUNOGENICITYNA0043263115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571428J,IMMUNOGENICITYNA0043383453C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B?C4591001ISC4591001 1057 10571428J,IMMUNOGENICITYNA0045207288C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1057 10571428J,IMMUNOGENICITYNA0042414504C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BFC4591001ISC4591001 1057 10571429J,IMMUNOGENICITYNA0043263253C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-24AC4591001ISC4591001 1057 10571429J,IMMUNOGENICITYNA0043383039C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B?C4591001ISC4591001 1057 10571429J,IMMUNOGENICITYNA0042360972C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1057 10571429J,IMMUNOGENICITYNA0042413589C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BFC4591001ISC4591001 1057 10571430J,IMMUNOGENICITYNA0043262372C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1057 10571430J,IMMUNOGENICITYNA0042361394C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B1C4591001ISC4591001 1057 10571431J,IMMUNOGENICITYNA0043263335C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1057 10571431J,IMMUNOGENICITYNA0042413792C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B0C4591001ISC4591001 1057 10571431J,IMMUNOGENICITYNA0044724446C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1057 10571432J,IMMUNOGENICITYNA0043262364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1057 10571432J,IMMUNOGENICITYNA0043263603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1057 10571432J,IMMUNOGENICITYNA0044723628C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-13BC4591001ISC4591001 1057 10571432J,IMMUNOGENICITYNA0042414514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B?C4591001ISC4591001 1057 10571433J,IMMUNOGENICITYNA0043263279C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1057 10571433J,IMMUNOGENICITYNA0043383766C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B4C4591001ISC4591001 1057 10571433J,IMMUNOGENICITYNA0049634094C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1057 10571434J,IMMUNOGENICITYNA0043262379C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-31AC4591001ISC4591001 1057 10571434J,IMMUNOGENICITYNA0043382674C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B2C4591001ISC4591001 1057 10571434J,IMMUNOGENICITYNA0041615570C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-10BC4591001ISC4591001 1057 10571434J,IMMUNOGENICITYNA0042361384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01B=C4591001ISC4591001 1057 10571435J,IMMUNOGENICITYNA0043263495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1057 10571435J,IMMUNOGENICITYNA0044743008C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B3C4591001ISC4591001 1057 10571435J,IMMUNOGENICITYNA0044723865C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1057 10571436J,IMMUNOGENICITYNA0043263119C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1057 10571436J,IMMUNOGENICITYNA0043383577C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B3C4591001ISC4591001 1057 10571436J,IMMUNOGENICITYNA0044726965C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1057 10571436J,IMMUNOGENICITYNA0044743685C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-22BC4591001ISC4591001 1057 10571437J,IMMUNOGENICITYNA0043238549C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1057 10571437J,IMMUNOGENICITYNA0042361418C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B9C4591001ISC4591001 1057 10571437J,IMMUNOGENICITYNA0041615906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-20BC4591001ISC4591001 1057 10571438J,IMMUNOGENICITYNA0043263291C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1057 10571438J,IMMUNOGENICITYNA0042413600C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B9C4591001ISC4591001 1057 10571438J,IMMUNOGENICITYNA0049635140C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1057 10571438J,IMMUNOGENICITYNA0042375340C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BAC4591001ISC4591001 1057 10571439J,IMMUNOGENICITYNA0043263216C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1057 10571439J,IMMUNOGENICITYNA0042361424C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B7C4591001ISC4591001 1057 10571439J,IMMUNOGENICITYNA0044723833C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1057 10571440J,IMMUNOGENICITYNA0043263524C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1057 10571440J,IMMUNOGENICITYNA0044742967C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1057 10571440J,IMMUNOGENICITYNA0049634361C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1057 10571441J,IMMUNOGENICITYNA0043263255C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1057 10571441J,IMMUNOGENICITYNA0043382643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1057 10571441J,IMMUNOGENICITYNA0044723631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1057 10571442J,IMMUNOGENICITYNA0043272071C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1057 10571442J,IMMUNOGENICITYNA0042360990C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B7C4591001ISC4591001 1057 10571442J,IMMUNOGENICITYNA0044575789C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1057 10571443J,IMMUNOGENICITYNA0043272067C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1057 10571443J,IMMUNOGENICITYNA0042361406C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B1C4591001ISC4591001 1057 10571443J,IMMUNOGENICITYNA0049352142C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-11BC4591001ISC4591001 1057 10571443J,IMMUNOGENICITYNA0042414540C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B=C4591001ISC4591001 1057 10571444J,IMMUNOGENICITYNA0043271514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1057 10571444J,IMMUNOGENICITYNA0042413616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B1C4591001ISC4591001 1057 10571444J,IMMUNOGENICITYNA0049352074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-11BC4591001ISC4591001 1057 10571444J,IMMUNOGENICITYNA0042361022C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B=C4591001ISC4591001 1057 10571445J,IMMUNOGENICITYNA0043272063C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1057 10571445J,IMMUNOGENICITYNA0042361014C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B6C4591001ISC4591001 1057 10571445J,IMMUNOGENICITYNA0042375327C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1057 10571445J,IMMUNOGENICITYNA0042442581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BDC4591001ISC4591001 1057 10571446J,IMMUNOGENICITYNA0043271785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1057 10571446J,IMMUNOGENICITYNA0043263526C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B5C4591001ISC4591001 1057 10571447J,IMMUNOGENICITYNA0043271596C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1057 10571447J,IMMUNOGENICITYNA0042361404C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1057 10571447J,IMMUNOGENICITYNA0044566662C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1057 10571447J,IMMUNOGENICITYNA0042380549C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B;C4591001ISC4591001 1057 10571448J,IMMUNOGENICITYNA0043271528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1057 10571448J,IMMUNOGENICITYNA0043263500C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B4C4591001ISC4591001 1057 10571448J,IMMUNOGENICITYNA0043383767C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1057 10571448J,IMMUNOGENICITYNA0042380570C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B;C4591001ISC4591001 1057 10571449J,IMMUNOGENICITYNA0043272046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571449J,IMMUNOGENICITYNA0044743194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1057 10571449J,IMMUNOGENICITYNA0044575792C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1057 10571449J,IMMUNOGENICITYNA0042442449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B@C4591001ISC4591001 1057 10571450J,IMMUNOGENICITYNA0043271542C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571450J,IMMUNOGENICITYNA0042413807C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1057 10571450J,IMMUNOGENICITYNA0042380384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1057 10571451J,IMMUNOGENICITYNA0043272053C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571451J,IMMUNOGENICITYNA0042414527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B2C4591001ISC4591001 1057 10571451J,IMMUNOGENICITYNA0043383446C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1057 10571451J,IMMUNOGENICITYNA0042380383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11B;C4591001ISC4591001 1057 10571452J,IMMUNOGENICITYNA0043271675C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571452J,IMMUNOGENICITYNA0042410940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-05B5C4591001ISC4591001 1057 10571452J,IMMUNOGENICITYNA0044724486C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1057 10571452J,IMMUNOGENICITYNA0042442461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15B?C4591001ISC4591001 1057 10571453J,IMMUNOGENICITYNA0043271526C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571453J,IMMUNOGENICITYNA0042413590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B1C4591001ISC4591001 1057 10571453J,IMMUNOGENICITYNA0044724466C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17B~C4591001ISC4591001 1057 10571453J,IMMUNOGENICITYNA0042410948C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1057 10571454J,IMMUNOGENICITYNA0043271660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1057 10571454J,IMMUNOGENICITYNA0044748858C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B3C4591001ISC4591001 1057 10571454J,IMMUNOGENICITYNA0043271664C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1057 10571454J,IMMUNOGENICITYNA0042379388C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10B:C4591001ISC4591001 1066 10661394J,IMMUNOGENICITYNA0043480237C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1066 10661394J,IMMUNOGENICITYNA0043398904C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1066 10661394J,IMMUNOGENICITYNA0044713637C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661394J,IMMUNOGENICITYNA0043348557C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01BSC4591001ISC4591001 1066 10661395J,IMMUNOGENICITYNA0041708548C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1066 10661395J,IMMUNOGENICITYNA0043398512C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B2C4591001ISC4591001 1066 10661395J,IMMUNOGENICITYNA0037534456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1066 10661395J,IMMUNOGENICITYNA0043386173C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01B[C4591001ISC4591001 1066 10661397J,IMMUNOGENICITYNA0041707335C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1066 10661397J,IMMUNOGENICITYNA0043479731C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B1C4591001ISC4591001 1066 10661397J,IMMUNOGENICITYNA0044713607C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661397J,IMMUNOGENICITYNA0042383105C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03B]C4591001ISC4591001 1066 10661401J,IMMUNOGENICITYNA0041708552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1066 10661401J,IMMUNOGENICITYNA0043480227C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B0C4591001ISC4591001 1066 10661401J,IMMUNOGENICITYNA0042376492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661401J,IMMUNOGENICITYNA0042383089C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03B\C4591001ISC4591001 1066 10661402J,IMMUNOGENICITYNA0041708549C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1066 10661402J,IMMUNOGENICITYNA0043398535C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1066 10661402J,IMMUNOGENICITYNA0044712256C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1066 10661402J,IMMUNOGENICITYNA0043348561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B[C4591001ISC4591001 1066 10661403J,IMMUNOGENICITYNA0040897308C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1066 10661403J,IMMUNOGENICITYNA0043398927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B9C4591001ISC4591001 1066 10661403J,IMMUNOGENICITYNA0044713596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661403J,IMMUNOGENICITYNA0044552073C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04B\C4591001ISC4591001 1066 10661404J,IMMUNOGENICITYNA0040919708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1066 10661404J,IMMUNOGENICITYNA0043283207C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B9C4591001ISC4591001 1066 10661404J,IMMUNOGENICITYNA0044552458C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1066 10661404J,IMMUNOGENICITYNA0040897430C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04B\C4591001ISC4591001 1066 10661405J,IMMUNOGENICITYNA0040919716C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1066 10661405J,IMMUNOGENICITYNA0043398533C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B2C4591001ISC4591001 1066 10661405J,IMMUNOGENICITYNA0044713631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661405J,IMMUNOGENICITYNA0042376192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BjC4591001ISC4591001 1066 10661407J,IMMUNOGENICITYNA0041708544C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1066 10661407J,IMMUNOGENICITYNA0043283116C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B1C4591001ISC4591001 1066 10661407J,IMMUNOGENICITYNA0044712380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1066 10661407J,IMMUNOGENICITYNA0044552010C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BaC4591001ISC4591001 1066 10661408J,IMMUNOGENICITYNA0043511539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1066 10661408J,IMMUNOGENICITYNA0043397752C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1066 10661408J,IMMUNOGENICITYNA0037547249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1066 10661409J,IMMUNOGENICITYNA0043480220C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1066 10661409J,IMMUNOGENICITYNA0043398896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B2C4591001ISC4591001 1066 10661409J,IMMUNOGENICITYNA0037547241C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1066 10661409J,IMMUNOGENICITYNA0040897393C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08B[C4591001ISC4591001 1066 10661410J,IMMUNOGENICITYNA0043511507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1066 10661410J,IMMUNOGENICITYNA0043283209C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1066 10661410J,IMMUNOGENICITYNA0042376476C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661410J,IMMUNOGENICITYNA0043386139C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B[C4591001ISC4591001 1066 10661411J,IMMUNOGENICITYNA0043480247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1066 10661411J,IMMUNOGENICITYNA0043283197C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1066 10661411J,IMMUNOGENICITYNA0037534878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1066 10661412J,IMMUNOGENICITYNA0043511528C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1066 10661412J,IMMUNOGENICITYNA0043283171C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B3C4591001ISC4591001 1066 10661412J,IMMUNOGENICITYNA0044713636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661412J,IMMUNOGENICITYNA0042370575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BaC4591001ISC4591001 1066 10661414J,IMMUNOGENICITYNA0043283074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1066 10661414J,IMMUNOGENICITYNA0043283185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1066 10661414J,IMMUNOGENICITYNA0037547252C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1066 10661414J,IMMUNOGENICITYNA0042383099C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BUC4591001ISC4591001 1066 10661415J,IMMUNOGENICITYNA0043283101C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1066 10661415J,IMMUNOGENICITYNA0043283176C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1066 10661415J,IMMUNOGENICITYNA0037534371C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1066 10661415J,IMMUNOGENICITYNA0044552087C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BUC4591001ISC4591001 1066 10661416J,IMMUNOGENICITYNA0043283069C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1066 10661416J,IMMUNOGENICITYNA0043480228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1066 10661416J,IMMUNOGENICITYNA0037534656C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1066 10661416J,IMMUNOGENICITYNA0043386345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B^C4591001ISC4591001 1066 10661417J,IMMUNOGENICITYNA0043283121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1066 10661417J,IMMUNOGENICITYNA0041746892C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1066 10661417J,IMMUNOGENICITYNA0040804378C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-18BC4591001ISC4591001 1066 10661418J,IMMUNOGENICITYNA0043283031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1066 10661418J,IMMUNOGENICITYNA0038317518C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B1C4591001ISC4591001 1066 10661418J,IMMUNOGENICITYNA0042383059C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1066 10661418J,IMMUNOGENICITYNA0042370543C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B[C4591001ISC4591001 1066 10661419J,IMMUNOGENICITYNA0043479736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1066 10661419J,IMMUNOGENICITYNA0043398527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1066 10661419J,IMMUNOGENICITYNA0041685687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1066 10661420J,IMMUNOGENICITYNA0040804592C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1066 10661420J,IMMUNOGENICITYNA0044552572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1066 10661421J,IMMUNOGENICITYNA0040804572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1066 10661421J,IMMUNOGENICITYNA0043398526C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B4C4591001ISC4591001 1066 10661421J,IMMUNOGENICITYNA0037534532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661422J,IMMUNOGENICITYNA0043480206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1066 10661422J,IMMUNOGENICITYNA0041746878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B4C4591001ISC4591001 1066 10661422J,IMMUNOGENICITYNA0042383223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1066 10661423J,IMMUNOGENICITYNA0043283302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1066 10661423J,IMMUNOGENICITYNA0044552051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B8C4591001ISC4591001 1066 10661423J,IMMUNOGENICITYNA0037534501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661424J,IMMUNOGENICITYNA0043283306C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1066 10661424J,IMMUNOGENICITYNA0044552071C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1066 10661424J,IMMUNOGENICITYNA0044714380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1066 10661424J,IMMUNOGENICITYNA0040897392C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BFC4591001ISC4591001 1066 10661425J,IMMUNOGENICITYNA0043283053C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1066 10661425J,IMMUNOGENICITYNA0043386182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B9C4591001ISC4591001 1066 10661425J,IMMUNOGENICITYNA0037547364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1066 10661425J,IMMUNOGENICITYNA0044552249C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B9C4591001ISC4591001 1066 10661426J,IMMUNOGENICITYNA0040804775C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1066 10661426J,IMMUNOGENICITYNA0042383086C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B:C4591001ISC4591001 1066 10661426J,IMMUNOGENICITYNA0037547396C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661426J,IMMUNOGENICITYNA0040897398C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04B:C4591001ISC4591001 1066 10661427J,IMMUNOGENICITYNA0040804792C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1066 10661427J,IMMUNOGENICITYNA0043348558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1066 10661427J,IMMUNOGENICITYNA0041685660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1066 10661427J,IMMUNOGENICITYNA0043386137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1066 10661428J,IMMUNOGENICITYNA0040804772C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1066 10661428J,IMMUNOGENICITYNA0042370576C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-03-15BEC4591001ISC4591001 1066 10661429J,IMMUNOGENICITYNA0040804779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1066 10661429J,IMMUNOGENICITYNA0043348577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1066 10661429J,IMMUNOGENICITYNA0037527791C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-26BC4591001ISC4591001 1066 10661430J,IMMUNOGENICITYNA0040804784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1066 10661430J,IMMUNOGENICITYNA0043347006C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B7C4591001ISC4591001 1066 10661430J,IMMUNOGENICITYNA0037527785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1066 10661430J,IMMUNOGENICITYNA0043386138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02B7C4591001ISC4591001 1066 10661431J,IMMUNOGENICITYNA0040804802C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1066 10661431J,IMMUNOGENICITYNA0042383076C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B8C4591001ISC4591001 1066 10661431J,IMMUNOGENICITYNA0043386258C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BGC4591001ISC4591001 1066 10661432J,IMMUNOGENICITYNA0040804761C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1066 10661432J,IMMUNOGENICITYNA0043386180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B8C4591001ISC4591001 1066 10661432J,IMMUNOGENICITYNA0042376455C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1066 10661432J,IMMUNOGENICITYNA0044552083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03B8C4591001ISC4591001 1066 10661433J,IMMUNOGENICITYNA0040804769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1066 10661433J,IMMUNOGENICITYNA0043348587C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1066 10661433J,IMMUNOGENICITYNA0037547373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1066 10661433J,IMMUNOGENICITYNA0042370584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BDC4591001ISC4591001 1066 10661434J,IMMUNOGENICITYNA0040804795C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1066 10661434J,IMMUNOGENICITYNA0044552270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1066 10661434J,IMMUNOGENICITYNA0037534605C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1066 10661434J,IMMUNOGENICITYNA0040897406C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1066 10661435J,IMMUNOGENICITYNA0043283299C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-12AC4591001ISC4591001 1066 10661435J,IMMUNOGENICITYNA0040897426C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1066 10661435J,IMMUNOGENICITYNA0037534581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1066 10661435J,IMMUNOGENICITYNA0040897407C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09B9C4591001ISC4591001 1077 10771274J,IMMUNOGENICITYNA0042431359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1077 10771274J,IMMUNOGENICITYNA0043445664C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B0C4591001ISC4591001 1077 10771274J,IMMUNOGENICITYNA0042387828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1077 10771275J,IMMUNOGENICITYNA0042431374C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1077 10771275J,IMMUNOGENICITYNA0044778411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B0C4591001ISC4591001 1077 10771275J,IMMUNOGENICITYNA0042402772C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1077 10771277J,IMMUNOGENICITYNA0040787845C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1077 10771277J,IMMUNOGENICITYNA0043445044C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1077 10771277J,IMMUNOGENICITYNA0043445438C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1077 10771278J,IMMUNOGENICITYNA0040787833C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1077 10771278J,IMMUNOGENICITYNA0042371188C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B2C4591001ISC4591001 1077 10771278J,IMMUNOGENICITYNA0044779008C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1077 10771279J,IMMUNOGENICITYNA0040788158C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1077 10771279J,IMMUNOGENICITYNA0042371453C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1077 10771279J,IMMUNOGENICITYNA0049612195C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1077 10771280J,IMMUNOGENICITYNA0040564669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1077 10771280J,IMMUNOGENICITYNA0042371424C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1077 10771280J,IMMUNOGENICITYNA0043445411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1077 10771281J,IMMUNOGENICITYNA0040564692C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1077 10771281J,IMMUNOGENICITYNA0042371445C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B3C4591001ISC4591001 1077 10771281J,IMMUNOGENICITYNA0049612200C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1077 10771282J,IMMUNOGENICITYNA0042564264C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1077 10771282J,IMMUNOGENICITYNA0042371409C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B5C4591001ISC4591001 1077 10771283J,IMMUNOGENICITYNA0042564267C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1077 10771283J,IMMUNOGENICITYNA0042371330C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1077 10771283J,IMMUNOGENICITYNA0042402764C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1077 10771284J,IMMUNOGENICITYNA0042564274C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1077 10771284J,IMMUNOGENICITYNA0042371408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1077 10771284J,IMMUNOGENICITYNA0044656315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1077 10771285J,IMMUNOGENICITYNA0042564259C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1077 10771285J,IMMUNOGENICITYNA0042371340C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B5C4591001ISC4591001 1077 10771285J,IMMUNOGENICITYNA0042350382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1077 10771286J,IMMUNOGENICITYNA0042564276C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1077 10771286J,IMMUNOGENICITYNA0042371335C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1077 10771286J,IMMUNOGENICITYNA0049612181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1077 10771287J,IMMUNOGENICITYNA0042564242C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1077 10771287J,IMMUNOGENICITYNA0042371135C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B?C4591001ISC4591001 1077 10771287J,IMMUNOGENICITYNA0049612206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1077 10771288J,IMMUNOGENICITYNA0042564266C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1077 10771288J,IMMUNOGENICITYNA0042371327C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1077 10771288J,IMMUNOGENICITYNA0049612180C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1077 10771289J,IMMUNOGENICITYNA0040788198C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1077 10771289J,IMMUNOGENICITYNA0042371347C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1077 10771290J,IMMUNOGENICITYNA0042564277C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1077 10771290J,IMMUNOGENICITYNA0042371163C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1077 10771291J,IMMUNOGENICITYNA0040787670C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1077 10771291J,IMMUNOGENICITYNA0042371423C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1077 10771291J,IMMUNOGENICITYNA0049612189C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1077 10771292J,IMMUNOGENICITYNA0042564273C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1077 10771292J,IMMUNOGENICITYNA0042370615C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1077 10771294J,IMMUNOGENICITYNA0041579521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1077 10771294J,IMMUNOGENICITYNA0042371138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1077 10771294J,IMMUNOGENICITYNA0042402182C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1077 10771295J,IMMUNOGENICITYNA0042593927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1077 10771295J,IMMUNOGENICITYNA0042370596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1077 10771295J,IMMUNOGENICITYNA0042371075C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-25B<C4591001ISC4591001 1077 10771296J,IMMUNOGENICITYNA0041579382C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1077 10771296J,IMMUNOGENICITYNA0042371125C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1077 10771296J,IMMUNOGENICITYNA0049612178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1077 10771297J,IMMUNOGENICITYNA0042564675C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1077 10771297J,IMMUNOGENICITYNA0042371115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1077 10771297J,IMMUNOGENICITYNA0049613785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1077 10771298J,IMMUNOGENICITYNA0042381296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1077 10771298J,IMMUNOGENICITYNA0042371074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1077 10771298J,IMMUNOGENICITYNA0042350376C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1077 10771299J,IMMUNOGENICITYNA0042381333C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1077 10771299J,IMMUNOGENICITYNA0042371225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B3C4591001ISC4591001 1077 10771299J,IMMUNOGENICITYNA0042387702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1077 10771300J,IMMUNOGENICITYNA0042381317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1077 10771300J,IMMUNOGENICITYNA0042371083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1077 10771300J,IMMUNOGENICITYNA0042370777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1084 10841541J,IMMUNOGENICITYNA0040902996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1084 10841541J,IMMUNOGENICITYNA0042379725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1084 10841541J,IMMUNOGENICITYNA0044749572C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1084 10841541J,IMMUNOGENICITYNA0042400135C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05B9C4591001ISC4591001 1084 10841542J,IMMUNOGENICITYNA0031396371C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1084 10841542J,IMMUNOGENICITYNA0042379741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1084 10841542J,IMMUNOGENICITYNA0042379650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-12B@C4591001ISC4591001 1084 10841543J,IMMUNOGENICITYNA0043477270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1084 10841543J,IMMUNOGENICITYNA0042400147C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841543J,IMMUNOGENICITYNA0044564757C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841543J,IMMUNOGENICITYNA0042400115C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841544J,IMMUNOGENICITYNA0043477239C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1084 10841544J,IMMUNOGENICITYNA0042400601C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841544J,IMMUNOGENICITYNA0041733591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1084 10841544J,IMMUNOGENICITYNA0042400125C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841545J,IMMUNOGENICITYNA0043477245C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1084 10841545J,IMMUNOGENICITYNA0042400626C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841545J,IMMUNOGENICITYNA0042400111C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841546J,IMMUNOGENICITYNA0043477271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1084 10841546J,IMMUNOGENICITYNA0042379729C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841546J,IMMUNOGENICITYNA0044749545C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1084 10841546J,IMMUNOGENICITYNA0042400110C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1084 10841547J,IMMUNOGENICITYNA0043308159C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841547J,IMMUNOGENICITYNA0042379439C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1084 10841547J,IMMUNOGENICITYNA0041733596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841547J,IMMUNOGENICITYNA0042400121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1084 10841548J,IMMUNOGENICITYNA0043474413C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841548J,IMMUNOGENICITYNA0042379435C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841548J,IMMUNOGENICITYNA0044567830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1084 10841548J,IMMUNOGENICITYNA0042379635C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841549J,IMMUNOGENICITYNA0043308139C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841549J,IMMUNOGENICITYNA0042400133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1084 10841549J,IMMUNOGENICITYNA0045312931C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841549J,IMMUNOGENICITYNA0042400136C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1084 10841550J,IMMUNOGENICITYNA0043308140C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841550J,IMMUNOGENICITYNA0031399836C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841550J,IMMUNOGENICITYNA0044568095C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-02BC4591001ISC4591001 1084 10841550J,IMMUNOGENICITYNA0042379717C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841551J,IMMUNOGENICITYNA0043307324C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841551J,IMMUNOGENICITYNA0042400584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841551J,IMMUNOGENICITYNA0049351869C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1084 10841551J,IMMUNOGENICITYNA0042400589C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1084 10841552J,IMMUNOGENICITYNA0043308150C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841552J,IMMUNOGENICITYNA0042400585C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1084 10841552J,IMMUNOGENICITYNA0044749303C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1084 10841552J,IMMUNOGENICITYNA0042379658C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1084 10841553J,IMMUNOGENICITYNA0043308161C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841553J,IMMUNOGENICITYNA0042379451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1084 10841553J,IMMUNOGENICITYNA0041733846C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-07BC4591001ISC4591001 1084 10841555J,IMMUNOGENICITYNA0043307504C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1084 10841555J,IMMUNOGENICITYNA0042379624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1084 10841555J,IMMUNOGENICITYNA0049351816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-30BC4591001ISC4591001 1084 10841555J,IMMUNOGENICITYNA0042400611C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1084 10841556J,IMMUNOGENICITYNA0040882659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841556J,IMMUNOGENICITYNA0042398242C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841556J,IMMUNOGENICITYNA0044565271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1084 10841556J,IMMUNOGENICITYNA0044757685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841557J,IMMUNOGENICITYNA0040882683C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841557J,IMMUNOGENICITYNA0042426766C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B<C4591001ISC4591001 1084 10841557J,IMMUNOGENICITYNA0043371618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-25B<C4591001ISC4591001 1084 10841558J,IMMUNOGENICITYNA0043307538C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841558J,IMMUNOGENICITYNA0044757247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841558J,IMMUNOGENICITYNA0042425927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841558J,IMMUNOGENICITYNA0044757699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841559J,IMMUNOGENICITYNA0043307516C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841559J,IMMUNOGENICITYNA0044757659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841559J,IMMUNOGENICITYNA0042376137C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841559J,IMMUNOGENICITYNA0044757665C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841560J,IMMUNOGENICITYNA0040882654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841560J,IMMUNOGENICITYNA0043371648C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B<C4591001ISC4591001 1084 10841560J,IMMUNOGENICITYNA0041733326C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1084 10841560J,IMMUNOGENICITYNA0043371627C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-25B<C4591001ISC4591001 1084 10841561J,IMMUNOGENICITYNA0043307519C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841561J,IMMUNOGENICITYNA0044756529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841561J,IMMUNOGENICITYNA0044749811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841561J,IMMUNOGENICITYNA0044757684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841562J,IMMUNOGENICITYNA0043307505C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1084 10841562J,IMMUNOGENICITYNA0031399854C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841562J,IMMUNOGENICITYNA0045312937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841562J,IMMUNOGENICITYNA0042399829C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B9C4591001ISC4591001 1084 10841563J,IMMUNOGENICITYNA0040753006C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841563J,IMMUNOGENICITYNA0044757681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841563J,IMMUNOGENICITYNA0042425937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841563J,IMMUNOGENICITYNA0044757690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841564J,IMMUNOGENICITYNA0043308167C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841564J,IMMUNOGENICITYNA0044757226C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841564J,IMMUNOGENICITYNA0041733329C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841564J,IMMUNOGENICITYNA0044757679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841565J,IMMUNOGENICITYNA0043305968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841565J,IMMUNOGENICITYNA0042399816C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841565J,IMMUNOGENICITYNA0041733353C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841565J,IMMUNOGENICITYNA0044757694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841566J,IMMUNOGENICITYNA0040752978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841566J,IMMUNOGENICITYNA0042379653C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841566J,IMMUNOGENICITYNA0051262955C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1084 10841566J,IMMUNOGENICITYNA0042398271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841567J,IMMUNOGENICITYNA0041754900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841567J,IMMUNOGENICITYNA0042379748C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1084 10841567J,IMMUNOGENICITYNA0045312936C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1084 10841567J,IMMUNOGENICITYNA0042400637C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1084 10841568J,IMMUNOGENICITYNA0040753020C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841568J,IMMUNOGENICITYNA0042400002C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08BEC4591001ISC4591001 1084 10841568J,IMMUNOGENICITYNA0042426276C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BEC4591001ISC4591001 1084 10841569J,IMMUNOGENICITYNA0041754874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841569J,IMMUNOGENICITYNA0042399824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841569J,IMMUNOGENICITYNA0041733577C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841569J,IMMUNOGENICITYNA0044757671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841570J,IMMUNOGENICITYNA0041754907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841570J,IMMUNOGENICITYNA0042398246C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841570J,IMMUNOGENICITYNA0041733824C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841570J,IMMUNOGENICITYNA0042400618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841571J,IMMUNOGENICITYNA0041754890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1084 10841571J,IMMUNOGENICITYNA0044757655C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841571J,IMMUNOGENICITYNA0041733368C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841571J,IMMUNOGENICITYNA0044757680C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1084 10841572J,IMMUNOGENICITYNA0041754915C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1084 10841572J,IMMUNOGENICITYNA0042426755C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1084 10841572J,IMMUNOGENICITYNA0041733362C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1084 10841573J,IMMUNOGENICITYNA0041754880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1084 10841573J,IMMUNOGENICITYNA0043371638C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841573J,IMMUNOGENICITYNA0044568094C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1084 10841573J,IMMUNOGENICITYNA0031396424C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841574J,IMMUNOGENICITYNA0040901192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1084 10841574J,IMMUNOGENICITYNA0042426682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841574J,IMMUNOGENICITYNA0044568083C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1084 10841574J,IMMUNOGENICITYNA0042400138C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841575J,IMMUNOGENICITYNA0041754897C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1084 10841575J,IMMUNOGENICITYNA0042426712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841575J,IMMUNOGENICITYNA0045300513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-16BgC4591001ISC4591001 1084 10841575J,IMMUNOGENICITYNA0042426420C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B6C4591001ISC4591001 1084 10841576J,IMMUNOGENICITYNA0031391168C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841576J,IMMUNOGENICITYNA0042379620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B0C4591001ISC4591001 1084 10841576J,IMMUNOGENICITYNA0044553912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1084 10841576J,IMMUNOGENICITYNA0044757663C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-22B0C4591001ISC4591001 1084 10841577J,IMMUNOGENICITYNA0040753017C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841577J,IMMUNOGENICITYNA0042426739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1084 10841577J,IMMUNOGENICITYNA0041733322C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1084 10841577J,IMMUNOGENICITYNA0042400636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1084 10841578J,IMMUNOGENICITYNA0031391169C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841578J,IMMUNOGENICITYNA0042426773C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1084 10841578J,IMMUNOGENICITYNA0044568111C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1084 10841578J,IMMUNOGENICITYNA0042426781C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1084 10841579J,IMMUNOGENICITYNA0041755024C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841579J,IMMUNOGENICITYNA0042426770C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1084 10841579J,IMMUNOGENICITYNA0043370775C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1084 10841580J,IMMUNOGENICITYNA0041755055C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841580J,IMMUNOGENICITYNA0042426782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1084 10841580J,IMMUNOGENICITYNA0051263067C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1084 10841580J,IMMUNOGENICITYNA0031399862C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-25B3C4591001ISC4591001 1084 10841581J,IMMUNOGENICITYNA0041755028C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841581J,IMMUNOGENICITYNA0042400652C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1084 10841581J,IMMUNOGENICITYNA0044749784C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841582J,IMMUNOGENICITYNA0040752980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1084 10841582J,IMMUNOGENICITYNA0042426732C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1084 10841582J,IMMUNOGENICITYNA0051262970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1084 10841582J,IMMUNOGENICITYNA0042426405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1084 10841583J,IMMUNOGENICITYNA0041755200C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841583J,IMMUNOGENICITYNA0042426667C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841583J,IMMUNOGENICITYNA0049352128C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1084 10841583J,IMMUNOGENICITYNA0031391156C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841584J,IMMUNOGENICITYNA0041755194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841584J,IMMUNOGENICITYNA0043371644C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841584J,IMMUNOGENICITYNA0051263079C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1084 10841584J,IMMUNOGENICITYNA0042426724C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841586J,IMMUNOGENICITYNA0042424399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841586J,IMMUNOGENICITYNA0042426436C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841586J,IMMUNOGENICITYNA0041733364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1084 10841586J,IMMUNOGENICITYNA0042426445C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841587J,IMMUNOGENICITYNA0041755181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841587J,IMMUNOGENICITYNA0031399850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841587J,IMMUNOGENICITYNA0041733323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1084 10841587J,IMMUNOGENICITYNA0042379739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841588J,IMMUNOGENICITYNA0041755057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841588J,IMMUNOGENICITYNA0042379745C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841588J,IMMUNOGENICITYNA0041733811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1084 10841588J,IMMUNOGENICITYNA0042426611C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841589J,IMMUNOGENICITYNA0043257474C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841589J,IMMUNOGENICITYNA0042426685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841589J,IMMUNOGENICITYNA0051262959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-23BC4591001ISC4591001 1084 10841589J,IMMUNOGENICITYNA0042426671C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841590J,IMMUNOGENICITYNA0042424390C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841590J,IMMUNOGENICITYNA0042426409C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841590J,IMMUNOGENICITYNA0044749793C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841590J,IMMUNOGENICITYNA0042426287C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841591J,IMMUNOGENICITYNA0042424424C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841591J,IMMUNOGENICITYNA0042426298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841591J,IMMUNOGENICITYNA0051263066C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1084 10841591J,IMMUNOGENICITYNA0042426689C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1084 10841592J,IMMUNOGENICITYNA0042424416C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841592J,IMMUNOGENICITYNA0042371682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B7C4591001ISC4591001 1084 10841592J,IMMUNOGENICITYNA0049351842C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1084 10841592J,IMMUNOGENICITYNA0042426284C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03B7C4591001ISC4591001 1084 10841593J,IMMUNOGENICITYNA0042424411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841593J,IMMUNOGENICITYNA0043371643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841593J,IMMUNOGENICITYNA0051262984C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1084 10841593J,IMMUNOGENICITYNA0042426642C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841594J,IMMUNOGENICITYNA0042424402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841594J,IMMUNOGENICITYNA0043371622C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841594J,IMMUNOGENICITYNA0049351873C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1084 10841594J,IMMUNOGENICITYNA0031396417C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841595J,IMMUNOGENICITYNA0041755185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841595J,IMMUNOGENICITYNA0042400663C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B0C4591001ISC4591001 1084 10841595J,IMMUNOGENICITYNA0044553898C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841595J,IMMUNOGENICITYNA0042426748C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-24B0C4591001ISC4591001 1084 10841596J,IMMUNOGENICITYNA0041755206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841596J,IMMUNOGENICITYNA0042426437C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841596J,IMMUNOGENICITYNA0044610947C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1084 10841596J,IMMUNOGENICITYNA0042426416C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841597J,IMMUNOGENICITYNA0042424387C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1084 10841597J,IMMUNOGENICITYNA0043371632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1084 10841597J,IMMUNOGENICITYNA0044749319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-07BxC4591001ISC4591001 1084 10841597J,IMMUNOGENICITYNA0043371636C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1091 10911394J,IMMUNOGENICITYNA0042430489C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1091 10911394J,IMMUNOGENICITYNA0039425001C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1091 10911394J,IMMUNOGENICITYNA0042505866C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1091 10911395J,IMMUNOGENICITYNA0042430508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1091 10911395J,IMMUNOGENICITYNA0039425008C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1091 10911395J,IMMUNOGENICITYNA0042505905C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1091 10911396J,IMMUNOGENICITYNA0042429114C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1091 10911396J,IMMUNOGENICITYNA0039426090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B0C4591001ISC4591001 1091 10911396J,IMMUNOGENICITYNA0034770575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-12BC4591001ISC4591001 1091 10911399J,IMMUNOGENICITYNA0042429130C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1091 10911399J,IMMUNOGENICITYNA0039425794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B?C4591001ISC4591001 1091 10911399J,IMMUNOGENICITYNA0044744307C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1091 10911400J,IMMUNOGENICITYNA0042429116C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1091 10911400J,IMMUNOGENICITYNA0039425662C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B7C4591001ISC4591001 1091 10911400J,IMMUNOGENICITYNA0042486693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1091 10911402J,IMMUNOGENICITYNA0042429100C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1091 10911402J,IMMUNOGENICITYNA0039425654C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1091 10911402J,IMMUNOGENICITYNA0049618675C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1091 10911403J,IMMUNOGENICITYNA0042430523C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1091 10911403J,IMMUNOGENICITYNA0039424986C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B3C4591001ISC4591001 1091 10911403J,IMMUNOGENICITYNA0042505850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1091 10911403J,IMMUNOGENICITYNA0043466700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BsC4591001ISC4591001 1091 10911404J,IMMUNOGENICITYNA0040637279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1091 10911404J,IMMUNOGENICITYNA0039425810C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09BAC4591001ISC4591001 1091 10911404J,IMMUNOGENICITYNA0049620462C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1091 10911405J,IMMUNOGENICITYNA0040525228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1091 10911405J,IMMUNOGENICITYNA0039426094C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B5C4591001ISC4591001 1091 10911405J,IMMUNOGENICITYNA0042486625C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-27BC4591001ISC4591001 1091 10911406J,IMMUNOGENICITYNA0040524979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1091 10911406J,IMMUNOGENICITYNA0039424973C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B2C4591001ISC4591001 1091 10911406J,IMMUNOGENICITYNA0042506000C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-06-14BC4591001ISC4591001 1091 10911407J,IMMUNOGENICITYNA0042429131C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1091 10911407J,IMMUNOGENICITYNA0039425688C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B1C4591001ISC4591001 1091 10911407J,IMMUNOGENICITYNA0049618667C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1091 10911407J,IMMUNOGENICITYNA0049620461C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-14BC4591001ISC4591001 1091 10911407J,IMMUNOGENICITYNA0034770551C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-19BC4591001ISC4591001 1091 10911408J,IMMUNOGENICITYNA0040599043C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1091 10911408J,IMMUNOGENICITYNA0039426096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-28B4C4591001ISC4591001 1091 10911408J,IMMUNOGENICITYNA0049619480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1091 10911409J,IMMUNOGENICITYNA0042430514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911409J,IMMUNOGENICITYNA0039426104C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1091 10911410J,IMMUNOGENICITYNA0040525224C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911410J,IMMUNOGENICITYNA0039424996C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1091 10911410J,IMMUNOGENICITYNA0042506247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1091 10911411J,IMMUNOGENICITYNA0042429093C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911411J,IMMUNOGENICITYNA0039425685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1091 10911411J,IMMUNOGENICITYNA0042486700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1091 10911412J,IMMUNOGENICITYNA0040637311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911412J,IMMUNOGENICITYNA0039425659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1091 10911412J,IMMUNOGENICITYNA0042505840C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-06-22BC4591001ISC4591001 1091 10911412J,IMMUNOGENICITYNA0043377141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BwC4591001ISC4591001 1091 10911413J,IMMUNOGENICITYNA0040525214C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911413J,IMMUNOGENICITYNA0039425715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B?C4591001ISC4591001 1091 10911413J,IMMUNOGENICITYNA0042486834C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1091 10911414J,IMMUNOGENICITYNA0040904353C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1091 10911414J,IMMUNOGENICITYNA0039425711C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B?C4591001ISC4591001 1091 10911415J,IMMUNOGENICITYNA0042429132C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911415J,IMMUNOGENICITYNA0039425009C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911415J,IMMUNOGENICITYNA0042486681C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1091 10911416J,IMMUNOGENICITYNA0043466868C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911416J,IMMUNOGENICITYNA0039422153C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911416J,IMMUNOGENICITYNA0042486865C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1091 10911417J,IMMUNOGENICITYNA0043466907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911417J,IMMUNOGENICITYNA0039425645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911417J,IMMUNOGENICITYNA0034770561C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 REPEAT SCREENING 1 2021-05-17BC4591001ISC4591001 1091 10911418J,IMMUNOGENICITYNA0043466896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911418J,IMMUNOGENICITYNA0039425015C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911418J,IMMUNOGENICITYNA0034769941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1091 10911419J,IMMUNOGENICITYNA0043466891C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911419J,IMMUNOGENICITYNA0039425643C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911419J,IMMUNOGENICITYNA0042506244C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1091 10911420J,IMMUNOGENICITYNA0043466909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911420J,IMMUNOGENICITYNA0039426077C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911420J,IMMUNOGENICITYNA0049619513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1091 10911421J,IMMUNOGENICITYNA0043465055C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1091 10911421J,IMMUNOGENICITYNA0039422175C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1091 10911421J,IMMUNOGENICITYNA0034770576C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1091 10911422J,IMMUNOGENICITYNA0043466887C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1091 10911422J,IMMUNOGENICITYNA0039425816C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1091 10911422J,IMMUNOGENICITYNA0049618680C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1091 10911422J,IMMUNOGENICITYNA0043377159C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-08BtC4591001ISC4591001 1091 10911423J,IMMUNOGENICITYNA0043466879C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1091 10911423J,IMMUNOGENICITYNA0039425888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B;C4591001ISC4591001 1091 10911423J,IMMUNOGENICITYNA0049619489C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-30BC4591001ISC4591001 1091 10911423J,IMMUNOGENICITYNA0043377121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-12BxC4591001ISC4591001 1091 10911424J,IMMUNOGENICITYNA0043466893C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1091 10911424J,IMMUNOGENICITYNA0039426084C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B1C4591001ISC4591001 1091 10911424J,IMMUNOGENICITYNA0034770449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1091 10911425J,IMMUNOGENICITYNA0043463560C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1091 10911425J,IMMUNOGENICITYNA0039425658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1091 10911425J,IMMUNOGENICITYNA0034770495C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1091 10911426J,IMMUNOGENICITYNA0043465054C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1091 10911426J,IMMUNOGENICITYNA0039425719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1091 10911426J,IMMUNOGENICITYNA0049618669C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1091 10911427J,IMMUNOGENICITYNA0043465057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1091 10911427J,IMMUNOGENICITYNA0039425883C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1091 10911427J,IMMUNOGENICITYNA0049618660C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1091 10911428J,IMMUNOGENICITYNA0043466874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1091 10911428J,IMMUNOGENICITYNA0039425695C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1091 10911428J,IMMUNOGENICITYNA0049619481C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1091 10911429J,IMMUNOGENICITYNA0043463557C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1091 10911429J,IMMUNOGENICITYNA0039425827C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1091 10911429J,IMMUNOGENICITYNA0043466719C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-01BkC4591001ISC4591001 1091 10911430J,IMMUNOGENICITYNA0043466906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1091 10911430J,IMMUNOGENICITYNA0039422170C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B1C4591001ISC4591001 1091 10911430J,IMMUNOGENICITYNA0034770487C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 REPEAT SCREENING 1 2021-05-17BC4591001ISC4591001 1091 10911431J,IMMUNOGENICITYNA0043463582C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911431J,IMMUNOGENICITYNA0039425977C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B9C4591001ISC4591001 1091 10911431J,IMMUNOGENICITYNA0049618687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1091 10911432J,IMMUNOGENICITYNA0043463556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911432J,IMMUNOGENICITYNA0039425650C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1091 10911432J,IMMUNOGENICITYNA0042505973C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-10BC4591001ISC4591001 1091 10911432J,IMMUNOGENICITYNA0043466694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BiC4591001ISC4591001 1091 10911433J,IMMUNOGENICITYNA0043463584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911433J,IMMUNOGENICITYNA0039425908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1091 10911434J,IMMUNOGENICITYNA0040525241C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911434J,IMMUNOGENICITYNA0039425823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1091 10911434J,IMMUNOGENICITYNA0043377311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1091 10911435J,IMMUNOGENICITYNA0043463575C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911435J,IMMUNOGENICITYNA0039425806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1091 10911435J,IMMUNOGENICITYNA0049618698C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1091 10911435J,IMMUNOGENICITYNA0043377140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BwC4591001ISC4591001 1091 10911436J,IMMUNOGENICITYNA0043463568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911436J,IMMUNOGENICITYNA0039425804C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1091 10911436J,IMMUNOGENICITYNA0049619508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1091 10911437J,IMMUNOGENICITYNA0043463581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1091 10911437J,IMMUNOGENICITYNA0039425818C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1091 10911437J,IMMUNOGENICITYNA0042486584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1091 10911438J,IMMUNOGENICITYNA0042429092C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1091 10911438J,IMMUNOGENICITYNA0039425953C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1091 10911438J,IMMUNOGENICITYNA0049618673C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1091 10911439J,IMMUNOGENICITYNA0040908608C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1091 10911439J,IMMUNOGENICITYNA0039425978C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B9C4591001ISC4591001 1091 10911439J,IMMUNOGENICITYNA0042486785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1091 10911440J,IMMUNOGENICITYNA0040908586C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1091 10911440J,IMMUNOGENICITYNA0039425710C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B5C4591001ISC4591001 1091 10911440J,IMMUNOGENICITYNA0049618702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1091 10911441J,IMMUNOGENICITYNA0043466889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1091 10911441J,IMMUNOGENICITYNA0039425814C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B5C4591001ISC4591001 1091 10911441J,IMMUNOGENICITYNA0034770546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1091 10911442J,IMMUNOGENICITYNA0043463590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1091 10911442J,IMMUNOGENICITYNA0039425893C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B5C4591001ISC4591001 1091 10911442J,IMMUNOGENICITYNA0043377323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1091 10911443J,IMMUNOGENICITYNA0043374916C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1091 10911443J,IMMUNOGENICITYNA0039425963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B6C4591001ISC4591001 1091 10911443J,IMMUNOGENICITYNA0044744466C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-12BC4591001ISC4591001 1091 10911444J,IMMUNOGENICITYNA0043398735C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1091 10911444J,IMMUNOGENICITYNA0039425819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1091 10911444J,IMMUNOGENICITYNA0042486850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1091 10911444J,IMMUNOGENICITYNA0034769949C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-29BC4591001ISC4591001 1091 10911445J,IMMUNOGENICITYNA0043398688C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1091 10911445J,IMMUNOGENICITYNA0044581775C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B@C4591001ISC4591001 1091 10911445J,IMMUNOGENICITYNA0034770567C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1091 10911446J,IMMUNOGENICITYNA0043398715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911446J,IMMUNOGENICITYNA0039425918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1091 10911446J,IMMUNOGENICITYNA0049620464C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1091 10911447J,IMMUNOGENICITYNA0043377081C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911447J,IMMUNOGENICITYNA0043376901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1091 10911447J,IMMUNOGENICITYNA0042486838C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1091 10911448J,IMMUNOGENICITYNA0043377074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911448J,IMMUNOGENICITYNA0043376895C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1091 10911448J,IMMUNOGENICITYNA0034770559C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 REPEAT SCREENING 1 2021-05-17BC4591001ISC4591001 1091 10911448J,IMMUNOGENICITYNA0043466685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-01BeC4591001ISC4591001 1091 10911449J,IMMUNOGENICITYNA0043398728C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911449J,IMMUNOGENICITYNA0039425704C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B1C4591001ISC4591001 1091 10911450J,IMMUNOGENICITYNA0043377093C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911450J,IMMUNOGENICITYNA0039425694C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B:C4591001ISC4591001 1091 10911450J,IMMUNOGENICITYNA0043462989C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1091 10911452J,IMMUNOGENICITYNA0043398722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911452J,IMMUNOGENICITYNA0039425901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1091 10911452J,IMMUNOGENICITYNA0034769930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1091 10911453J,IMMUNOGENICITYNA0043377109C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1091 10911453J,IMMUNOGENICITYNA0043376890C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B:C4591001ISC4591001 1091 10911453J,IMMUNOGENICITYNA0049620601C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1091 10911454J,IMMUNOGENICITYNA0043377106C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1091 10911454J,IMMUNOGENICITYNA0043463000C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1091 10911454J,IMMUNOGENICITYNA0049619897C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1091 10911454J,IMMUNOGENICITYNA0043377133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-19BC4591001ISC4591001 1091 10911455J,IMMUNOGENICITYNA0043377079C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1091 10911455J,IMMUNOGENICITYNA0044581350C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B<C4591001ISC4591001 1091 10911455J,IMMUNOGENICITYNA0043253556C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1091 10911456J,IMMUNOGENICITYNA0043377091C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1091 10911456J,IMMUNOGENICITYNA0043463013C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B1C4591001ISC4591001 1091 10911456J,IMMUNOGENICITYNA0049563610C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1091 10911457J,IMMUNOGENICITYNA0043463567C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1091 10911457J,IMMUNOGENICITYNA0043376913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B1C4591001ISC4591001 1091 10911457J,IMMUNOGENICITYNA0049620451C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1091 10911458J,IMMUNOGENICITYNA0043377085C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1091 10911458J,IMMUNOGENICITYNA0043377033C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1091 10911458J,IMMUNOGENICITYNA0049620584C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1091 10911459J,IMMUNOGENICITYNA0043377092C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1091 10911459J,IMMUNOGENICITYNA0043399747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1091 10911459J,IMMUNOGENICITYNA0043377355C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1091 10911460J,IMMUNOGENICITYNA0039425867C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1091 10911460J,IMMUNOGENICITYNA0043462999C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1091 10911460J,IMMUNOGENICITYNA0049620459C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1091 10911461J,IMMUNOGENICITYNA0039425881C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1091 10911461J,IMMUNOGENICITYNA0043376896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1091 10911461J,IMMUNOGENICITYNA0049620472C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1091 10911462J,IMMUNOGENICITYNA0039425877C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1091 10911462J,IMMUNOGENICITYNA0044581364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1091 10911462J,IMMUNOGENICITYNA0043258756C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-27BC4591001ISC4591001 1091 10911463J,IMMUNOGENICITYNA0039425869C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1091 10911463J,IMMUNOGENICITYNA0044581366C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1091 10911463J,IMMUNOGENICITYNA0034770558C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1091 10911463J,IMMUNOGENICITYNA0034770472C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04ByC4591001ISC4591001 1091 10911464J,IMMUNOGENICITYNA0039425882C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1091 10911464J,IMMUNOGENICITYNA0043377062C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B5C4591001ISC4591001 1091 10911464J,IMMUNOGENICITYNA0044744722C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-29BC4591001ISC4591001 1091 10911464J,IMMUNOGENICITYNA0034769918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-05-04ByC4591001ISC4591001 1091 10911465J,IMMUNOGENICITYNA0039426054C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1091 10911465J,IMMUNOGENICITYNA0044581368C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1091 10911465J,IMMUNOGENICITYNA0043258510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1091 10911466J,IMMUNOGENICITYNA0039426049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-11AC4591001ISC4591001 1091 10911466J,IMMUNOGENICITYNA0043399785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-08B9C4591001ISC4591001 1091 10911466J,IMMUNOGENICITYNA0034770475C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231422J,IMMUNOGENICITYNA0043489918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1123 11231422J,IMMUNOGENICITYNA0040761988C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B1C4591001ISC4591001 1123 11231422J,IMMUNOGENICITYNA0042414321C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BbC4591001ISC4591001 1123 11231425J,IMMUNOGENICITYNA0043489908C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1123 11231425J,IMMUNOGENICITYNA0042366327C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B0C4591001ISC4591001 1123 11231425J,IMMUNOGENICITYNA0041733405C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-17BC4591001ISC4591001 1123 11231425J,IMMUNOGENICITYNA0043529107C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05B^C4591001ISC4591001 1123 11231428J,IMMUNOGENICITYNA0042434204C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1123 11231428J,IMMUNOGENICITYNA0042353439C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B0C4591001ISC4591001 1123 11231428J,IMMUNOGENICITYNA0041733416C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-15BC4591001ISC4591001 1123 11231428J,IMMUNOGENICITYNA0045270399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BpC4591001ISC4591001 1123 11231431J,IMMUNOGENICITYNA0033812228C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1123 11231431J,IMMUNOGENICITYNA0043528705C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B5C4591001ISC4591001 1123 11231431J,IMMUNOGENICITYNA0044607624C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231431J,IMMUNOGENICITYNA0042414336C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08B_C4591001ISC4591001 1123 11231432J,IMMUNOGENICITYNA0041579538C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1123 11231432J,IMMUNOGENICITYNA0043528716C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B5C4591001ISC4591001 1123 11231432J,IMMUNOGENICITYNA0044633967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1123 11231432J,IMMUNOGENICITYNA0042346367C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08B_C4591001ISC4591001 1123 11231434J,IMMUNOGENICITYNA0042433649C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1123 11231434J,IMMUNOGENICITYNA0043529219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B6C4591001ISC4591001 1123 11231438J,IMMUNOGENICITYNA0043459844C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1123 11231438J,IMMUNOGENICITYNA0040529140C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B;C4591001ISC4591001 1123 11231438J,IMMUNOGENICITYNA0042346520C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BVC4591001ISC4591001 1123 11231439J,IMMUNOGENICITYNA0043459836C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1123 11231439J,IMMUNOGENICITYNA0040591229C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B;C4591001ISC4591001 1123 11231439J,IMMUNOGENICITYBRNHKP C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1123 11231439J,IMMUNOGENICITYNA0042346510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BVC4591001ISC4591001 1123 11231440J,IMMUNOGENICITYNA0040873810C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231440J,IMMUNOGENICITYNA0043529352C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B0C4591001ISC4591001 1123 11231440J,IMMUNOGENICITYNA0041733399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1123 11231440J,IMMUNOGENICITYNA0042369334C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BVC4591001ISC4591001 1123 11231441J,IMMUNOGENICITYNA0040873811C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231441J,IMMUNOGENICITYNA0040529107C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B;C4591001ISC4591001 1123 11231442J,IMMUNOGENICITYNA0040873805C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231442J,IMMUNOGENICITYNA0043528900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1123 11231442J,IMMUNOGENICITYNA0041732562C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231442J,IMMUNOGENICITYNA0042346069C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BVC4591001ISC4591001 1123 11231443J,IMMUNOGENICITYNA0042433658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231443J,IMMUNOGENICITYNA0043528887C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B7C4591001ISC4591001 1123 11231443J,IMMUNOGENICITYNA0042346067C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BVC4591001ISC4591001 1123 11231445J,IMMUNOGENICITYNA0040873823C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231445J,IMMUNOGENICITYNA0040752938C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1123 11231445J,IMMUNOGENICITYNA0045270403C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BjC4591001ISC4591001 1123 11231446J,IMMUNOGENICITYNA0040873787C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-09AC4591001ISC4591001 1123 11231446J,IMMUNOGENICITYNA0042366349C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B2C4591001ISC4591001 1123 11231447J,IMMUNOGENICITYNA0043450264C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1123 11231447J,IMMUNOGENICITYNA0043529447C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B6C4591001ISC4591001 1123 11231447J,IMMUNOGENICITYNA0041733377C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1123 11231447J,IMMUNOGENICITYNA0042346074C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BUC4591001ISC4591001 1123 11231448J,IMMUNOGENICITYNA0041737871C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1123 11231448J,IMMUNOGENICITYNA0043528888C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B7C4591001ISC4591001 1123 11231448J,IMMUNOGENICITYNA0042346514C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BSC4591001ISC4591001 1123 11231449J,IMMUNOGENICITYNA0041737880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1123 11231449J,IMMUNOGENICITYNA0043529204C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1123 11231449J,IMMUNOGENICITYNA0044633934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1123 11231449J,IMMUNOGENICITYNA0043300545C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1123 11231450J,IMMUNOGENICITYNA0041737861C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1123 11231450J,IMMUNOGENICITYNA0043528717C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1123 11231450J,IMMUNOGENICITYNA0041732571C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231450J,IMMUNOGENICITYNA0043300569C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BcC4591001ISC4591001 1123 11231451J,IMMUNOGENICITYNA0041579548C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1123 11231451J,IMMUNOGENICITYNA0043529457C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B4C4591001ISC4591001 1123 11231451J,IMMUNOGENICITYNA0041733404C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-28BC4591001ISC4591001 1123 11231451J,IMMUNOGENICITYNA0042345388C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BQC4591001ISC4591001 1123 11231452J,IMMUNOGENICITYNA0033812241C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1123 11231452J,IMMUNOGENICITYNA0042366332C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B1C4591001ISC4591001 1123 11231452J,IMMUNOGENICITYNA0044636295C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-07BC4591001ISC4591001 1123 11231452J,IMMUNOGENICITYNA0042346049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BPC4591001ISC4591001 1123 11231453J,IMMUNOGENICITYNA0041579383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1123 11231453J,IMMUNOGENICITYNA0042353270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B8C4591001ISC4591001 1123 11231453J,IMMUNOGENICITYNA0044638907C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1123 11231453J,IMMUNOGENICITYNA0042346060C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BPC4591001ISC4591001 1123 11231454J,IMMUNOGENICITYNA0033812231C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1123 11231454J,IMMUNOGENICITYNA0042353280C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B8C4591001ISC4591001 1123 11231454J,IMMUNOGENICITYNA0042369412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-20BDC4591001ISC4591001 1123 11231455J,IMMUNOGENICITYNA0041579379C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1123 11231455J,IMMUNOGENICITYNA0043529439C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1123 11231455J,IMMUNOGENICITYNA0041733391C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1123 11231455J,IMMUNOGENICITYNA0042414189C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B^C4591001ISC4591001 1123 11231456J,IMMUNOGENICITYNA0033812219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1123 11231456J,IMMUNOGENICITYNA0043529480C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B1C4591001ISC4591001 1123 11231456J,IMMUNOGENICITYNA0044638740C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231456J,IMMUNOGENICITYNA0042414195C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B\C4591001ISC4591001 1123 11231457J,IMMUNOGENICITYNA0041579535C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1123 11231457J,IMMUNOGENICITYNA0043529478C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1123 11231457J,IMMUNOGENICITYNA0044638761C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1123 11231457J,IMMUNOGENICITYNA0042362502C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16B[C4591001ISC4591001 1123 11231458J,IMMUNOGENICITYNA0041579199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1123 11231458J,IMMUNOGENICITYNA0043528906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1123 11231458J,IMMUNOGENICITYNA0039427950C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-02BC4591001ISC4591001 1123 11231458J,IMMUNOGENICITYNA0042346039C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BPC4591001ISC4591001 1123 11231459J,IMMUNOGENICITYNA0041579358C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1123 11231459J,IMMUNOGENICITYNA0043529443C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B0C4591001ISC4591001 1123 11231459J,IMMUNOGENICITYNA0044639340C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231460J,IMMUNOGENICITYNA0042432632C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1123 11231460J,IMMUNOGENICITYNA0043528740C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B3C4591001ISC4591001 1123 11231460J,IMMUNOGENICITYNA0043529111C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-17B?C4591001ISC4591001 1123 11231461J,IMMUNOGENICITYNA0043490069C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1123 11231461J,IMMUNOGENICITYNA0043528866C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1123 11231461J,IMMUNOGENICITYNA0044633950C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1123 11231462J,IMMUNOGENICITYNA0042432613C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1123 11231462J,IMMUNOGENICITYNA0042353301C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B6C4591001ISC4591001 1123 11231462J,IMMUNOGENICITYNA0041733402C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-02BC4591001ISC4591001 1123 11231462J,IMMUNOGENICITYNA0042346527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BMC4591001ISC4591001 1123 11231463J,IMMUNOGENICITYNA0043273737C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1123 11231463J,IMMUNOGENICITYNA0043528764C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B1C4591001ISC4591001 1123 11231463J,IMMUNOGENICITYNA0041732566C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231463J,IMMUNOGENICITYNA0042362485C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BYC4591001ISC4591001 1123 11231465J,IMMUNOGENICITYNA0043273736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1123 11231465J,IMMUNOGENICITYNA0043528988C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1123 11231465J,IMMUNOGENICITYNA0044633739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1123 11231465J,IMMUNOGENICITYNA0043300592C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23B`C4591001ISC4591001 1123 11231466J,IMMUNOGENICITYNA0043273603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1123 11231466J,IMMUNOGENICITYNA0043529463C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B0C4591001ISC4591001 1123 11231466J,IMMUNOGENICITYNA0041733380C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1123 11231466J,IMMUNOGENICITYNA0043529127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BLC4591001ISC4591001 1123 11231467J,IMMUNOGENICITYNA0043273753C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231467J,IMMUNOGENICITYNA0042369352C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1123 11231467J,IMMUNOGENICITYNA0044638762C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1123 11231467J,IMMUNOGENICITYNA0042346551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BNC4591001ISC4591001 1123 11231468J,IMMUNOGENICITYNA0043273751C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231468J,IMMUNOGENICITYNA0042353315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B3C4591001ISC4591001 1123 11231468J,IMMUNOGENICITYNA0044633969C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-04BC4591001ISC4591001 1123 11231468J,IMMUNOGENICITYNA0042346379C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-02BHC4591001ISC4591001 1123 11231469J,IMMUNOGENICITYNA0043273743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231469J,IMMUNOGENICITYNA0043528999C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B5C4591001ISC4591001 1123 11231469J,IMMUNOGENICITYNA0044636699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1123 11231469J,IMMUNOGENICITYNA0043300588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BYC4591001ISC4591001 1123 11231470J,IMMUNOGENICITYNA0040761794C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231470J,IMMUNOGENICITYNA0042352070C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1123 11231470J,IMMUNOGENICITYNA0041733221C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231470J,IMMUNOGENICITYNA0042346521C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-03BIC4591001ISC4591001 1123 11231472J,IMMUNOGENICITYNA0043273748C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231472J,IMMUNOGENICITYNA0043529146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B:C4591001ISC4591001 1123 11231472J,IMMUNOGENICITYBRNHKL C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1123 11231472J,IMMUNOGENICITYNA0042414312C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BNC4591001ISC4591001 1123 11231473J,IMMUNOGENICITYNA0043273580C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231473J,IMMUNOGENICITYNA0043529484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B3C4591001ISC4591001 1123 11231473J,IMMUNOGENICITYNA0044607591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231473J,IMMUNOGENICITYNA0042362499C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BVC4591001ISC4591001 1123 11231474J,IMMUNOGENICITYNA0043273594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231474J,IMMUNOGENICITYNA0042367271C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1123 11231474J,IMMUNOGENICITYNA0044636679C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231474J,IMMUNOGENICITYNA0042414166C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BRC4591001ISC4591001 1123 11231475J,IMMUNOGENICITYNA0043273727C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231475J,IMMUNOGENICITYNA0043529226C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1123 11231475J,IMMUNOGENICITYNA0044638900C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231475J,IMMUNOGENICITYNA0042414177C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BRC4591001ISC4591001 1123 11231476J,IMMUNOGENICITYNA0043273774C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231476J,IMMUNOGENICITYNA0041593934C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1123 11231476J,IMMUNOGENICITYNA0044638753C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1123 11231476J,IMMUNOGENICITYNA0042414325C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BNC4591001ISC4591001 1123 11231477J,IMMUNOGENICITYNA0043273782C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231477J,IMMUNOGENICITYNA0042452096C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1123 11231477J,IMMUNOGENICITYNA0042346365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BKC4591001ISC4591001 1123 11231478J,IMMUNOGENICITYNA0043293110C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231478J,IMMUNOGENICITYNA0042353298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B2C4591001ISC4591001 1123 11231478J,IMMUNOGENICITYNA0042346529C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BKC4591001ISC4591001 1123 11231479J,IMMUNOGENICITYNA0043273773C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231479J,IMMUNOGENICITYNA0042369386C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B9C4591001ISC4591001 1123 11231481J,IMMUNOGENICITYNA0043273800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1123 11231481J,IMMUNOGENICITYNA0042353284C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1123 11231481J,IMMUNOGENICITYNA0031354274C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-03BC4591001ISC4591001 1123 11231481J,IMMUNOGENICITYNA0042386588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25B_C4591001ISC4591001 1123 11231482J,IMMUNOGENICITYNA0043293146C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231482J,IMMUNOGENICITYNA0042353297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1123 11231482J,IMMUNOGENICITYNA0044606786C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1123 11231482J,IMMUNOGENICITYNA0043529307C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BJC4591001ISC4591001 1123 11231483J,IMMUNOGENICITYNA0043293123C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231483J,IMMUNOGENICITYNA0043528962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1123 11231484J,IMMUNOGENICITYNA0040761761C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231484J,IMMUNOGENICITYNA0042367266C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1123 11231484J,IMMUNOGENICITYNA0044638897C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1123 11231484J,IMMUNOGENICITYNA0043300948C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BTC4591001ISC4591001 1123 11231485J,IMMUNOGENICITYNA0043293109C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231485J,IMMUNOGENICITYNA0043528966C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B2C4591001ISC4591001 1123 11231485J,IMMUNOGENICITYNA0044633953C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1123 11231485J,IMMUNOGENICITYNA0042369339C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-08BMC4591001ISC4591001 1123 11231486J,IMMUNOGENICITYNA0043293125C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231486J,IMMUNOGENICITYNA0042353302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B1C4591001ISC4591001 1123 11231486J,IMMUNOGENICITYNA0043300944C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23B\C4591001ISC4591001 1123 11231487J,IMMUNOGENICITYNA0043293151C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231487J,IMMUNOGENICITYNA0043528980C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B3C4591001ISC4591001 1123 11231487J,IMMUNOGENICITYNA0044633937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231487J,IMMUNOGENICITYNA0042369387C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-09BNC4591001ISC4591001 1123 11231488J,IMMUNOGENICITYNA0043293169C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231488J,IMMUNOGENICITYNA0042369371C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B:C4591001ISC4591001 1123 11231488J,IMMUNOGENICITYNA0044638901C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231488J,IMMUNOGENICITYNA0042346061C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-05BJC4591001ISC4591001 1123 11231489J,IMMUNOGENICITYNA0043293184C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231489J,IMMUNOGENICITYNA0042353285C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1123 11231489J,IMMUNOGENICITYBRNHKT C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1123 11231489J,IMMUNOGENICITYNA0043300567C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BXC4591001ISC4591001 1123 11231491J,IMMUNOGENICITYNA0043293185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1123 11231491J,IMMUNOGENICITYNA0042367242C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1123 11231491J,IMMUNOGENICITYNA0043300549C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BXC4591001ISC4591001 1123 11231492J,IMMUNOGENICITYNA0043273583C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231492J,IMMUNOGENICITYNA0043528884C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B3C4591001ISC4591001 1123 11231492J,IMMUNOGENICITYNA0044636311C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231492J,IMMUNOGENICITYNA0043300969C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BWC4591001ISC4591001 1123 11231493J,IMMUNOGENICITYNA0043273614C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231493J,IMMUNOGENICITYNA0041593676C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B4C4591001ISC4591001 1123 11231493J,IMMUNOGENICITYNA0044638878C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1123 11231493J,IMMUNOGENICITYNA0042414171C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1123 11231494J,IMMUNOGENICITYNA0043273747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231494J,IMMUNOGENICITYNA0043529000C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B3C4591001ISC4591001 1123 11231494J,IMMUNOGENICITYNA0044639319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231494J,IMMUNOGENICITYNA0042362488C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BTC4591001ISC4591001 1123 11231495J,IMMUNOGENICITYNA0043293444C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231495J,IMMUNOGENICITYNA0042366366C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1123 11231495J,IMMUNOGENICITYNA0044638889C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1123 11231495J,IMMUNOGENICITYNA0042362483C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1123 11231496J,IMMUNOGENICITYNA0043282418C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231496J,IMMUNOGENICITYNA0043528899C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1123 11231496J,IMMUNOGENICITYNA0041732580C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1123 11231496J,IMMUNOGENICITYNA0042414199C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1123 11231497J,IMMUNOGENICITYNA0043293460C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1123 11231497J,IMMUNOGENICITYNA0042414423C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B:C4591001ISC4591001 1123 11231497J,IMMUNOGENICITYNA0044633971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-28BC4591001ISC4591001 1123 11231497J,IMMUNOGENICITYNA0042362491C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BUC4591001ISC4591001 1123 11231499J,IMMUNOGENICITYNA0043282427C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231499J,IMMUNOGENICITYNA0042352950C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1123 11231499J,IMMUNOGENICITYNA0044641412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-14BC4591001ISC4591001 1123 11231499J,IMMUNOGENICITYNA0045270819C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BdC4591001ISC4591001 1123 11231500J,IMMUNOGENICITYNA0043282408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231500J,IMMUNOGENICITYNA0043529121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1123 11231500J,IMMUNOGENICITYNA0045270852C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BdC4591001ISC4591001 1123 11231501J,IMMUNOGENICITYNA0043282415C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231501J,IMMUNOGENICITYNA0043300563C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-22BUC4591001ISC4591001 1123 11231501J,IMMUNOGENICITYNA0044633750C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1123 11231502J,IMMUNOGENICITYNA0043293449C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231502J,IMMUNOGENICITYNA0042414434C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B5C4591001ISC4591001 1123 11231502J,IMMUNOGENICITYNA0044606783C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1123 11231502J,IMMUNOGENICITYNA0043300550C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BRC4591001ISC4591001 1123 11231503J,IMMUNOGENICITYNA0043282448C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231503J,IMMUNOGENICITYNA0042352960C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B5C4591001ISC4591001 1123 11231503J,IMMUNOGENICITYNA0044633767C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1123 11231503J,IMMUNOGENICITYNA0042386586C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29B\C4591001ISC4591001 1123 11231504J,IMMUNOGENICITYNA0043293188C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231504J,IMMUNOGENICITYNA0042352973C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1123 11231504J,IMMUNOGENICITYNA0044638906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231504J,IMMUNOGENICITYNA0045270390C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BWC4591001ISC4591001 1123 11231505J,IMMUNOGENICITYNA0043273615C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231505J,IMMUNOGENICITYNA0042352943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B4C4591001ISC4591001 1123 11231505J,IMMUNOGENICITYNA0044633941C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-01BC4591001ISC4591001 1123 11231505J,IMMUNOGENICITYNA0042386605C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31B^C4591001ISC4591001 1123 11231506J,IMMUNOGENICITYNA0043273787C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231506J,IMMUNOGENICITYNA0042369364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B2C4591001ISC4591001 1123 11231506J,IMMUNOGENICITYNA0044636700C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231506J,IMMUNOGENICITYNA0042386596C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BXC4591001ISC4591001 1123 11231507J,IMMUNOGENICITYNA0043273769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231507J,IMMUNOGENICITYNA0042352961C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B3C4591001ISC4591001 1123 11231507J,IMMUNOGENICITYNA0042414162C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BVC4591001ISC4591001 1123 11231508J,IMMUNOGENICITYNA0043293178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1123 11231508J,IMMUNOGENICITYNA0042414443C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B6C4591001ISC4591001 1123 11231508J,IMMUNOGENICITYNA0044606790C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1123 11231509J,IMMUNOGENICITYNA0042384647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1123 11231509J,IMMUNOGENICITYNA0044633946C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-26BC4591001ISC4591001 1123 11231509J,IMMUNOGENICITYNA0042346041C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-04BBC4591001ISC4591001 1123 11231510J,IMMUNOGENICITYNA0042384631C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1123 11231510J,IMMUNOGENICITYNA0042369377C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1123 11231510J,IMMUNOGENICITYNA0041732568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1123 11231510J,IMMUNOGENICITYNA0043300685C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30B\C4591001ISC4591001 1123 11231511J,IMMUNOGENICITYNA0043293484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231511J,IMMUNOGENICITYNA0042369331C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1123 11231511J,IMMUNOGENICITYNA0042414204C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BNC4591001ISC4591001 1123 11231512J,IMMUNOGENICITYNA0043293133C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231512J,IMMUNOGENICITYNA0042369302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B7C4591001ISC4591001 1123 11231512J,IMMUNOGENICITYNA0042362501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BNC4591001ISC4591001 1123 11231513J,IMMUNOGENICITYNA0043282690C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231513J,IMMUNOGENICITYNA0042369301C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B8C4591001ISC4591001 1123 11231513J,IMMUNOGENICITYNA0045270376C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30B[C4591001ISC4591001 1123 11231514J,IMMUNOGENICITYNA0043291209C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231514J,IMMUNOGENICITYNA0042414435C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1123 11231514J,IMMUNOGENICITYNA0041732569C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1123 11231514J,IMMUNOGENICITYNA0045270386C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BUC4591001ISC4591001 1123 11231515J,IMMUNOGENICITYNA0043293264C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231515J,IMMUNOGENICITYNA0042352966C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B0C4591001ISC4591001 1123 11231515J,IMMUNOGENICITYNA0045270374C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BUC4591001ISC4591001 1123 11231516J,IMMUNOGENICITYNA0043293285C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231516J,IMMUNOGENICITYNA0042352965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1123 11231516J,IMMUNOGENICITYNA0041733374C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-15BC4591001ISC4591001 1123 11231516J,IMMUNOGENICITYNA0043300580C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BTC4591001ISC4591001 1123 11231517J,IMMUNOGENICITYNA0043282736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231517J,IMMUNOGENICITYNA0042369384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B4C4591001ISC4591001 1123 11231517J,IMMUNOGENICITYNA0044638885C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1123 11231518J,IMMUNOGENICITYNA0042384615C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231518J,IMMUNOGENICITYNA0042414407C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B3C4591001ISC4591001 1123 11231518J,IMMUNOGENICITYNA0044606765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1123 11231518J,IMMUNOGENICITYNA0042362513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BTC4591001ISC4591001 1123 11231519J,IMMUNOGENICITYNA0043282712C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231519J,IMMUNOGENICITYNA0042352948C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B2C4591001ISC4591001 1123 11231519J,IMMUNOGENICITYNA0044606779C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1123 11231519J,IMMUNOGENICITYNA0045270393C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BUC4591001ISC4591001 1123 11231520J,IMMUNOGENICITYNA0043282715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231520J,IMMUNOGENICITYNA0042369361C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B0C4591001ISC4591001 1123 11231520J,IMMUNOGENICITYNA0044636708C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1123 11231521J,IMMUNOGENICITYNA0043273607C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1123 11231521J,IMMUNOGENICITYNA0040761777C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1123 11231522J,IMMUNOGENICITYNA0038318411C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1123 11231522J,IMMUNOGENICITYNA0043529302C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1123 11231522J,IMMUNOGENICITYNA0044641394C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231522J,IMMUNOGENICITYNA0043300617C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BAC4591001ISC4591001 1123 11231523J,IMMUNOGENICITYNA0038318410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1123 11231523J,IMMUNOGENICITYNA0043529296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1123 11231523J,IMMUNOGENICITYNA0044638734C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1123 11231523J,IMMUNOGENICITYNA0043300622C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-10BAC4591001ISC4591001 1123 11231524J,IMMUNOGENICITYNA0038318425C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1123 11231524J,IMMUNOGENICITYNA0042345369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B4C4591001ISC4591001 1123 11231524J,IMMUNOGENICITYNA0042452525C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1123 11231524J,IMMUNOGENICITYNA0042386591C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BPC4591001ISC4591001 1123 11231525J,IMMUNOGENICITYNA0042384618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1123 11231525J,IMMUNOGENICITYNA0042346552C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-04B9C4591001ISC4591001 1123 11231525J,IMMUNOGENICITYNA0042452508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-28BC4591001ISC4591001 1123 11231525J,IMMUNOGENICITYNA0043300686C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-31BTC4591001ISC4591001 1123 11231526J,IMMUNOGENICITYNA0043293198C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1123 11231526J,IMMUNOGENICITYNA0042346383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B7C4591001ISC4591001 1123 11231526J,IMMUNOGENICITYNA0041732595C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1123 11231526J,IMMUNOGENICITYNA0042410968C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06BYC4591001ISC4591001 1124 11241236J,IMMUNOGENICITYNA0040908909C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241236J,IMMUNOGENICITYNA0042360031C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1124 11241238J,IMMUNOGENICITYNA0040908913C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241238J,IMMUNOGENICITYNA0011571296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1124 11241238J,IMMUNOGENICITYNA0041737269C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1124 11241239J,IMMUNOGENICITYNA0040908932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241239J,IMMUNOGENICITYNA0011571310C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1124 11241239J,IMMUNOGENICITYNA0041737298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1124 11241240J,IMMUNOGENICITYNA0040908940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241240J,IMMUNOGENICITYNA0011571298C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1124 11241240J,IMMUNOGENICITYNA0042397300C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241241J,IMMUNOGENICITYNA0040908200C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241241J,IMMUNOGENICITYNA0011571282C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1124 11241241J,IMMUNOGENICITYNA0042397291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241242J,IMMUNOGENICITYNA0040908926C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1124 11241242J,IMMUNOGENICITYNA0011571315C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B5C4591001ISC4591001 1124 11241243J,IMMUNOGENICITYNA0040908912C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1124 11241243J,IMMUNOGENICITYNA0011571240C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B9C4591001ISC4591001 1124 11241243J,IMMUNOGENICITYNA0041737291C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1124 11241244J,IMMUNOGENICITYNA0040908943C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1124 11241244J,IMMUNOGENICITYNA0011571192C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B8C4591001ISC4591001 1124 11241244J,IMMUNOGENICITYNA0041737297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1124 11241245J,IMMUNOGENICITYNA0040908933C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1124 11241245J,IMMUNOGENICITYNA0042359553C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B;C4591001ISC4591001 1124 11241245J,IMMUNOGENICITYNA0041737282C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1124 11241246J,IMMUNOGENICITYNA0040908930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1124 11241246J,IMMUNOGENICITYNA0041737288C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1124 11241247J,IMMUNOGENICITYNA0040885408C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1124 11241247J,IMMUNOGENICITYNA0011571266C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1124 11241247J,IMMUNOGENICITYNA0041737296C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-29BC4591001ISC4591001 1124 11241248J,IMMUNOGENICITYNA0040885413C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1124 11241248J,IMMUNOGENICITYNA0011571290C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1124 11241248J,IMMUNOGENICITYNA0042397290C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241249J,IMMUNOGENICITYNA0040885398C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1124 11241249J,IMMUNOGENICITYNA0011571194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B7C4591001ISC4591001 1124 11241249J,IMMUNOGENICITYNA0042402839C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1124 11241250J,IMMUNOGENICITYNA0040885415C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1124 11241250J,IMMUNOGENICITYNA0011571317C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1124 11241250J,IMMUNOGENICITYNA0042397314C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241251J,IMMUNOGENICITYNA0040885423C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1124 11241251J,IMMUNOGENICITYNA0011571195C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1124 11241251J,IMMUNOGENICITYNA0040853906C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1124 11241252J,IMMUNOGENICITYNA0040885410C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1124 11241252J,IMMUNOGENICITYNA0011571208C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1124 11241252J,IMMUNOGENICITYNA0011570605C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1124 11241253J,IMMUNOGENICITYNA0040853921C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1124 11241253J,IMMUNOGENICITYNA0042359546C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1124 11241253J,IMMUNOGENICITYNA0042402863C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1124 11241254J,IMMUNOGENICITYNA0040853918C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1124 11241254J,IMMUNOGENICITYNA0011571247C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1124 11241254J,IMMUNOGENICITYNA0011571399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-30BC4591001ISC4591001 1124 11241255J,IMMUNOGENICITYNA0040853949C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1124 11241255J,IMMUNOGENICITYNA0011571245C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1124 11241255J,IMMUNOGENICITYNA0042397279C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1124 11241256J,IMMUNOGENICITYNA0040853932C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1124 11241256J,IMMUNOGENICITYNA0011571231C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B4C4591001ISC4591001 1124 11241257J,IMMUNOGENICITYNA0030520283C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1124 11241257J,IMMUNOGENICITYNA0011571181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-15B8C4591001ISC4591001 1124 11241257J,IMMUNOGENICITYNA0042397272C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241258J,IMMUNOGENICITYNA0030520299C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1124 11241258J,IMMUNOGENICITYNA0011571248C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B3C4591001ISC4591001 1124 11241258J,IMMUNOGENICITYNA0042397303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241259J,IMMUNOGENICITYNA0030520312C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1124 11241259J,IMMUNOGENICITYNA0042359554C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-11B3C4591001ISC4591001 1124 11241259J,IMMUNOGENICITYNA0041737262C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-14BC4591001ISC4591001 1124 11241260J,IMMUNOGENICITYNA0030520303C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1124 11241260J,IMMUNOGENICITYNA0011571254C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1124 11241260J,IMMUNOGENICITYBS85X9 C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-09BC4591001ISC4591001 1124 11241261J,IMMUNOGENICITYNA0030520297C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1124 11241261J,IMMUNOGENICITYNA0011571237C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B2C4591001ISC4591001 1124 11241262J,IMMUNOGENICITYNA0030520290C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1124 11241262J,IMMUNOGENICITYNA0042360186C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B9C4591001ISC4591001 1124 11241263J,IMMUNOGENICITYNA0030520320C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1124 11241263J,IMMUNOGENICITYNA0042360194C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1124 11241263J,IMMUNOGENICITYNA0042397292C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1124 11241264J,IMMUNOGENICITYNA0030520286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1124 11241264J,IMMUNOGENICITYNA0042360209C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-18B4C4591001ISC4591001 1124 11241264J,IMMUNOGENICITYNA0011570602C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1124 11241265J,IMMUNOGENICITYNA0040885218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1124 11241265J,IMMUNOGENICITYNA0042360207C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1124 11241265J,IMMUNOGENICITYNA0041737606C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1124 11241266J,IMMUNOGENICITYNA0040885232C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1124 11241266J,IMMUNOGENICITYNA0042360181C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1124 11241266J,IMMUNOGENICITYNA0041737603C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1124 11241267J,IMMUNOGENICITYNA0040885213C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1124 11241267J,IMMUNOGENICITYNA0042360211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-17B3C4591001ISC4591001 1124 11241267J,IMMUNOGENICITYNA0042397310C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1124 11241268J,IMMUNOGENICITYBNZ56M C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1124 11241268J,IMMUNOGENICITYNA0042403020C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B;C4591001ISC4591001 1124 11241268J,IMMUNOGENICITYNA0011570565C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1124 11241269J,IMMUNOGENICITYBNZ56V C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1124 11241269J,IMMUNOGENICITYNA0044751535C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B4C4591001ISC4591001 1124 11241269J,IMMUNOGENICITYNA0042402860C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-20BC4591001ISC4591001 1124 11241270J,IMMUNOGENICITYNA0042359381C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1124 11241270J,IMMUNOGENICITYNA0042360219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-23B2C4591001ISC4591001 1124 11241271J,IMMUNOGENICITYNA0042359401C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1124 11241271J,IMMUNOGENICITYNA0011571281C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-23B2C4591001ISC4591001 1124 11241271J,IMMUNOGENICITYNA0042402865C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1124 11241272J,IMMUNOGENICITYNA0042359357C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1124 11241272J,IMMUNOGENICITYNA0042403007C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B9C4591001ISC4591001 1124 11241272J,IMMUNOGENICITYNA0011570597C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1124 11241273J,IMMUNOGENICITYNA0042359397C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1124 11241273J,IMMUNOGENICITYNA0044751527C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1124 11241273J,IMMUNOGENICITYNA0042402243C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1124 11241274J,IMMUNOGENICITYNA0042359373C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1124 11241274J,IMMUNOGENICITYNA0044751532C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1124 11241274J,IMMUNOGENICITYNA0042397288C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1124 11241275J,IMMUNOGENICITYNA0042359369C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1124 11241275J,IMMUNOGENICITYNA0044751539C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B2C4591001ISC4591001 1124 11241275J,IMMUNOGENICITYNA0011571336C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-11BC4591001ISC4591001 1125 11251241J,IMMUNOGENICITYNA0016710509C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1125 11251241J,IMMUNOGENICITYBMPGR6 C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B4C4591001ISC4591001 1125 11251241J,IMMUNOGENICITYNA0042426038C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1125 11251242J,IMMUNOGENICITYNA0016710501C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-07AC4591001ISC4591001 1125 11251242J,IMMUNOGENICITYNA0040920440C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B9C4591001ISC4591001 1125 11251242J,IMMUNOGENICITYNA0042440053C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1125 11251244J,IMMUNOGENICITYNA0014220830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-08AC4591001ISC4591001 1125 11251244J,IMMUNOGENICITYBPTN6R C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B5C4591001ISC4591001 1125 11251244J,IMMUNOGENICITYNA0044619383C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-17BC4591001ISC4591001 1125 11251246J,IMMUNOGENICITYNA0040875659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-10AC4591001ISC4591001 1125 11251246J,IMMUNOGENICITYNA0030545979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B1C4591001ISC4591001 1125 11251246J,IMMUNOGENICITYNA0042440051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-23BC4591001ISC4591001 1125 11251248J,IMMUNOGENICITYNA0041737832C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1125 11251248J,IMMUNOGENICITYBMPGR7 C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-27B0C4591001ISC4591001 1125 11251248J,IMMUNOGENICITYNA0042350703C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1125 11251249J,IMMUNOGENICITYNA0041737789C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-11AC4591001ISC4591001 1125 11251249J,IMMUNOGENICITYNA0040921141C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-29B2C4591001ISC4591001 1125 11251249J,IMMUNOGENICITYNA0042404618C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1125 11251250J,IMMUNOGENICITYNA0041737800C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1125 11251250J,IMMUNOGENICITYNA0040919995C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1125 11251250J,IMMUNOGENICITYNA0042426062C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1125 11251251J,IMMUNOGENICITYNA0041737803C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1125 11251251J,IMMUNOGENICITYNA0040920032C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1125 11251251J,IMMUNOGENICITYNA0042426044C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1125 11251252J,IMMUNOGENICITYNA0037550791C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1125 11251252J,IMMUNOGENICITYNA0040921128C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B;C4591001ISC4591001 1125 11251252J,IMMUNOGENICITYNA0040760006C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1125 11251253J,IMMUNOGENICITYNA0037550765C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1125 11251253J,IMMUNOGENICITYNA0040920004C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1125 11251253J,IMMUNOGENICITYNA0042350699C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-25BC4591001ISC4591001 1125 11251254J,IMMUNOGENICITYNA0037547736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-28AC4591001ISC4591001 1125 11251254J,IMMUNOGENICITYNA0040920461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-19B6C4591001ISC4591001 1125 11251254J,IMMUNOGENICITYNA0044549286C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1125 11251255J,IMMUNOGENICITYNA0040790595C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1125 11251255J,IMMUNOGENICITYNA0040789968C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B2C4591001ISC4591001 1126 11261229J,IMMUNOGENICITYNA0040885785C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1126 11261229J,IMMUNOGENICITYNA0043282389C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-18B2C4591001ISC4591001 1126 11261229J,IMMUNOGENICITYNA0040875599C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-16BC4591001ISC4591001 1126 11261229J,IMMUNOGENICITYNA0039407799C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BsC4591001ISC4591001 1126 11261230J,IMMUNOGENICITYNA0031440367C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-11-30AC4591001ISC4591001 1126 11261230J,IMMUNOGENICITYNA0040804361C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B4C4591001ISC4591001 1126 11261230J,IMMUNOGENICITYNA0042515956C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-26CC4591001ISC4591001 1126 11261230J,IMMUNOGENICITYNA0040681156C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BjC4591001ISC4591001 1126 11261233J,IMMUNOGENICITYNA0040932048C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1126 11261233J,IMMUNOGENICITYNA0040804323C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B4C4591001ISC4591001 1126 11261233J,IMMUNOGENICITYNA0040875583C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261233J,IMMUNOGENICITYNA0044641456C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BkC4591001ISC4591001 1126 11261235J,IMMUNOGENICITYNA0042537027C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-01AC4591001ISC4591001 1126 11261235J,IMMUNOGENICITYNA0040804349C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B3C4591001ISC4591001 1126 11261235J,IMMUNOGENICITYNA0040875559C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1126 11261235J,IMMUNOGENICITYNA0042406235C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BfC4591001ISC4591001 1126 11261239J,IMMUNOGENICITYNA0042537051C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261239J,IMMUNOGENICITYNA0040884874C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1126 11261239J,IMMUNOGENICITYNA0040875551C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261239J,IMMUNOGENICITYNA0042406229C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BeC4591001ISC4591001 1126 11261240J,IMMUNOGENICITYNA0042537046C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261240J,IMMUNOGENICITYNA0043282359C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-19B1C4591001ISC4591001 1126 11261240J,IMMUNOGENICITYNA0040875775C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1126 11261240J,IMMUNOGENICITYNA0042406265C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BeC4591001ISC4591001 1126 11261241J,IMMUNOGENICITYNA0042537049C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261241J,IMMUNOGENICITYNA0040804345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1126 11261241J,IMMUNOGENICITYNA0040875625C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1126 11261243J,IMMUNOGENICITYNA0042537058C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261243J,IMMUNOGENICITYNA0040884860C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B4C4591001ISC4591001 1126 11261243J,IMMUNOGENICITYNA0040875616C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-14BC4591001ISC4591001 1126 11261243J,IMMUNOGENICITYNA0042516964C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-13BC4591001ISC4591001 1126 11261246J,IMMUNOGENICITYNA0042537055C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261246J,IMMUNOGENICITYNA0043282399C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B2C4591001ISC4591001 1126 11261246J,IMMUNOGENICITYNA0040932661C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1126 11261246J,IMMUNOGENICITYNA0043282052C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BsC4591001ISC4591001 1126 11261249J,IMMUNOGENICITYNA0040885050C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261249J,IMMUNOGENICITYNA0040884879C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B4C4591001ISC4591001 1126 11261249J,IMMUNOGENICITYNA0040875787C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-18BC4591001ISC4591001 1126 11261249J,IMMUNOGENICITYNA0042362267C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-06B~C4591001ISC4591001 1126 11261250J,IMMUNOGENICITYNA0042537066C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-02AC4591001ISC4591001 1126 11261250J,IMMUNOGENICITYNA0040804367C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-22B4C4591001ISC4591001 1126 11261250J,IMMUNOGENICITYNA0042516983C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261250J,IMMUNOGENICITYNA0042362257C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-30BwC4591001ISC4591001 1126 11261253J,IMMUNOGENICITYNA0040885783C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1126 11261253J,IMMUNOGENICITYNA0040804357C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B1C4591001ISC4591001 1126 11261253J,IMMUNOGENICITYNA0040875588C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261254J,IMMUNOGENICITYNA0042537034C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1126 11261254J,IMMUNOGENICITYNA0043282310C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24BTC4591001ISC4591001 1126 11261254J,IMMUNOGENICITYNA0040932687C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-22BC4591001ISC4591001 1126 11261254J,IMMUNOGENICITYNA0042404104C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BgC4591001ISC4591001 1126 11261255J,IMMUNOGENICITYNA0040680979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1126 11261255J,IMMUNOGENICITYNA0043254621C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-26B7C4591001ISC4591001 1126 11261255J,IMMUNOGENICITYNA0040932684C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-22BC4591001ISC4591001 1126 11261255J,IMMUNOGENICITYNA0042404126C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BgC4591001ISC4591001 1126 11261258J,IMMUNOGENICITYNA0042536853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-03AC4591001ISC4591001 1126 11261258J,IMMUNOGENICITYNA0043282378C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-21B2C4591001ISC4591001 1126 11261258J,IMMUNOGENICITYNA0040932672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-29BC4591001ISC4591001 1126 11261258J,IMMUNOGENICITYNA0039407792C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BoC4591001ISC4591001 1126 11261262J,IMMUNOGENICITYNA0042536848C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1126 11261262J,IMMUNOGENICITYNA0040804355C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B0C4591001ISC4591001 1126 11261262J,IMMUNOGENICITYNA0043282963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-02-10BEC4591001ISC4591001 1126 11261263J,IMMUNOGENICITYNA0042536875C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1126 11261263J,IMMUNOGENICITYNA0040804327C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-20B0C4591001ISC4591001 1126 11261263J,IMMUNOGENICITYNA0040932693C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-24BC4591001ISC4591001 1126 11261263J,IMMUNOGENICITYNA0042406227C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BbC4591001ISC4591001 1126 11261264J,IMMUNOGENICITYNA0042536835C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-04AC4591001ISC4591001 1126 11261264J,IMMUNOGENICITYNA0043254646C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-01-25B5C4591001ISC4591001 1126 11261264J,IMMUNOGENICITYNA0040932668C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-25BC4591001ISC4591001 1126 11261265J,IMMUNOGENICITYNA0042536859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261265J,IMMUNOGENICITYNA0043254347C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1126 11261265J,IMMUNOGENICITYNA0040875767C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261266J,IMMUNOGENICITYNA0042536870C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261266J,IMMUNOGENICITYNA0043254364C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-01B2C4591001ISC4591001 1126 11261266J,IMMUNOGENICITYNA0040875788C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261267J,IMMUNOGENICITYNA0042536872C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261267J,IMMUNOGENICITYNA0043254628C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1126 11261267J,IMMUNOGENICITYNA0040875776C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1126 11261267J,IMMUNOGENICITYNA0043254412C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B`C4591001ISC4591001 1126 11261268J,IMMUNOGENICITYNA0042536850C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261268J,IMMUNOGENICITYNA0040804240C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B6C4591001ISC4591001 1126 11261268J,IMMUNOGENICITYNA0044640706C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1126 11261268J,IMMUNOGENICITYNA0044641423C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B_C4591001ISC4591001 1126 11261269J,IMMUNOGENICITYNA0042516739C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261269J,IMMUNOGENICITYNA0043238657C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1126 11261269J,IMMUNOGENICITYNA0041737960C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-12BC4591001ISC4591001 1126 11261269J,IMMUNOGENICITYNA0042406223C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BYC4591001ISC4591001 1126 11261270J,IMMUNOGENICITYNA0042536878C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261270J,IMMUNOGENICITYNA0043238658C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1126 11261270J,IMMUNOGENICITYNA0040875768C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1126 11261270J,IMMUNOGENICITYNA0044641445C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17B^C4591001ISC4591001 1126 11261271J,IMMUNOGENICITYNA0042516758C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261271J,IMMUNOGENICITYNA0043238659C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B4C4591001ISC4591001 1126 11261271J,IMMUNOGENICITYNA0041737930C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1126 11261271J,IMMUNOGENICITYNA0044640707C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BeC4591001ISC4591001 1126 11261273J,IMMUNOGENICITYNA0042516757C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-14AC4591001ISC4591001 1126 11261273J,IMMUNOGENICITYNA0043282945C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B:C4591001ISC4591001 1126 11261273J,IMMUNOGENICITYNA0041737971C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1126 11261274J,IMMUNOGENICITYNA0042516736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1126 11261274J,IMMUNOGENICITYNA0043254341C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B3C4591001ISC4591001 1126 11261274J,IMMUNOGENICITYNA0040875766C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1126 11261274J,IMMUNOGENICITYNA0039407825C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BdC4591001ISC4591001 1126 11261275J,IMMUNOGENICITYNA0042537032C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1126 11261275J,IMMUNOGENICITYNA0043282974C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-02-08B8C4591001ISC4591001 1126 11261276J,IMMUNOGENICITYNA0042536866C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1126 11261276J,IMMUNOGENICITYNA0043282949C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-02-08B8C4591001ISC4591001 1126 11261277J,IMMUNOGENICITYNA0042516752C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1126 11261277J,IMMUNOGENICITYNA0043238641C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1126 11261277J,IMMUNOGENICITYNA0041737958C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1126 11261277J,IMMUNOGENICITYNA0044641461C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B^C4591001ISC4591001 1126 11261278J,IMMUNOGENICITYNA0042516743C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-15AC4591001ISC4591001 1126 11261278J,IMMUNOGENICITYNA0043238677C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B2C4591001ISC4591001 1126 11261278J,IMMUNOGENICITYNA0041737963C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-13BC4591001ISC4591001 1126 11261278J,IMMUNOGENICITYNA0041728718C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18B^C4591001ISC4591001 1126 11261279J,IMMUNOGENICITYNA0042516750C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261279J,IMMUNOGENICITYNA0043238645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1126 11261279J,IMMUNOGENICITYNA0040875771C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1126 11261279J,IMMUNOGENICITYNA0042406210C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BVC4591001ISC4591001 1126 11261280J,IMMUNOGENICITYNA0040927733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261280J,IMMUNOGENICITYNA0043254345C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B3C4591001ISC4591001 1126 11261280J,IMMUNOGENICITYNA0040875778C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1126 11261280J,IMMUNOGENICITYNA0042406218C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BVC4591001ISC4591001 1126 11261281J,IMMUNOGENICITYNA0042516769C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261281J,IMMUNOGENICITYNA0043254401C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B;C4591001ISC4591001 1126 11261281J,IMMUNOGENICITYNA0041737975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1126 11261282J,IMMUNOGENICITYNA0040885896C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261282J,IMMUNOGENICITYNA0043254355C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1126 11261282J,IMMUNOGENICITYNA0040932702C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1126 11261282J,IMMUNOGENICITYNA0044640738C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BcC4591001ISC4591001 1126 11261283J,IMMUNOGENICITYNA0042516749C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261283J,IMMUNOGENICITYNA0043254377C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1126 11261283J,IMMUNOGENICITYNA0040875554C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261283J,IMMUNOGENICITYNA0042362277C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-01BkC4591001ISC4591001 1126 11261284J,IMMUNOGENICITYNA0042516754C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261284J,IMMUNOGENICITYNA0043254365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1126 11261284J,IMMUNOGENICITYNA0040875581C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261285J,IMMUNOGENICITYNA0042537044C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261285J,IMMUNOGENICITYNA0043238664C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B2C4591001ISC4591001 1126 11261285J,IMMUNOGENICITYNA0040932707C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-06-30BC4591001ISC4591001 1126 11261286J,IMMUNOGENICITYNA0042516764C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261286J,IMMUNOGENICITYNA0043282973C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1126 11261286J,IMMUNOGENICITYNA0040932704C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1126 11261287J,IMMUNOGENICITYNA0040681029C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261287J,IMMUNOGENICITYNA0043254400C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B9C4591001ISC4591001 1126 11261287J,IMMUNOGENICITYNA0040875744C19NIGN-binding antibody SEROLOGYPOSNAPOSSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-20BC4591001ISC4591001 1126 11261288J,IMMUNOGENICITYNA0038901312C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-16AC4591001ISC4591001 1126 11261289J,IMMUNOGENICITYNA0040804510C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1126 11261289J,IMMUNOGENICITYNA0043238647C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-03B1C4591001ISC4591001 1126 11261289J,IMMUNOGENICITYNA0040875568C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261289J,IMMUNOGENICITYNA0043282035C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02BkC4591001ISC4591001 1126 11261290J,IMMUNOGENICITYNA0040804508C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1126 11261290J,IMMUNOGENICITYNA0043238672C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-02B0C4591001ISC4591001 1126 11261290J,IMMUNOGENICITYNA0040875595C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1126 11261290J,IMMUNOGENICITYNA0042406219C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-11BUC4591001ISC4591001 1126 11261291J,IMMUNOGENICITYNA0040804488C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1126 11261291J,IMMUNOGENICITYNA0043254371C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1126 11261291J,IMMUNOGENICITYNA0041737967C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-15BC4591001ISC4591001 1126 11261292J,IMMUNOGENICITYNA0040804493C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-17AC4591001ISC4591001 1126 11261292J,IMMUNOGENICITYNA0043254640C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-04B2C4591001ISC4591001 1126 11261292J,IMMUNOGENICITYNA0040875563C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261292J,IMMUNOGENICITYNA0043282042C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-29BgC4591001ISC4591001 1126 11261293J,IMMUNOGENICITYNA0040804474C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261293J,IMMUNOGENICITYNA0043281952C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1126 11261293J,IMMUNOGENICITYNA0041736075C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-16BC4591001ISC4591001 1126 11261293J,IMMUNOGENICITYNA0044640714C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19B\C4591001ISC4591001 1126 11261294J,IMMUNOGENICITYNA0040804492C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261294J,IMMUNOGENICITYNA0043238646C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1126 11261294J,IMMUNOGENICITYNA0040932696C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-06BC4591001ISC4591001 1126 11261294J,IMMUNOGENICITYNA0041737936C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-07-16BC4591001ISC4591001 1126 11261294J,IMMUNOGENICITYNA0044640725C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23B`C4591001ISC4591001 1126 11261295J,IMMUNOGENICITYNA0040804513C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261295J,IMMUNOGENICITYNA0040804365C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1126 11261295J,IMMUNOGENICITYNA0043282348C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-07BC4591001ISC4591001 1126 11261295J,IMMUNOGENICITYNA0044640711C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BaC4591001ISC4591001 1126 11261296J,IMMUNOGENICITYNA0040804484C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261296J,IMMUNOGENICITYNA0043238642C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1126 11261296J,IMMUNOGENICITYNA0042362264C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-04-07BoC4591001ISC4591001 1126 11261296J,IMMUNOGENICITYNA0043282880C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BUC4591001ISC4591001 1126 11261297J,IMMUNOGENICITYNA0040804473C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261297J,IMMUNOGENICITYNA0043282347C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-05B2C4591001ISC4591001 1126 11261297J,IMMUNOGENICITYNA0040875752C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261297J,IMMUNOGENICITYNA0042406225C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BUC4591001ISC4591001 1126 11261298J,IMMUNOGENICITYNA0041728736C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-18AC4591001ISC4591001 1126 11261298J,IMMUNOGENICITYNA0043254404C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-10B7C4591001ISC4591001 1126 11261298J,IMMUNOGENICITYNA0040932691C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-01BC4591001ISC4591001 1126 11261298J,IMMUNOGENICITYNA0042406211C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-12BUC4591001ISC4591001 1126 11261299J,IMMUNOGENICITYNA0040804507C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-21AC4591001ISC4591001 1126 11261299J,IMMUNOGENICITYNA0043282975C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-09B3C4591001ISC4591001 1126 11261299J,IMMUNOGENICITYNA0041737937C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-19BC4591001ISC4591001 1126 11261299J,IMMUNOGENICITYNA0044640703C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B\C4591001ISC4591001 1126 11261300J,IMMUNOGENICITYNA0041728714C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1126 11261300J,IMMUNOGENICITYNA0043282962C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-08B1C4591001ISC4591001 1126 11261300J,IMMUNOGENICITYNA0040875573C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261300J,IMMUNOGENICITYNA0044640731C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22B[C4591001ISC4591001 1126 11261301J,IMMUNOGENICITYNA0040804490C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-22AC4591001ISC4591001 1126 11261301J,IMMUNOGENICITYNA0043254406C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-12B5C4591001ISC4591001 1126 11261301J,IMMUNOGENICITYNA0040932682C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-08BC4591001ISC4591001 1126 11261301J,IMMUNOGENICITYNA0040932061C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-16BUC4591001ISC4591001 1126 11261302J,IMMUNOGENICITYNA0043282206C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-23AC4591001ISC4591001 1126 11261302J,IMMUNOGENICITYNA0040875747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-21BC4591001ISC4591001 1126 11261302J,IMMUNOGENICITYNA0043254389C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-15BSC4591001ISC4591001 1126 11261303J,IMMUNOGENICITYNA0040804498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1126 11261303J,IMMUNOGENICITYNA0043254420C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1126 11261303J,IMMUNOGENICITYNA0043282055C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-02B_C4591001ISC4591001 1126 11261304J,IMMUNOGENICITYNA0043282185C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-29AC4591001ISC4591001 1126 11261304J,IMMUNOGENICITYNA0043254384C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-16B2C4591001ISC4591001 1126 11261305J,IMMUNOGENICITYNA0040804233C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1126 11261305J,IMMUNOGENICITYNA0043282854C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L OPEN LABEL TREATMENT2021-02-24B9C4591001ISC4591001 1126 11261306J,IMMUNOGENICITYNA0040804239C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2020-12-30AC4591001ISC4591001 1126 11261306J,IMMUNOGENICITYNA0043282853C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B9C4591001ISC4591001 1126 11261306J,IMMUNOGENICITYNA0040875571C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1126 11261306J,IMMUNOGENICITYNA0044641462C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-17BNC4591001ISC4591001 1126 11261307J,IMMUNOGENICITYNA0043282178C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1126 11261307J,IMMUNOGENICITYNA0043282862C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1126 11261307J,IMMUNOGENICITYNA0038901830C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1126 11261307J,IMMUNOGENICITYNA0043282048C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BQC4591001ISC4591001 1126 11261308J,IMMUNOGENICITYNA0040804269C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1126 11261308J,IMMUNOGENICITYNA0043282842C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1126 11261308J,IMMUNOGENICITYNA0040875620C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-18BC4591001ISC4591001 1126 11261308J,IMMUNOGENICITYNA0043282024C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BQC4591001ISC4591001 1126 11261309J,IMMUNOGENICITYNA0040804256C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-04AC4591001ISC4591001 1126 11261309J,IMMUNOGENICITYNA0043282859C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B2C4591001ISC4591001 1126 11261309J,IMMUNOGENICITYNA0031440498C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-21BC4591001ISC4591001 1126 11261309J,IMMUNOGENICITYNA0043282026C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BQC4591001ISC4591001 1126 11261310J,IMMUNOGENICITYNA0043281959C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1126 11261310J,IMMUNOGENICITYNA0042404132C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B5C4591001ISC4591001 1126 11261310J,IMMUNOGENICITYNA0040681090C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-20BC4591001ISC4591001 1126 11261310J,IMMUNOGENICITYNA0042516970C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-04-14BdC4591001ISC4591001 1126 11261311J,IMMUNOGENICITYNA0043281928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1126 11261311J,IMMUNOGENICITYNA0043282852C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B3C4591001ISC4591001 1126 11261311J,IMMUNOGENICITYNA0044641452C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-06-02BC4591001ISC4591001 1126 11261311J,IMMUNOGENICITYNA0039407831C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-24BOC4591001ISC4591001 1126 11261312J,IMMUNOGENICITYNA0043281927C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-05AC4591001ISC4591001 1126 11261312J,IMMUNOGENICITYNA0043282873C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-22B1C4591001ISC4591001 1126 11261312J,IMMUNOGENICITYNA0039407788C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1126 11261312J,IMMUNOGENICITYNA0043282057C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-25BPC4591001ISC4591001 1126 11261313J,IMMUNOGENICITYNA0043281965C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1126 11261313J,IMMUNOGENICITYNA0042406270C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-03B9C4591001ISC4591001 1126 11261313J,IMMUNOGENICITYNA0043282798C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1126 11261314J,IMMUNOGENICITYNA0041728716C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1126 11261314J,IMMUNOGENICITYNA0040875569C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-19BC4591001ISC4591001 1126 11261315J,IMMUNOGENICITYNA0043281951C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-06AC4591001ISC4591001 1126 11261315J,IMMUNOGENICITYNA0042404108C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-26B4C4591001ISC4591001 1126 11261315J,IMMUNOGENICITYNA0040875319C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-23BC4591001ISC4591001 1126 11261315J,IMMUNOGENICITYNA0043282039C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-26BPC4591001ISC4591001 1126 11261316J,IMMUNOGENICITYNA0041728756C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261316J,IMMUNOGENICITYNA0043282876C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1126 11261316J,IMMUNOGENICITYNA0043282828C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L FOLLOW-UP 2021-07-23BC4591001ISC4591001 1126 11261317J,IMMUNOGENICITYNA0043281940C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261317J,IMMUNOGENICITYNA0043282844C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1126 11261317J,IMMUNOGENICITYNA0040875594C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-17BC4591001ISC4591001 1126 11261317J,IMMUNOGENICITYNA0044641418C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-18BGC4591001ISC4591001 1126 11261318J,IMMUNOGENICITYNA0043281925C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261318J,IMMUNOGENICITYNA0042404121C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1126 11261318J,IMMUNOGENICITYNA0040885645C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-08-05BC4591001ISC4591001 1126 11261318J,IMMUNOGENICITYNA0039407800C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-23BLC4591001ISC4591001 1126 11261319J,IMMUNOGENICITYNA0040804480C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261319J,IMMUNOGENICITYNA0043282843C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-24B1C4591001ISC4591001 1126 11261319J,IMMUNOGENICITYNA0039434238C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-08-04BC4591001ISC4591001 1126 11261319J,IMMUNOGENICITYNA0044640741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-19BHC4591001ISC4591001 1126 11261320J,IMMUNOGENICITYNA0041728746C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261320J,IMMUNOGENICITYNA0042404092C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-02-25B2C4591001ISC4591001 1126 11261320J,IMMUNOGENICITYNA0040875574C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18BC4591001ISC4591001 1126 11261321J,IMMUNOGENICITYNA0041728733C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261321J,IMMUNOGENICITYNA0042404130C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1126 11261321J,IMMUNOGENICITYNA0043282806C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-22BC4591001ISC4591001 1126 11261321J,IMMUNOGENICITYNA0044640715C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BKC4591001ISC4591001 1126 11261322J,IMMUNOGENICITYNA0040804511C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-07AC4591001ISC4591001 1126 11261322J,IMMUNOGENICITYNA0042404112C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B6C4591001ISC4591001 1126 11261322J,IMMUNOGENICITYNA0042516979C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-24BC4591001ISC4591001 1126 11261322J,IMMUNOGENICITYNA0044640742C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BKC4591001ISC4591001 1126 11261323J,IMMUNOGENICITYNA0041728741C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1126 11261323J,IMMUNOGENICITYNA0043282822C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1126 11261323J,IMMUNOGENICITYNA0044640709C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BJC4591001ISC4591001 1126 11261324J,IMMUNOGENICITYNA0041728747C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1126 11261324J,IMMUNOGENICITYNA0042404127C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-01B5C4591001ISC4591001 1126 11261324J,IMMUNOGENICITYNA0031440928C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D`V4_MONTH6_L REPEAT SCREENING 1 2021-07-26BC4591001ISC4591001 1126 11261324J,IMMUNOGENICITYNA0044640713C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G6XV201_SURVEIL_CONSENT FOLLOW-UP 2021-03-22BJC4591001ISC4591001 1126 11261325J,IMMUNOGENICITYNA0043282322C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody AssayY.D]V1_DAY1_VAX1_L SCREENING 2021-01-08AC4591001ISC4591001 1126 11261325J,IMMUNOGENICITYNA0042406253C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .D_V3_MONTH1_POSTVAX2_L FOLLOW-UP 2021-03-02B6C4591001ISC4591001 1126 11261325J,IMMUNOGENICITYNA0040875590C19NIGN-binding antibody SEROLOGYNEGNANEGSERUMN-binding Antibody Assay .G0V101_VAX3 OPEN LABEL TREATMENT2021-05-18B